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ABSTRACT 
Plant-based diets are primarily derived from plant sources, including fruits and 
vegetables. Such patterns are associated with health benefits by promoting general health and 
preventing many diseases and metabolic disorders. Fruits and vegetables are key sources of high-
quality nutrients such as dietary fibers and polyphenols. Since they are rich in dietary fibers and 
polyphenols, whole fruits and vegetables represent unique and somewhat understudied 
modulators of the gut microbiota and its associated functions. This study aims to (i) investigate 
the impact of varying dilutions of cherry juices concentrate on the composition of the murine gut 
microbiota, (ii) investigate the impact of cranberry juice consumption on the bacterial 
composition of gut and vaginal microbiota in postmenopausal women, and (iii) investigate the 
impact of the amounts and botanical diversity of fruits and vegetables on gut microbiota profiles 
in healthy adults. Fecal samples were collected from mice consuming increasing tart cherry juice 
concentrations in their drinking water. A randomized, crossover controlled dietary intervention 
was conducted with cranberry juice and a matched control, and postmenopausal female 
volunteers provided stool and vaginal swabs for microbiota analyses. Two pilot studies looking 
at the impact of low and adequate intake of fruits and vegetables (SMART-Diet), as well as low 
versus high botanical diversity (SMART-Valid), were conducted at Colorado State University; 
stool samples were collected for gut microbiota analyses and short-chain fatty acids 
measurements. Microbial analyses were performed using Illumina following a dual-indexing 16S 
rRNA gene amplicon. Each dietary intervention resulted in distinct microbiota modulations and 
effects. Cherry juices consumption significantly increased the relative abundance of 
Akkermansia and Barnesiella and decreased the relative abundance of Bacteroides. Consumption 
of cranberry juice modulated the gut microbiota composition by elevating the relative abundance 
of Bifidobacterium, Clostridium XIVa members, Eggerthella, and Prevotella. Cranberry juice 
consumption also resulted in a beneficial impact on vaginal microbiota by decreasing the relative 
abundance of Streptococcus compared to a placebo. Finally, the SMART-Diet study showed that 
fruit and vegetable consumption resulted in a reduction of the Firmicutes/Bacteroidetes ratio 
whereas the SMART-Valid study showed an increase in the Firmicutes/Bacteroidetes ratio after 
fruit and vegetable consumption, and a significant increase in production of beneficial short-
chain fatty acids. Our findings suggest that consumption of cherry juices, cranberry juice, and 
fruit and vegetable inclusive diets all have a beneficial impact on the composition of gut 
microbiota. This body of work is consistent with the emerging concept that whole foods should 
be considered rather than extracts when it comes to gut microbiota and microbiome studies. 
Human dietary studies with larger sample size are warranted by these suggested beneficial 
modulations. 
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Diet plays a crucial role not only on the host’s general health but also on modulating the 
gut microbiota ecosystem. This connecting role of gut microbiota has been illustrated by their 
impact on many aspects of human homeostasis including immune system modulation and 
metabolic and physiologic effects. The imbalance of the gut microbiota, often termed dysbiosis, 
has been associated with several diseases and metabolic disorders. With either beneficial or 
deleterious consequences, specific dietary patterns can impact the gut microbiota composition 
and its impact on health. A growing body of studies has shown the beneficial impact of plant-
based diet on general health by preventing diseases and disorders as well as improving the gut 
microbiota ecosystem. 
Plant-based diets typically consist of foods that are derived from plant sources, mainly 
fruits and vegetables. Fruits and vegetables are rich in bioactive compounds such as dietary 
fibers and polyphenols, as well as other essential nutrients, including vitamins and minerals. The 
impact of dietary fibers and polyphenols on the gut microbiota composition and diversity has 
been receiving attention in recent years. Gut microbes use dietary fibers as the primary source of 
energy and produce bioactive metabolites, such as short‐chain fatty acids which are the main 
fermentation end-products (acetate, propionate, and butyrate). Some metabolites have been 
shown to exert beneficial impact on various physiological processes. Additionally, gut 
microbiota plays a vital role in polyphenols bioavailability. Polyphenols with high molecular 
weights cannot be absorbed in the small intestine; however, gut microbiota in the large intestine 
converts unabsorbed polyphenols to smaller bioactive metabolites which make them available to 
the host. These bioactive metabolites might be responsible for potential health benefits rather 
than the original native polyphenols. 
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The vast majority of published papers in the human nutrition and gut microbiome field 
have focused on studying the influence of extracted food compounds on gut microbiota 
ecosystem instead of whole foods. Therefore, this present dissertation brings attention to the 
impact of whole foods — including cherry juices, cranberries juice, and the amount and 
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Abstract 
Fruits and vegetables are a fundamental source of dietary fibers, polyphenols, and 
essential nutrients, including vitamins and minerals. Nutritional recommendations emphasize 
fruit and vegetable consumption due to their health benefits on the host. Fruits and vegetables 
rich in dietary fibers and polyphenols can impact the gut microbiota composition and associated 
functions, whereas gut microbiota can metabolize components in fruits and vegetables into 
bioactive metabolites. Gut microbiota and a diet-rich in fruits and vegetables play a significant 
role in promoting the host’s general health and preventing multiple diseases and metabolic 
disorders. This review recapitulates the latest findings on the impact of whole fruit and vegetable 
consumption on gut microbiota composition as well as the role of gut microbiota and a diet-rich 
in fruits and vegetables in disease and disorder prevention. This body of literature, while still 
limited especially in terms of randomized human dietary intervention, strongly suggests overall 
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beneficial modulation of the gut microbiome by common and less common fruits, and possibly 
vegetables. 
Keywords: Fruits, Vegetables, Gut microbiota, Polyphenols, Dietary fibers. 
1.1 Introduction 
Since the emergence of human nutrition as a scientific discipline and the development of 
nutritional guidelines, what constitutes a healthful diet is still intensely debated. Recently, the 
debate has become even more complicated with emerging evidence of the complex modulation 
of nutrients because of overlooked metabolic processes and their influence on health and disease. 
The mutualistic relationship between diet and gut microbiota is an example of exponential 
scientific interest. Diet is the most effective factor for shaping gut microbiota composition and 
consequently metabolites production and absorption with potential impacts on the host’s general 
health. 
Gut microbiota refers to the ecological communities that live in the gastrointestinal tract. 
There are trillions of microbes with thousands of life bacterial species in the human gut. The gut 
microbiota profile is not constant among humans, and is strongly individualized. This variation 
occurs due to several factors including host genetics, diet, age, mode of birth, and antibiotics. 
Disruption of the gut microbiota composition can alter gut homeostasis and thereby cause a 
variety of diseases. Therefore, the maintenance of the gut microbiota equilibrium is important to 
maintain a healthy status. 
Diet is one of the most important factors that impact the shape, composition, and 
diversity of gut microbiota. This is to be expected, since microorganisms use undigested foods as 
fuel for their essential biological processes. Thus, changes in dietary patterns alter the bacterial 
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metabolism, which in turn influence the abundance of different types of bacteria in the gut. 
Specific dietary patterns strongly alter gut microbiota and can affect its impact on health, with 
either beneficial or deleterious consequences. 
Western diet is typically characterized by high total energy due to saturated fat (butter, 
red meat) and sugar with an associated reduced consumption of fruits and vegetables. The high 
intake of energy-dense and processed foods is a risk factor for many chronic diseases including 
obesity, diabetes, inflammatory bowel diseases (IBD), and cardiovascular diseases. Inflammation 
is one of the underlying mechanisms linked with Western diet. There is a growing recognition 
for the influence of gut microbiota to the complexity of these disorders. 
For decades, many studies have sought to substantiate the purported beneficial effects of 
fruits and vegetables-based diet. Epidemiological and dietary intervention studies have 
consistently indicated that plant-based diets provide a beneficial impact on human health and 
biomarkers. The present review discusses the importance of plant-based diets in shaping the gut 
microbiota and the potential health effects of these diet-microbiota interactions. 
1.2 Plant-based dietary patterns 
A plant-based diet is a diet that is mostly or completely derived from plant sources. It can 
be obtained by increasing the intake of plant based foods such as fruits, vegetables, beans, seeds, 
pulses, herbs, whole grains, and nuts and reducing or excluding processed foods and animal 
products, including red meat, poultry, fish, eggs, and dairy products (Ostfeld, 2017; Tuso, Ismail, 
Ha, & Bartolotto, 2013). Plant-based dietary patterns have exploded in popularity over the past 
several decades. In the United States, the percentage of adults who chose a plant-based diet was 
approximately 3.3% in 2016 ("How Many Adults in the U.S are Vegetarian and Vegan?," 2016). 
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More recently, the department of agricultural economics at Oklahoma State University 
developed a project to track consumer’s food preferences. This project was a series of monthly 
surveys called “Food Demand Survey (FooDS)” and was conducted between 2013 and 2018. 
The project data showed an increase in the number of self-identified vegetarians in the United 
States, around 4.1% between 2013 and 2018 ("Food demand Survey," 2018). Furthermore, the 
interest in the potential benefits of plant-based diets has increased in the last few decades. This 
not only underscores the increased interest in plant-based diets among consumers and food 
industries but also indicates the improved awareness and understanding of how plant-based diets 
impact human health. 
1.2.1 Health benefits of plant-based diets 
Plant-based dietary patterns are typically rich in dietary fiber and a variety of 
phytonutrients, antioxidants, vitamins, and minerals and lower in fat, particularly saturated fat 
(Hever & Cronise, 2017). Plant-based diets have become a topic of formal scientific inquiry. A 
substantial number of studies have been conducted to confirm the beneficial effect of plant-based 
nutrition on the host. Plant-based foods have been associated with a reduced risk of many 
diseases and metabolic disorders, including obesity, diabetes, cardiovascular diseases, and 
cancer. 
1.2.1.1 Lower risk of obesity 
Obesity is a serious pandemic worldwide. The World Health Organization (WHO) 
estimated that more than 1.9 billion people are obese or overweight in 2016 ("Obesity and 
overweight," 2020). According to the Centers for Disease Control and Prevention (CDC), the 
prevalence of obesity in the United States among adults was 42.4% in 2017-2018 (Hales, Carroll, 
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Fryar, & Ogden, 2020). Obesity is associated with severe health conditions and triggers obesity-
related diseases, including type 2 diabetes, cardiovascular diseases, and cancers ("Obesity and 
overweight," 2020; Wright, Wilson, Smith, Duncan, & McHugh, 2017). 
Poor diet plays a key role in the genesis of obesity. In contrast, plant-based diets show 
evidence to achieve and maintain healthy body weight (Melina, Craig, & Levin, 2016). A 
growing body of studies has examined the use of plant-based dietary patterns for weight loss and 
obesity prevention. Berkow and Barnard reviewed numerous published articles containing 
information on vegetarians and plant-based diets. While the systematic review indicated the 
impact of plant-derived foods in weight loss compared with other diets, there was also a clear 
pattern for subjects who follow plant-based diets to be at a lower risk of obesity. The 
observational studies showed a lower average body weight in vegetarian individuals compared to 
non-vegetarians, approximately 3% to 20%. In addition, vegetarians have a consistently lower 
obesity prevalence rate, 0% to 6%, compared to non-vegetarians, 5% to 45% (Berkow & 
Barnard, 2006).The Oxford component of the European Prospective Investigation into Cancer 
and Nutrition (EPIC) compared changes in weight and body mass index (BMI) over a five-year 
period in approximately 22,000 meat-eating, fish-eating, vegetarian, and vegan participants in 
the United Kingdom. The study results showed that the lowest weight gain was associated with 
individuals who followed a vegan diet and those who had changed to a diet containing less 
animal products. The result also showed a significant difference in BMI between the four diet 
groups, with the meat-eaters having the highest BMI and the vegans had the lowest BMI (Rosell, 
Appleby, Spencer, & Key, 2006). In 2016, a meta-analysis of randomized controlled trials was 
performed to compare the influence of vegetarian diets and non-vegetarian diets on weight loss 
among individuals. This review included twelve randomized controlled studies with 
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approximately 1,150 subjects. The results showed a significant weight reduction among 
individuals assigned to vegetarian diets compared to individuals assigned to non-vegetarian diets 
(Huang, Huang, Hu, & Chavarro, 2016). A randomized controlled trial study was performed to 
investigate the impact of a whole food plant-based diet on either obese or overweight individuals 
with a diagnosis of  either type 2 diabetes, ischaemic heart disease, or the cardiovascular risk 
factors of hypertension or hypercholesterolaemia. At 6 and 12 months, the whole food plant-
based diet reduced the BMI to 4.4 and 4.2 kg m
−2, 
respectively, compared with the subjects’ 
typical diet. Furthermore, the total cholesterol tended to decrease after the implementation of 
whole food plant-based diet in both intervention periods (Wright et al., 2017). Data from the 
Adventist Health Study-2 showed that obesity and abdominal adiposity were significantly lower 
among non-Hispanic white adults who followed a vegetarian diet (Matsumoto et al., 2019). 
1.2.1.2 Lower risk of diabetes 
Diabetes is one of the most significant global health crises of this century ("Diabetes," 
2020). Globally, the number of people diagnosed with diabetes in 2017 was approximately 425 
million (Cho et al., 2018). In the United States, around 13% of all US adults over 18 years of age 
had been diagnosed diabetes in 2018 (Centers for Disease Control and, 2020). Lifestyle changes, 
mainly dietary changes, can play a crucial role in preventing, treating, or promoting type 2 
diabetes (McMacken & Shah, 2017). Unlike calorie-dense foods, such as diets high in saturated 
fat and sugar, plant-based diets may effectively prevent or treat type 2 diabetes (McMacken & 
Shah, 2017; Papier et al., 2019). 
The association between dietary patterns and the incidence of diabetes was investigated 
using data from the Adventist Health Study-2. The results showed that vegans, lacto ovo-
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vegetarians, and semi-vegetarians were less likely to develop diabetes (Tonstad et al., 2013). A 
meta-analysis study showed that fruit and vegetable consumption, especially green leafy 
vegetables, is associated with a significant reduction of type 2 diabetes incidence (M. Li, Fan, 
Zhang, Hou, & Tang, 2014). Data from the Nurses' Health Study, Nurses' Health Study 2, and 
the Health Professionals Follow-up Study suggested that plant-based diets, mainly diets with 
high-quality plant foods, are associated with a lower risk of developing type 2 diabetes (Satija et 
al., 2016). A study was conducted to investigate the correlation between a vegetarian diet and the 
risk of diabetes in a Taiwanese population which stated that a vegetarian diet might protect 
against diabetes (Chiu, Pan, Lin, & Lin, 2018). The EPIC‐Oxford cohort study was used to 
examine the association between vegetarian diets and the risk of type 2 diabetes in British adults. 
The study results suggested that vegetarian and low-meat diets may reduce the risk of developing 
diabetes development (Papier et al., 2019). 
1.2.1.3 Lower risk of cardiovascular diseases 
Cardiovascular diseases are the most prevalent cause of death worldwide, with more than 
17.6 million deaths per year. Approximately one-third of all global deaths are caused by 
cardiovascular diseases ("Cardiovascular diseases (CVDs)," 2017; "Heart Disease and Stroke 
Statistics-2019 At-a-Glance," 2019). Plant-based diets are associated with a reduction in the risk 
of cardiovascular diseases and cardiovascular disease mortality (Dinu, Abbate, Gensini, Casini, 
& Sofi, 2017; H. Kim et al., 2019). Plant-derived foods also showed evidence of reducing heart 
disease risk factors such as serum total cholesterol, blood glucose, abdominal obesity, and blood 
pressure (Rizzo, Sabaté, Jaceldo-Siegl, & Fraser, 2011; Wang et al., 2015; Yokoyama, Barnard, 
Levin, & Watanabe, 2014; Yokoyama, Nishimura, et al., 2014). 
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The EPIC‐Oxford cohort study results were used to investigate the impact of different 
dietary patterns on serum lipid concentration. The study showed that vegans had the lowest total 
cholesterol in serum compared to individuals assigned to other diet patterns (Bradbury et al., 
2014). A meta-analysis of 11 randomized controlled trials found that the total low-density 
lipoprotein and high-density lipoprotein cholesterols were low among vegetarians. These 
findings, perhaps, explain why plant-based diets reduce the risk of cardiovascular disease and 
cardiovascular disease mortality (Wang et al., 2015). A comprehensive meta-analysis reported 
that vegetarian diets significantly decrease the incidence and/or mortality from ischaemic heart 
disease by about 25% (Dinu et al., 2017). Data from the Adventist Health Study-2 (AHS-2) were 
analyzed to assess the association between dietary patterns and cardiovascular disease risk 
factors among non-Hispanic white adults. The investigation showed that vegetarian diets were 
associated with significantly lower levels of cardiovascular disease risk factors than non-
vegetarian diets (Matsumoto et al., 2019). 
1.2.1.4 Lower risk of cancers 
Cancer is a major public health issue worldwide and is the second leading cause of death 
globally. In 2018, the total number of deaths caused by cancer was around 9.6 million deaths, 
meaning that one of every six deaths was cancer-related ("Cancer," 2018). According to The 
American Cancer Society (ACS), the estimated number of new cancer cases and cancer deaths in 
the United States was 1.8 million and 606,520, respectively, in 2020 (Siegel, Miller, & Jemal, 




Data from the Adventist Health Study-2 was used to investigate the association between 
plant-based dietary patterns and the overall cancer incidence among 69,120 participants. The 
results showed that vegetarian diets seem to be linked with lower overall cancer risks, especially 
a lower risk of gastrointestinal cancer. The vegan diet appeared to confer greater protection 
against overall cancer incidence, especially female-specific cancer, than any other dietary 
patterns (Tantamango-Bartley, Jaceldo-Siegl, Fan, & Fraser, 2013). A study using the Adventist 
Health Study-2 data stated that vegetarian diets potentially associated with lowering the 
incidence of colorectal cancers (Orlich et al., 2015). Other papers reported that a vegan diet 
might correlate with a lower risk of prostate cancer (Tantamango-Bartley et al., 2016). A 
comprehensive meta-analysis study revealed that vegan and vegetarian diets significantly 
reduced the incidence and mortality of all cancers by around 15% and 8% respectively (Dinu et 
al., 2017). 
Based on prior studies, it is clear that dietary patterns that are higher in plant foods and 
lower in animal foods are promoting general health and lowering the incidence of several 
diseases and metabolic disorders. 
1.3 Gut Microbiota Modulation by Plant-Based Foods 
1.3.1 Gut Microbiota: General Aspects 
The human gastrointestinal tract harbors diverse and complex microbial community 
composed mainly of bacteria and termed gut microbiota. The actual numbers of microorganisms 
inhabiting the gastrointestinal tract have been the subject of controversies and exaggerated 
claims. The initial estimate of the number of bacteria inhabiting the gastrointestinal tract was 
10
14
, which is approximately ten times more than the cells of human body (Savage, 1977); 
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however, a more recent calculation estimated there to be 10
13
 bacteria inhabiting the 
gastrointestinal tract making the ratio of bacteria to human cells closer to 1:1 (Sender, Fuchs, & 
Milo, 2016). The bacterial density and diversity in the intestinal tract are quite different 
depending on the location. The colon has the highest bacterial biodiversity, whereas the upper 
part has the lowest number of microbes (Hillman, Lu, Yao, & Nakatsu, 2017). Gut microbiota is 
referred to as the “hidden metabolic organ” due to its substantial impact on general human 
health, including metabolism, nutrition, and physiological and immune function (Thursby & 
Juge, 2017). 
In earlier times, members of a microbial community were studied and identified using 
culture-dependent approaches. These methods are broadly used in the microbiology field; 
however, they have some limitations, especially in the study of microbial ecology. The culture-
dependent methods are limited in terms of bacterial identification as a wide range of bacterial 
strains cannot be grown and cultured in the laboratory. Additionally, these methods are limited to 
distinguish bacteria at lower taxonomic levels (Morgan & Huttenhower, 2012). 
Recently, culture-independent approaches, including high-throughput and low-cost 
sequencing methods, have been widely used to investigate numerous characteristics of microbial 
communities such as taxonomic diversity and functional metagenomics. 16S ribosomal RNA 
(rRNA) gene has been by far the most common phylogenetic marker used to study gut microbial 
diversity and taxonomy (Poretsky, Rodriguez-R, Luo, Tsementzi, & Konstantinidis, 2014). Many 
aspects make the 16S rRNA gene the ideal targeted gene for gut microbial phylogeny and 
taxonomy studies. These aspects include (1) the presence in all bacteria and archaea; (2) the 
evolution at relatively constant rates; (3) and the existence of conservative regions, used for 
designing amplification primers, and highly variable regions (V1-V9), used for distinguishing 
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and identifying  bacterial species (Janda & Abbott, 2007; Mizrahi-Man, Davenport, & Gilad, 
2013). 
Based on 16S rRNA-based studies, human intestinal bacteria involve around 1000 
bacterial species belonging to six different bacterial phyla. Bacteroidetes and Firmicutes are the 
most dominant phyla, whereas Actinobacteria, Proteobacteria, Verrucomicrobia, and 
Fusobacteria mostly present in lower proportions (Eckburg et al., 2005; Huttenhower et al., 
2012; Rajilić-Stojanović & de Vos, 2014; Rowland et al., 2018). In lower taxonomic  levels, 
bacteria like Bifidobacterium, Lactobacillus, Clostridiaceae, Lachnospiraceae, 
Ruminococcaceae, Prevotella, and Akkermansia are considered beneficial bacteria, while 
Escherichia coli, Salmonella, Staphylococcus, Bacillus, and Enterococcus are potential 
pathogens (Cui et al., 2019; Lavefve, Howard, & Carbonero, 2020).  
Gut microbiota collaborates with the host immune system to form a complex and 
reciprocally beneficial relationship (Bäckhed, Ley, Sonnenburg, Peterson, & Gordon, 2005; 
Lazar et al., 2018; Round & Mazmanian, 2009, 2010; H.-J. Wu & Wu, 2012). Gut microbiota 
reinforces the function of the immune system and prevents the colonization of pathogens 
(Okumura & Takeda, 2017; Ubeda, Djukovic, & Isaac, 2017). On the other hand, the immune 
system has co-evolved to live in a cooperative relationship with the healthy microbiota and fight 
against pathogens (Jandhyala et al., 2015; Round & Mazmanian, 2009, 2010). In addition to the 
immunological protective functions, gut microbiota helps to maintain the integrity of the 
mucosal barrier and regulate host digestion and metabolism (Okumura & Takeda, 2018). 
Changing in the gut microbial composition can lead to beneficial or harmful effects on 
human health (Thursby & Juge, 2017). The imbalance of the gut microbiota symbiotic 
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ecosystem, known as dysbiosis, links to several pathologies including IBD, celiac disease, and 
metabolic disorders (Biragyn & Ferrucci, 2018; Schippa & Conte, 2014). Life style changes 
might disrupt the gut microbiota ecosystem, which may explain the increased incidence of 
microbiome-linked pathologies over the past few decades (Logan, Jacka, & Prescott, 2016). 
Many factors can abnormally shift in the composition of gut microbiota and, in turn, increase the 
incidence of diseases including diet, environmental changes, physical and psychological stress, 
and antibiotic exposure (Karl et al., 2018). Many scientific studies have linked the domination of 
some gut microbiota groups with positive health outcomes, and these microbes are commonly 
identified as "potentially beneficial bacteria." The most common bacterial strains that fall in this 
category belong to the genera Bifidobacterium, Lactobacillus, Akkermansia, Faecalibacterium, 
Eubacterium, Roseburia, and Blautia (Hiippala et al., 2018; LeBlanc et al., 2017; Quigley, 2013; 
Q. Yang et al., 2020; Y.-J. Zhang et al., 2015). Other bacterial groups have been associated with 
the development or progression of several diseases and disorders, and these groups include some 
species from the genera Clostridium, Enterobacter, Enterococcus, and Bacteroides (Alhinai, 
Walton, & Commane, 2019; Gagnière et al., 2016; Kowalska-Duplaga et al., 2019; Q. Yang et 
al., 2020). The potential correlation between the Firmicutes and Bacteroidetes population and 
BMI has been intensively studied. Several studies demonstrated that the increase of the 
Firmicutes/Bacteroidetes ratio might contribute to the pathophysiology of obesity (Barlow, Yu, 
& Mathur, 2015; Fernandes, Su, Rahat-Rozenbloom, Wolever, & Comelli, 2014; Kasai et al., 
2015; Koliada et al., 2017; Mathur & Barlow, 2015; Turnbaugh et al., 2006). Other studies, 
however, have contradictory results and showed no statistically significant difference in the 
Firmicutes/Bacteroidetes ratio between obese and lean individuals (Aguirre & Venema, 2015; 
H.-J. Hu et al., 2015; Jumpertz et al., 2011; Tims et al., 2013; Walters, Xu, & Knight, 2014). The 
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contradicting results from previous studies suggest that the Firmicutes/Bacteroidetes ratio may 
not be valid as an eventual biomarker for obesity. 
1.3.2 Effect of Plant-Based Diets on Gut Microbiota Composition 
The contribution of dietary patterns to modulate and modify the community structure and 
function of gut microbiota has been a hot topic in recent decades. Diet can directly influence the 
microbial composition in the gastrointestinal tract and play a key role in promoting or inhibiting 
their growth. Different dietary patterns, such as plant-based diets and the Western-style diet, 
have a significant impact on the gut microbiota ecology (Tomova et al., 2019). The Western-
style diet, which is low in dietary fibers and high in fat content, has been linked to microbial 
disruptions in the digestive system and a reduction of microbial diversity (Sonnenburg et al., 
2016). On the other hand, plant-based diets promote healthy and stable gut microbiota due to 
their high content of two critical nutrients, dietary fibers and phytonutrients (Hever & Cronise, 
2017; Tomova et al., 2019). 
Dietary fibers are edible carbohydrate polymers with three or more monomeric units that 
resist hydrolysis by digestive enzymes in the small intestine but can be fermented by microbial 
residents in the large intestine (Gentile & Weir, 2018; Williams, Grant, Gidley, & Mikkelsen, 
2017). Gut microbiota uses dietary fibers as the primary source of energy through a metabolic 
process called fermentation. This fermentative activity results in the generation of bioactive 
metabolites such as short‐chain fatty acids (SCFAs), primarily acetate, propionate, and butyrate. 
These organic products have a beneficial impact on various physiological processes, including 
the regulation of host metabolism, immune system, and cell proliferation (Koh, De Vadder, 
Kovatcheva-Datchary, & Bäckhed, 2016). Dietary fiber intake is not only promoting a healthy 
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environment in the gut but also enhances the richness and diversity of the gut microbiota (Cui et 
al., 2019). 
Phytonutrients are a wide variety of chemical compounds produced by plants. One of the 
major types of these plant products is dietary polyphenols. Dietary polyphenols are naturally 
found in many foods and beverages, namely in fruits, vegetables, cereals, tea, coffee, and wine 
(Kumar Singh et al., 2019). During recent decades, there has been a growing interest in the 
bioactivity of polyphenol-rich foods. Many clinical and preclinical studies have been published 
showing the antioxidant and anti-inflammatory properties of phenolic compounds. This may 
suggest a potential link between polyphenol-rich food consumption and the reduction of several 
chronic disorders including obesity, diabetes, cancers,  IBD, cardiovascular disease, and 
neurodegenerative diseases (Costa et al., 2017; Crascì, Lauro, Puglisi, & Panico, 2018; Kinger, 
Kumar, & Kumar, 2018; Rahman et al., 2018). 
Chemically, polyphenols are a large heterogeneous group of compounds characterized by 
hydroxylated phenyl moieties. Generally, polyphenols are classified into three major classes, 
flavonoids, stilbenoids, and phenolic acids, and flavonoids are the most prevalent class among 
them (Papuc, Goran, Predescu, Nicorescu, & Stefan, 2017). There are more than 9,000 different 
chemical structures of flavonoids that have been identified in nature. Based on their chemical 
structure differences, flavonoids are classified into subclasses including, anthocyanidins, 
flavanones, flavones, flavanonols, flavonols, flavan-3-ols or flavanols, isoflavones, 
neoflavonoids, and chalcones (Cardona, Andrés-Lacueva, Tulipani, Tinahones, & Queipo-
Ortuño, 2013; Kawabata, Yoshioka, & Terao, 2019; Papuc et al., 2017).  
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The beneficial properties of dietary polyphenols are primarily reliant on their 
bioavailability. Gut microbial residents play a vital role in polyphenols bioavailability, especially 
in the colon. In general, approximately 5–10% of the total digested polyphenols are absorbed in 
the small intestine, while the remaining 90–95% pass to the large intestine (Peron et al., 2019). 
Typically, polyphenols with a low molecular weight are partially absorbed in the small intestine. 
However, the vast majority of polyphenols have a high molecular weight in their native state, 
making them unabsorbed in the small intestine (Cassidy & Minihane, 2017; Kawabata et al., 
2019). The high molecular weight polyphenols and other unabsorbed low molecular weight are 
transported into the large intestine where the gut microbial community in the colon breaks them 
down into absorbable low molecular weight phenolic metabolites (Cardona et al., 2013; Cassidy 
& Minihane, 2017). These metabolic products might be responsible for the potential health 
benefits derived from polyphenol-rich foods, rather than the original native polyphenols 
(Cardona et al., 2013). 
Consuming a diet rich in fruits and vegetables exerts an important influence on gut 
microbiota diversity and ecological structure. Fruits and vegetables are important foods in daily 
meals (Sharoba, Farrag, & Abd El-Salam, 2013). In accordance with the US Department of 
Health and Human Services (DHHS) and the United States Department of Agriculture (USDA), 
fruits and vegetables should make up half of the meal ("2015–2020 Dietary Guidelines," 2015). 
Due to the high content of dietary fibers and phenolic compounds, fruit and vegetable intake 
improves the richness and diversity of the gut microbial community. The increased interest and 
awareness among consumers in maintaining a healthy diet urges scientists and researchers to 




1.3.3 Impact of Fruits and Vegetables on Gut Microbiota Composition 
Fruits and vegetables are a fundamental source of dietary fibers, polyphenols, and 
micronutrients such as vitamins and minerals. Many studies have investigated the potential 
impact of the consumption of fruits and vegetables and their extracts on the gut microbiota 
ecosystem. This review summarizes the latest findings on the effects of whole fruits and 
vegetables as well as their products, such as juices, on the gut microbiota composition and 
diversity. 
1.3.3.1 Berries 
The impact of berry consumption on the composition and diversity of the gut microbial 
community has been studied intensively in recent years. In general, berries are an excellent 
source of bioactive compounds, mainly phenolic compounds, including anthocyanins, flavonols, 
flavanols, tannins, or phenolic acids (Nile & Park, 2014). Recently an exhaustive was published 
review which covers the specific area of berries and gut microbiome and health (Lavefve et al., 
2020). This review will focus only on gut microbiota composition reports (Table 1. 1). 
1.3.3.1.1 Strawberries 
Strawberry consumption altered the gut microbial composition in diabetic db/db mice. 
The phylum Actinobacteria slightly increased after the strawberry supplementation with a 
significant increase of its commensal genera Bifidobacterium. The phylum Verrucomicrobia and 
the genera Bacteroides and Akkermansia were significantly reduced in the mice that  ate 
strawberries with no impact observed to Dehalobacterium, Dorea, Lactobacillus, and 
Turicibacter  (Petersen et al., 2019). Moreover, strawberry administration alleviated the gut 
microbiota dysbiosis caused by the dextran-sulfate-sodium (DSS)-induced colitis in mice. 
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Strawberry supplementation induced the abundance of Bifidobacterium and Lactobacillus and 
reduced the abundance of Dorea, Bilophila, Akkermansia, and Bacteroides in colitis mice 
compared to the control group (Y. Han et al., 2019). The increased abundance of Bilophila, an 
opportunistic pathogen, was observed in colitis mice (I. Yang et al., 2013). Bifidobacterium and 
Lactobacillus spp. are generally considered probiotic microorganisms (Aoki et al., 2017). 
Although Akkermansia has been claimed to associate mostly with healthier clinical profiles, 
recent studies showed that the relative abundance of Akkermansia was elevated in several 
diseases, such as Parkinson’s disease and Alzheimer’s disease (Cirstea, Radisavljevic, & Finlay, 
2018; Heintz‐Buschart et al., 2018; Hill‐Burns et al., 2017; Vogt et al., 2017). 
A randomized controlled trial showed that the mixture of strawberries, raspberries, and 
cloudberries potentially altered the gut microbiota composition in human subjects with 
symptoms of metabolic syndrome. Unfortunately, the individual variations in the gut microbiota 
composition were not provided (Puupponen‐Pimiä et al., 2013). 
1.3.3.1.2 Cranberries 
Whole cranberries altered the gut microbiota community of a human in vitro by 
increasing the relative abundance of the families Porphyromonadaceae and Bacteroidaceae and 
stabilizing the commensal families Ruminococcaceae and Lachnospiraceae. Additionally, a 
reduction in the relative abundance of Enterobacteriaceae was observed after the cranberry 
treatment (O’Connor et al., 2019). A high level of the Enterobacteriaceae has often been reported 
in patients with IBD (Zeng, Inohara, & Nuñez, 2017). 
In vitro, dietary cranberry (Vaccinium macrocarpon) ameliorated the gut microbiota 
dysbiosis caused by DSS-induced colitis in mice by reversing the reduction of the α-diversity. At 
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the genus level, cranberry consumption altered the gut microbiota composition by increasing the 
relative abundance of potentially beneficial bacteria, e.g., Bifidobacterium, Lactobacillus, and 
Akkermansia, and decreasing the relative abundance of potentially harmful bacteria, e.g., 
Sutterella and Bilophila (Cai et al., 2019). 
Cranberry consumption altered gut microbiota relative abundance in a short-period (5 
days) in healthy human volunteers. The Firmicutes/Bacteroidetes ratio was influenced by the 
cranberry intake with an increase in Bacteroidetes level and a decrease in Firmicutes level. 
Cranberry intake also impacts bacterial abundance in the genus level by increasing the 
abundance of Lachnospira and Anaerostipes, SCFAs-producing bacteria, and decreasing the 
abundance of Oribacterium (Rodríguez-Morató, Matthan, Liu, de la Torre, & Chen, 2018).  
1.3.3.1.3 Black and red raspberries 
The impact of red and black raspberries on reshaping the gut microbial composition has 
also been studied. Black raspberries significantly increased the genera Akkermansia and 
Desulfovibrio abundance in healthy rats. A number of butyrate-producing genera, such as 
Anaerostipes, were also increased after the black raspberry consumption (Pan et al., 2017). A 
similar impact was observed in a study using specific-pathogen-free mice where the black 
raspberry supplementation remarkably increased the abundance of the phylum Verrucomicrobia 
and its genera Akkermansia muciniphila. Black raspberries also altered the 
Firmicutes/Bacteroidetes ratio by increasing the relative abundance of Bacteroidetes and 
reducing Firmicutes abundance (Tu et al., 2018). A. muciniphila is believed to have several 
health benefits to humans and inversely correlated with various diseases (Cani & de Vos, 2017; 
Jayachandran, Chung, & Xu, 2019). Another mice study also supported the effect of black 
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raspberries on lowering the Firmicutes/Bacteroidetes ratio. At the genus level, Barnesiella 
and Turicibacter were significantly higher in mice fed a black raspberry-rich diet compared to 
the control group, while Clostridium and Lactobacillus were significantly lower (Gu et al., 
2019). Barnesiella, a recently discovered genus, belongs to the Porphyromonadaceae family 
which was found to metabolize glucose to produce butyrate and isobutyrate (Sakamoto, Lan, & 
Benno, 2007; Sakamoto et al., 2009; Wylie et al., 2012). Additionally, a positive correlation 
between Barnesiella and the level of SCFAs has been reported (Ying Zhao et al., 2013). 
Turicibacter was found to have a positive correlation with butyric acid (Zhong, Nyman, & Fåk, 
2015). 
Supplementation with red raspberries was associated with significant changes in the fecal 
microbiota of obese diabetic mice. The relative abundance of Lachnospiraceae was increased in 
the red raspberry supplemented group. Additionally, a decrease in the relative abundance of 
Lactobacillus, Odoribacter, and the fiber degrader S24-7 family as well as unknown groups of 
Bacteroidales and Enterobacteriaceae was observed after red raspberry supplementation (Garcia-
Mazcorro, Pedreschi, et al., 2018). 
1.3.3.1.4 Blueberries 
Blueberries markedly impacted the gut microbiota composition. In the IBD mouse model, 
a blueberry-rich diet significantly reduced Clostridium perfringens, Enterococcus, E. coli, and 
Lactobacillus with no impact to Bacteroides-Prevotella-Porphyromonas group and 
Bifidobacterium (Paturi et al., 2012). C. perfringens and Enterococcus faecalis are potentially 
associated with IBD (Balish & Warner, 2002; Falk et al., 2007; Paturi et al., 2012; Tannock, 
2010). Furthermore, blueberry consumption led to lowering the Firmicutes/Bacteroidetes ratio in 
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mice. The abundance of the phylum Tenericutes increased, and the family Deferribacteres 
decreased in blueberry-fed mice (Wankhade et al., 2019). Another study showed that blueberry 
administration increased the relative abundance of Turicibacter sp. H121 in mice fed a high-fat 
and high-sucrose diet (Morissette et al., 2020).  
In rats, a Lowbush wild blueberry-enriched diet influenced the gut microbiota profile by 
significantly increasing the relative abundance of the phylum Actinobacteria, the order 
Actinomycetales, and a number of genera under the family Bifidobacteriaceae and 
Coriobacteriaceae, and significantly decreasing  the relative abundance of Lactobacillus and 
Enterococcus. The Lowbush wild blueberry consumption increased the 
Bifidobacterium/Coriobacteriaceae ratio compared with the control diet (Lacombe et al., 2013). 
The increased Bifidobacterium/Coriobacteriaceae ratio positively impacted plasma cholesterol 
levels in hamsters (Martínez et al., 2009). Blueberry juice supplementation contributed to 
ameliorating the alteration in the gut microbiota composition caused by carbon tetrachloride 
(CCl4) in a CCl4-induced rat liver fibrosis model (Yan et al., 2019).  
In healthy humans, wild blueberry (Vaccinium angustifolium) consumption modulated 
the intestinal microbiota. The abundance of commensal Bifidobacterium was significantly 
increased following the wild blueberry treatment with no significant impact to Bacteroides, 
Prevotella, Enterococcus, and Clostridium coccoides (Vendrame et al., 2011). Another human 
study showed that the consumption of a wild blueberry drink modulated the most abundant 
bifidobacterial taxonomic groups with significant stimulation of Bifidobacterium longum subsp. 




1.3.3.1.5 Other berries 
A variety of eight Nordic berries; strawberry (Fragaria ananassa Senga Sengana), 
bilberry (Vaccinium myrtillus), red raspberry (Rubus idaeus, var. Ottawa), cloudberry (Rubus 
chamaemorus), blackcurrant (Ribes nigrum, var. Öjeby), and sea buckthorn berry (Hippophae 
rhamnoides) showed antimicrobial activity against selected Gram‐positive and Gram‐negative 
bacteria in vitro. Staphylococcus and Salmonella were the most sensitive bacteria to the berry 
intervention (Puupponen‐Pimiä et al., 2005). Salmonella is a well-known foodborne pathogen 
and considered the leading bacterial cause of acute gastroenteritis (Majowicz et al., 2010; 
Rivera-Chávez et al., 2016). Sea buckthorn berry juice influenced gut microbiota in vitro by 
increasing the growth of Bifidobacteria, Bacteroides/Prevotella, and Lactic acid bacteria (Attri, 
Sharma, Raigond, & Goel, 2018). A similar impact on the beneficial microbial population was 
observed in a following in vitro study when the sea buckthorn berry juice supplementation 
stimulated the growth of Bifidobacteria, Lactobacilli, and Bacteroides/Prevotella (Attri & Goel, 
2018). Bifidobacterium and Lactobacillus spp. are well-known probiotic microorganisms (Aoki 
et al., 2017). 
Juçara (Euterpe edulis) significantly increased the relative abundance of Bifidobacterium 
after 24 hours of fermentation in vitro  (Guergoletto, Costabile, Flores, Garcia, & Gibson, 2016). 
Similarly, juçara pulp reinstated Bifidobacterium content in rats fed a high-fat diet (Jamar et al., 
2018). Bifidobacterium has been found to play a role in preventing cognitive impairment in 
Alzheimer’s disease (Kobayashi et al., 2017). 
Lonicera caerulea L. Berry (LCBP) modified the gut microbiota composition in a high-
fat diet-induced mice model (S. Wu et al., 2018). The results revealed that supplementation with 
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LCBP impacted the Firmicutes/Bacteroidetes ratio by lowering the abundance of Firmicutes and 
elevating Bacteroidetes abundance as well as increasing the abundance of Parabacteroides and 
Verrucomicrobia. In the genus level, the LCBP diet induced the relative abundance of 
Akkermansia, which was suggested to play a role against obesity (Everard et al., 2013; Plovier et 
al., 2017). LCBP supplementation increased the relative abundance of Bacteroides and 
Parabacteroides, which were found to be reduced with non-alcoholic fatty liver disease and the 
high fat-induced diet (Del Chierico et al., 2017; Liu et al., 2016). Additionally, the relative 
abundance of Staphylococcus, Lactobacillus, Oscillospira, and Ruminococcus was reduced after 
LCBP supplementation. The increased abundance of Lactobacillus, Ruminococcus, and 
Oscillospira was associated with intestinal permeability, systemic inflammation, and 
macrophage dysfunction (Santisteban et al., 2017; Thevaranjan et al., 2017; S. Wu et al., 2018). 
These findings express the potential health benefits of LCBP. 
Goji berry (Lycium barbarum) modulated the gut microbial population in IL‐10‐deficient 
mice, which will develop a chronic IBD spontaneously. Dietary Goji markedly enhanced the 
growth of Actinobacteria phylum and its genera Bifidobacterium. Butyrate‐producing bacteria, 
including Lachnospiraceae family and its genera Roseburia spp. and Ruminococcaceae family 
and its genera  Faecalibacterium prausnitzii, were also promoted by Goji berry (Kang, Yang, 
Zhang, Ross, & Zhu, 2018). These genera have been described as potentially protective against 
human IBD (Kumari, Ahuja, & Paul, 2013; Martín et al., 2014; Rossi et al., 2016; Tamanai-
Shacoori et al., 2017). F. prausnitzii dysbiosis is associated with several intestinal and metabolic 
disorders such as IBD, irritable bowel syndrome (IBS), colorectal cancer (CRC), obesity, and 
celiac disease (Balamurugan, Rajendiran, George, Samuel, & Ramakrishna, 2008; De Palma et 
al., 2010; Furet et al., 2010; Neish, 2009; Rajilić–Stojanović et al., 2011; Sokol et al., 2008). 
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Furthermore, many studies have reported the anti-inflammatory effects of F. prausnitzii (Martín 
et al., 2017; Miquel et al., 2015; Quévrain et al., 2016; Rossi et al., 2015; Sarrabayrouse et al., 
2014). 
Lingonberries lowered the Firmicutes/Bacteroidetes ratio in Apoe
−/−
 mice, 
atherosclerosis-prone mice, fed a high-fat diet. The genera Bacteroides, Clostridium, and 
Parabacteroides, and the species A. muciniphila, Blautia producta, Clostridium difficile, 
and Eubacterium dolichum were increased after Lingonberries supplementation. A decrease in 
the abundance of Mucispirillum and Oscillospira was observed in mice fed the high-fat diet 
(Matziouridou, Marungruang, Nguyen, Nyman, & Fåk, 2016). E. dolichum is a butyrate‐
producer bacterium, and butyrate has anti‐inflammatory properties and can play a role against the 
development of IBD (M. Zhang et al., 2016).  
A berry mixture is consisting of blueberries, blackberries, raspberries, Portuguese 
crowberries, and strawberries mitigated the gut microbiota alteration caused by a salt-induced 
hypertension diet in rats (Gomes et al., 2019). The Bacteroidetes population was significantly 
increased after the berry mixture intake while the Firmicutes and Proteobacteria were decreased.  
The berry mixture supplementation increased the abundance of Bacteroidaceae, S24-7, and 
Ruminococcaceae families. Moreover, the berry mixture intake significantly decreased the 
relative abundance of Erysipelotrichaceae, which has been correlated with inflammation (Dinh et 
al., 2015; Gomes et al., 2019). 
Blackcurrants and raspberries modulated the gut microbiota composition in rats. The 
result showed a clear difference in the diversity index between the rats fed blackcurrants and 
raspberries as the diversity index was higher for the rats fed raspberries than blackcurrants. 
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However, the modulation in the composition of specific bacteria has not been reported 
(Jakobsdottir et al., 2013). 
A randomized, double-blind placebo-controlled study revealed that Schisandra shinensis 
fruit modulates the gut microbiota composition in obese women. Schisandra chinensis fruit 
intake lowered the Firmicutes/Bacteroidetes ratio by increasing Bacteroidetes abundance and 
decreasing Firmicutes abundance. At the genus level, Bifidobacterium, Akkermansia, Roseburia, 
Prevotella, and Bacteroides showed a superior increase in the treatment group compared to the 
placebo group (Song, Wang, Eom, & Kim, 2015). These bacteria were found to be associated 
with reducing and controlling obesity (Dao et al., 2016; Everard et al., 2013; Hjorth et al., 2018; 
H. I. Kim et al., 2019; Neyrinck et al., 2012; Plovier et al., 2017; Tamanai-Shacoori et al., 2017; 
J. Y. Yang et al., 2017).  
A variety of eight Nordic berries; bilberry (Vaccinium myrtillus), red raspberry (Rubus 
idaeus, var. Ottawa), cloudberry (Rubus chamaemorus), strawberry (Fragaria ananassa Senga 
Sengana), blackcurrant (Ribes nigrum, var. Öjeby) and sea buckthorn berry (Hippophae 
rhamnoides) showed antimicrobial activity against selected Gram‐positive and Gram‐negative 
bacteria, including Staphylococcus and Salmonella, which were the most sensitive to the berries 
(Puupponen‐Pimiä et al., 2005). Salmonella is a well-known foodborne pathogen and considered 
the leading bacterial cause of acute gastroenteritis (Majowicz et al., 2010; Rivera-Chávez et al., 
2016). 
1.3.3.2 Cherries 
Cherries contain a high level of dietary fibers and bioactive compounds, such as 
polyphenols (Budak, 2017; Mikulic‐Petkovsek, Stampar, Veberic, & Sircelj, 2016; Redondo, 
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Arias, Oria, & Venturini, 2017). The impact of cherries on gut microbiota composition and 
diversity has been receiving attention in recent years (Table 1. 2). A recent study investigated 
the impact of tart cherries and tart cherry juice on the human gut microbiota composition in vitro 
and in vivo. In the in vitro study, fermentation of tart cherry powder and tart cherry juice 
significantly increased the abundance of Bacteroides, Collinsella, Veillonella, Bilophila, 
Escherichia, Clostridium XIVa, and Enterobacteriaceae (Mayta-Apaza et al., 2018). In the in 
vivo study, tart cherry juice intake influenced the gut microbiota profile among healthy human 
volunteers. Individuals with an initial high abundance of Bacteroides showed a decrease in the 
abundance of Bifidobacterium, Bacteroides, Parabacteroides, and Alistipes after the tart cherry 
intervention, while Lactobacillus, Lachnospiraceae, Rumainococcus, Streptococcus, and 
Collinsella were increased. Interestingly, the treatment showed an opposite effect on the gut 
microbiota profile in individuals with an initial low abundance of Bacteroides. Individuals with 
low-Bacteroides abundance showed induced levels of Bifidobacterium, Bacteroides, and 
Lactobacillus (numerical) along with reduced levels of Lachnospiraceae, Collinsella, 
Ruminococcus, Streptococcus, Dialister, Blautia, and Roseburia (Mayta-Apaza et al., 2018). In 
another study, dark sweet cherries (Prunus avium) modulated the gut bacterial composition in 
obese diabetic db/db mice by increasing the abundance of Akkermansia spp. and fiber-degraders 
(the S24-7 family) and decreasing the abundance of Lactobacillus and Enterobacteriaceae 
(Garcia-Mazcorro, Lage, et al., 2018). In a more recent study, the increasing concentration of 
sweet and tart cherry juices resulted in significant growth of Barnesiella and Akkermansia in 




Mangoes exhibit a wide range of health benefits due to the high content of 
phytochemicals such as polyphenols, carotenoids, vitamin E, and vitamin C with excellent 
antioxidant properties. Additionally, mangoes haves a high content of dietary fiber; the pulp 
alone contains approximately 1.3–3.8g/100g total fiber (Ajila, Naidu, Bhat, & Rao, 2007; Gondi, 
Basha, Bhaskar, Salimath, & Prasada Rao, 2015; Masibo & He, 2009). Several studies have 
investigated the impact of mangoes on preventing disease and metabolic disorders through, for 
example, inhibiting adipogenesis, ameliorating hyperglycemia and hyperlipidemia, reducing 
blood glucose, and preventing the growth of colonic cancer cells (Evans et al., 2014; Gondi et 
al., 2015; Noratto et al., 2010; Taing et al., 2012). The high content of dietary fiber and 
polyphenols make mangoes promising candidate for modulating the gut microbiota profile 
(Table 1. 3).  
A study published in 2016 showed the ability of mango supplementation to restore the 
relative abundance of the beneficial genera Bifidobacteria, Akkermansia, and Aldercreutzia in 
the mice previously exposed to a high-fat diet. Additionally, mango supplementation increased 
the relative abundance of Ruminococcus and reduced the abundance of Bacteroides and 
Parabacteroides despite the high-fat feeding (Ojo et al., 2016). Aldercreutzia was characterized 
to produce equol, an antioxidant from dietary isoflavonoids (Maruo, Sakamoto, Ito, Toda, & 
Benno, 2008). A more recent study showed that mango intake caused a trend toward increasing 
the relative abundance of Lactococcus lactis, a tannase‐producing bacterium. It reduced the 
relative abundance of Clostridium leptum,an endotoxin‐producing bacterium, and Bacteroides 




Apples are a rich source of bioactive compounds such as dietary polyphenols and dietary 
fiber, mainly pectin, which is the primary soluble fiber in apples. Pectin resists degradation by 
gastric acid and intestinal enzymes and passes to the large intestine where it subjected to 
fermentation activity by the bacterial residents. Therefore, pectin is known to have a positive 
impact on gut microbiota composition and diversity and promoting health (Chung et al., 2017; 
Denis et al., 2016; Koutsos, Tuohy, & Lovegrove, 2015; Masumoto et al., 2016). Pectin has a 
prebiotic activity and has been shown to enhance beneficial bacteria such as F. prausnitzii 
(Chung et al., 2017).  
To the best of our knowledge, a few studies have investigated the impact of whole apple 
consumption on gut microbiota (Table 1. 4). Three commercial apple varieties, Renetta Canada, 
Golden Delicious, and Pink Lady, modulated the gut microbiota composition in vitro. At the 
phylum level, all the apple varieties significantly increased Actinobacteria proportion with no 
effect on Firmicutes proportion. Only Renetta Canada and Golden Delicious varieties 
significantly increased the abundance of Proteobacteria and significantly decreased the 
abundance of Bacteroidetes. At the genus level, the population of Bifidobacterium spp. was 
significantly increased after the administration of Renetta Canada and Golden Delicious. Renetta 
Canada administration significantly increased the abundance of F. prausnitzii, unlike Golden 
Delicious and Pink Lady, which showed no impact on F. prausnitzii population (Koutsos et al., 
2017). 
In vivo, apple consumption modulated the gut microbiota composition in rats fed whole 
apples for four and 14 weeks. In the short-term intervention, Bacteroidetes level was decreased 
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after the apple supplementation (Licht et al., 2010). In a more recent in vivo study, apple 
supplementation impacted the Firmicutes/Bacteroidetes ratio by increasing Firmicutes population 
and decreasing Bacteroidetes in rats fed a high-fat diet compared to the control group. 
Additionally, apple supplementation increased the abundance of Blautia in rats fed a low-fat diet 
compared to the control group. At lower taxonomic levels, apple supplementation significantly 
increased the abundance of an unknown group of Clostridiales, with a decrease in the abundance 
of Bacteroidaceae (Garcia-Mazcorro et al., 2019). In mice fed a high fat diet, whole apples 
increased the relative abundance of Akkermansia, whereas the apple peel supplementation 
increased the level of Bacteroides (Elkahoui, Levin, Bartley, Yokoyama, & Friedman, 2019). 
In humans, apple intake significantly increased the abundance of Bifidobacteria with a 
suggestive increase in the abundance of Lactobacillus, Streptococcus, and Enterococcus. A 
significant reduction was observed in the abundance of Enterobacteriaceae and Lecithinase-
positive clostridia, including C. perfringens and a suggestive decrease in the Pseudomonas 
abundance (Shinohara, Ohashi, Kawasumi, Terada, & Fujisawa, 2010). Unfortunately, this study 
used culture techniques to investigate the potential modulation on gut microbiota, which gives a 
limited description of microbial communities. Another human study showed that the whole apple 
consumption lowered fecal pH and resulted in differences in the denaturing gradient gel 
electrophoresis (DGGE) profile (Ravn-Haren et al., 2013). However, the specific modification of 
the gut microbiota population was not confirmed. 
1.3.3.5 Grapes 
Grapes are rich in bioactive polyphenolic compounds, including flavonoids, such as 
anthocyanins and flavan-3-ols, and non-flavonoids, such as stilbenes (Nash et al., 2018). Due to 
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the anti-inflammatory and antioxidant properties, grape consumption has a beneficial effect on 
intestinal or systemic inflammation including reducing adiposity and markers of inflammation as 
well as improving glucose tolerance (Collins et al., 2016; Van Hul et al., 2018). Unfortunately, a 
limited number of studies assess the impact of whole grapes on the gut microbiota structure and 
composition (Table 1. 5). The vast majority of grape-based studies focused on phenolic 
compound extracts from grape pomace, seed, or juice (Anonye, 2017; W. Liu et al., 2017; F. Lu 
et al., 2019; Van Hul et al., 2018). This review will address papers that used whole grapes to 
investigate the potential impact on modulating the gut microbiota profile.  
The grape supplementation decreased the relative abundance of sulfidogenic bacteria 
Desulfobacter spp. and Bilophila wadsworthia in mice fed the high-fat diet compared to control 
groups (Baldwin et al., 2016). Hydrogen sulfide, produced by sulfidogenic bacteria, triggers pro-
inflammatory pathways and hyperproliferation and may cause colorectal cancer and other 
intestinal disorders, including inflammatory bowel disease and irritable bowel syndrome (Feng, 
Stams, De Vos, & Sánchez-Andrea, 2017; Z. Feng et al., 2017). The results also showed a 
suggestive increase in the abundance of A. muciniphila, a mucin-degrading bacterium, in mice 
fed the high-fat diet compared to control groups. Additionally, Allobaculum abundance was 
increased in mice fed the high-fat diet with the grape supplementation compared to the high-fat 
diet control group (Baldwin et al., 2016). A follow-up study also investigated the impact of grape 
intake on composition gut microbiota in mice fed a high-fat diet. Unlike the previous study, this 
study used a higher level of dietary fat and a longer intervention time-period, 16 vs. 10 weeks. In 
this study, the whole-grape supplementation did not have the same positive outcomes in the gut 
microbiota modulation in mice as in the previous study (Collins et al., 2016). More recently, an 
in vivo study showed that the supplementation of whole grapes increased the relative abundance 
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of various taxa belonging to the Lachnospiraceae family in mice under healthy and diseased 
conditions (Yiying Zhao, Nakatsu, & Jiang, 2019). 
A randomized, crossover, controlled intervention study showed that red wine and de-
alcoholized red wine significantly changes the gut microbiota composition in healthy volunteers. 
The relative abundance of Bifidobacterium, Enterococcus, Eggerthella lenta, the Blautia 
coccoides–Eubacterium rectale group, and the phylum Fusobacteria were significantly increased 
after the red wine and de-alcoholized red wine compared to the baseline (Queipo-Ortuño et al., 
2012). The Blautia coccoides-Eubacterium rectale group, Enterococcus spp., and 
Bifidobacterium spp. are generally considered to be beneficial due to their anti-inflammatory and 
neoplastic properties (Dueñas et al., 2015). Another randomized, crossover, controlled 
intervention study evaluated the modulation of red wine and de-alcoholized red wine on gut 
microbiota profiles in obese individuals diagnosed with metabolic syndrome (MetS) (Moreno-
Indias et al., 2016). The red wine and de-alcoholized red wine intake significantly increased the 
abundance of gut mucosal barrier protectors, such as Bifidobacterium spp. and Lactobacillus spp. 
Furthermore, a positive impact of the red wine and de-alcoholized red wine intake on the growth 
of the butyrate producers, namely the Blautia coccoides–Eubacterium rectale group, 
Faecalibacterium prausnitzii, and Roseburia was observed. The red wine and de-alcoholized red 
wine also showed an inhibitory effect on the Clostridium histolyticum group, pathogens 





Kiwifruits are rich in nutrients, such as dietary fiber and phytochemicals, which have 
prebiotic effects on intestinal bacteria (Leontowicz et al., 2016). Kiwifruits have shown to 
modify gut microbial ecology (Table 1. 6). Green and gold kiwifruits increased the relative 
abundances of Bifidobacterium spp. and Bacteroides spp. in vitro (Blatchford et al., 2015). 
Another study showed that green and gold kiwifruits increased the total intestinal bacteria 
composition in rats compared to the control diet. Both green and gold kiwifruit significantly 
increased the abundance of Lachnospiraceae, a family that contains members among the primary 
producers of SCFAs and other members found to be associated with diseases (Paturi, Butts, 
Bentley‐Hewitt, & Ansell, 2014; Vacca et al., 2020). The relative abundance of the Bacteroides–
Prevotella–Porphyromonas group and Enterococcus spp. were induced with gold kiwifruit 
supplementation (Paturi et al., 2014). In a pig model, dietary treatment with green kiwifruits 
significantly increased the number of total bacteria with a significant increase in the abundance 
of Bacteroides as well as a significant decrease of E. coli abundance. The ratio of 
Lactobacillus/Enterobacteria was significantly increased after kiwifruit supplementation 
compared to the control (K. S. Han, Balan, Molist Gasa, & Boland, 2011). Therefore, kiwifruits 
may play a role in enhancing the relative abundance of beneficial bacteria such as 
Bifidobacterium and Lactobacillus as well as inhibiting the growth of opportunistic pathogens 
such as E. coli and Enterobacteria. 
1.3.3.7 Oranges 
The importance of oranges in promoting general health has long been established due to 
the richness in nutrients including vitamin C, dietary fiber, and other bioactive compounds such 
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as polyphenols. Flavonoids are among the most dominant polyphenols in oranges and orange 
juice (Stella, Ferrarezi, dos Santos, & Monteiro, 2011; Stinco et al., 2012). The bioactive 
components present in orange juice are associated with the gut microbiota metabolism (Laparra 
& Sanz, 2010; Pereira-Caro et al., 2015; Pereira‐Caro et al., 2015). Numerous scientific papers 
have investigated the impact of orange juice in modulation gut microbiota ecology (Table 1. 7). 
An in vitro study reported that fresh orange juice induced the growth of Bifidobacterium spp., 
Lactobacillus spp., Enterococcus spp., and Clostridium spp. while the juice reduced the level of 
the Enterobacteria. Pasteurized orange juice showed a similar effect in gut microbiota by 
increasing the growth of Lactobacillus spp. and reducing Enterobacteria (Duque, Monteiro, 
Adorno, Sakamoto, & Sivieri, 2016). Two different orange juices from Citrus sinensis variety, 
cv. “Cara Cara” and cv. “Bahia”, influenced the composition of gut microbiota in humans in a 
short-term intervention. Cara Cara orange juice increased the relative abundance of 
Mogibacteriaceae and Tissierellaceae families while the relative abundance of Odoribacteraceae 
family and the Odoribacter genus were decreased. In the Bahia group, Mogibacteriaceae, 
Enterococcaceae, and Veillonellaceae families were increased, whereas the Ruminococcaceae 
family was decreased after the juice consumption. The Porphyromonadaceae, Odoribacteraceae, 
Christensenellaceae, Enterobacteriaceae, Lachnospiraceae, and Ruminococcaceae families and 
Parabacteroides and Butyricimonas genera were increased in Cara Cara orange juice compared to 
the control group. The relative abundance of the Coriobacteriaceae family and Adlercreutzia 
genus, Enterococcaceae family and Enterococcus genus, Clostridiaceae family and Clostridium 
genus, Ruminococcaceae family and Anaerotruncus genus, and Pasteurellaceae family were 
significantly higher in Bahia orange juice compared to the control group (Brasili et al., 2019). A 
long-term intervention, eight weeks, of orange juice positively modulated the gut microbiota 
35 
 
population in healthy volunteers by significantly increasing the relative abundance of 
Bifidobacterium spp. and Lactobacillus spp. (Lima et al., 2019). 
1.3.3.8 Pomegranates 
Pomegranate fruits and products are widely consumed and recognized for their health 
benefits (Z. Li, Henning, et al., 2015). The health benefits are attributed to the presence of 
phenolic compounds, mainly ellagitannins (Henning et al., 2017; Z. Li, Henning, et al., 2015). 
Several studies have shown the impact of pomegranate fruits and products on the gut microbiota 
composition (Table 1. 8). The residual materials, which are left after the pomegranate juice 
production, are pressed and extracted with water to make the pomegranate by-product (POMx) 
which is commercially available as a dietary supplement (Bialonska et al., 2010). POMx was 
reported to increase the total bacteria and the level of Bifidobacterium spp. and Lactobacillus 
spp. in vitro (Bialonska et al., 2010). In agreement with the previous study, another in vitro study 
showed that the pomegranate (POM) juice and POMx increased the level of Bifidobacterium and 
Lactobacillus. B. fragilis group, clostridia, and Enterobacteriaceae was significantly inhibited by 
the POM juice and POMx in a dose–response manner (Z. Li, Summanen, et al., 2015). 
In an in vivo study, an increase in the relative abundance of Ruminococcaceae, a family 
that has been reported to have anti-inflammatory activities (X. Zhang et al., 2012), was observed 
in rats supplemented with the pomegranate beverage compared to the control group (Kim et al., 
2017). Moreover, pomegranate juice abolished the dysbiosis in gut microbiota caused by acrolein 
in apoE−/− mice (Rom et al., 2017). 
POMx supplementation significantly increased the relative abundance of the commensal 
bacterium A. muciniphila in healthy volunteers (Henning et al., 2017). Furthermore, POMx 
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supplementation significantly increased the Actinobacteria population and decreased the 
Firmicutes population in healthy individuals. At the genus level, Lactobacillus, Akkermansia, 
Prevotella, Butyrivibrio, Enterobacter, Escherichia, Serratia, and Veillonella were increased 
after POMx intake, whereas Collinsella significantly decreased (Z. Li, Henning, et al., 2015). 
1.3.3.9 Avocados 
Avocados are rich in dietary fiber, monounsaturated fat, and a selection of essential 
phytochemicals, including lutein (Dreher & Davenport, 2013; Q.-Y. Lu et al., 2009). A few 
studies have investigated the potential impact of avocado administration on shaping the intestinal 
microbiota (Table 1. 9).  A recent study showed that the Firmicutes/Bacteroidetes ratio was 
maintained by avocado consumption in healthy overweight and obese individuals. A significant 
increase was observed in the abundance of Veillonellaceae and Sutterellaceae with a suggestive 
increase in the abundance of Ruminoccocaceae and its genera Ruminococcus and Prevotellaceae 
and its genera Prevotella after the avocado intervention. The genera Bacteroides and 
Methanosphaera were decreased in the avocado group with a significant increase in the 
abundance of Dialister, Sutterella, Bilophila, Holdemanella, Herbaspirillum, and Acetivibrio, of 
which several have the capability to ferment fiber (Bang et al., 2018; Fouhse, Gänzle, Beattie, 
Vasanthan, & Zijlstra, 2017; Henning et al., 2019). A randomized controlled trial study showed 
that the avocado consumption significantly increased the relative abundances of Lachnospira and 
suggestively elevated the abundance of Faecalibacterium in overweight or obese adults 
(Thompson, Edwards, Reeser, Khan, & Holscher, 2019). Lachnospira and Faecalibacterium are 
thought to play a role in maintaining gut homeostasis and epithelial integrity due to their ability 
to produce butyrate (Ferrario et al., 2014; Vital, Howe, & Tiedje, 2014). Lachnospira belongs to 
Lachnospiraceae, which has been reported to restrain the growth of the opportunistic pathogen, 
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Clostridium difficile (Bhaduri, Dubey, & Basu, 2019; Reeves, Koenigsknecht, Bergin, & Young, 
2012). 
1.3.3.10 Bitter melons 
Bitter melon fruit is an excellent source of physiologically active compounds, including 
dietary fiber and polyphenols, mainly catechin (Bai, Zhu, & Dong, 2016; Hwang, 2018; Ri, 
Magbagbeola, Akinwande, & Okunowo, 2010). A good number of studies reported the impact of 
the bitter melon fruit in hypoglycemic, hypolipidemic, and improving insulin resistance in the 
obese (Bao et al., 2013; Juan, Ying, & Ying, 2017; Xu et al., 2014; S. J. Yang et al., 2015; Zhu, 
Bai, Zhang, Xiao, & Dong, 2016). However, a few studies have investigated the potential impact 
on gut microbiota ecology, most of which were conducted with obesity-induced diets (Bai et al., 
2016; Nerurkar, Orias, Soares, Kumar, & Nerurkar, 2019; Zhu et al., 2016) (Table 1. 10). In 
obese rats, the level of the families Desulfovibrionaceae and Enterobacteriaceae were reduced by 
the bitter melon supplemented diet compared to the high-fat diet, whereas the Odoribacteraceae, 
a butyrate producer, level was significantly increased after the dietary intervention (Bai et al., 
2016). The association of Enterobacteriaceae and Desulfovibrionaceae families with a systemic 
inflammatory state have been reported (Hakansson & Molin, 2011; Zeng et al., 2017). At the 
genus level, the abundance of Escherichia, which contains opportunistic pathogens, was 
significantly decreased in the group supplemented with bitter melons compared to the high-fat 
diet group. This was coordinated with an increase in the abundance of the butyrate-producing 
genera Faecalibacterium, Allobaculum, Butyricimonas, and Odoribacter (Bai et al., 2016). A 
follow-up study showed that the bitter melon powder supplementation increased the 
Verrucomicrobia population in obese rats fed a high-fat diet. At the genus level, the bitter melon 
powder treatment significantly increased the relative abundance of Blautia, Anaerotruncus, 
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Lactococcus, Allobaculum, and Oceanobacillus and decreased Prevotella and Anaeroplasma 
(Bai, Zhu, & Dong, 2018). Blautia and Allobaculum are SCFAs producing-bacteria (Greetham et 
al., 2004; Park, Kim, Roh, & Bae, 2012). Bitter melon juice improved the ratio of 
Firmicutes/Bacteroidetes with a reduction in Actinobacteria abundance in mice fed a high-fat 
diet compared to the high-fat control group. Additionally, an increase in the abundance of 
Clostridiaceae, Lactobacillales, and Lactobacillus and a decrease in Bacteroides abundance was 
reported after bitter melon juice administration compared to the control group (Nerurkar et al., 
2019). Lactobacillales is negatively correlated with colonic injury as well (Ritchie et al., 2015). 
1.3.3.11 Broccoli 
Broccoli is a good source of dietary fiber and phytochemicals, including glucosinolates 
and polyphenols (X. Liu et al., 2017). Glucosinolates are relatively non bioactive in their native 
state. However, the gut microbial residence can hydrolyze glucosinolates to form the bioactive 
glucosinolates derivatives, mainly isothiocyanates (Angelino et al., 2015; Tian, Liu, Lei, Zhang, 
& Shan, 2018). Several studies showed that broccoli consumption could alter the composition of 
gut microbiota (Table 1. 11). Cooked broccoli supplementation significantly increased the 
relative abundance of the genera Akkermansia and Oscillospira as well as the family 
Ruminococcaceae. The broccoli consumption significantly decreased the relative abundance of 
Blautia, Clostridium, and Dorea in rats (X. Liu et al., 2017). A controlled feeding and 
randomized crossover study showed that daily consumption of cooked broccoli in human 
volunteers increased the relative abundance of Bacteroidetes and its genus Bacteroides and 
decreased the relative abundance in Firmicutes (Kaczmarek et al., 2019). An in vivo study 
reported that the broccoli supplementation decreased the abundance of C. perfringens and E. 
coli, bacteria that are known to be associated with IBD, in mdr1a−/− mice, a model for IBD. 
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The broccoli-supplemented diet also lowered the abundance of Enterococcus spp., Lactobacillus 
spp., and F. prausnitzii compared to the control diet (Paturi et al., 2012). 
1.3.3.12 Mushrooms 
Mushrooms contain a high content of bioactive components, including dietary fiber and 
polyphenols (Amirullah, Abidin, & Abdullah, 2018; Sánchez, 2017). Beside the anti-
inflammation and antioxidant effects, whole mushroom supplementation has been reported to 
influence the gut microbial ecosystem in animal models (Iuchi et al., 2015; S. P. Therkelsen, G. 
Hetland, T. Lyberg, I. Lygren, & E. Johnson, 2016; Stig Palm Therkelsen, Geir Hetland, Torstein 
Lyberg, Idar Lygren, & Egil Johnson, 2016; Vetvicka & Vetvickova, 2014) (Table 1. 11). White 
button mushrooms increased the Bacteroidetes population and decreased Firmicutes in mice. At 
the class level, the mushroom supplementation increased the abundance of Mollicutes, 
Proteobacteria sub-classes Delta, Gamma, and Epsilon, and Verrucomicrobia and decreased the 
abundance of Erysipelotrichi, Deferribacteres, as well as the potentially pathogenic bacteria 
Clostridia (Varshney et al., 2013). The dietary supplementation of white button mushrooms 
altered the composition of gut microbiota in pigs (Solano-Aguilar et al., 2018). A mushroom 
treatment enriched the abundance of the family Ruminococcaceae and its genera Oscillibacter 
and Butyricicoccus and the family Lachnospiraceae and its genera Fusicatenibacter, 
Robinsoniella, and Eisenbergiella, which have a role in plant fibers degradation and SCFAs 
production (Chassard, Delmas, Robert, Lawson, & Bernalier-Donadille, 2012; Meehan & Beiko, 
2014). In addition, the white button supplementation increased the abundance of 
Fusicatenibacter, Eisenbergiella, Lachnobacterium, and Robinsoniella witch were found to be 
associated with many health outcomes, including lowering levels of cholesterol, correcting the 
dysbiosis caused by obesity, and improving outcomes for patients with primary biliary cirrhosis 
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(Lv et al., 2016; Prieto et al., 2018; Togo et al., 2016). Feeding pigs with mushrooms reduced the 
relative abundance of Bifidobacterium and increased the relative abundance of Prevotella, which 
was found to be associated with improving glucose metabolism (Kovatcheva-Datchary et al., 
2015). In contrast, the Armillariella tabescens administration promoted Lactobacillus spp. and 
Bifidobacterium spp. and inhibited E.coli growth (Chen et al., 2017). A variety of mushrooms 
increased the Firmicutes and Actinobacteria population and decreased the population of 
Bacteroidetes and Proteobacteria in mice fed a high-fat diet compared to the high-fat diet group. 
Furthermore, there was a tendency toward an increased relative abundance of SCFAs-producing 
bacteria, Allobaculum, Bifidobacterium, and Ruminococcus, as well as lactic acid-producing 
bacteria, Lactobacillus, Lactococcus, and Streptococcus, in mice fed mushrooms compared to 
the high-fat diet group. Additionally, Adlercreutzia and Sutterella showed a suggestive increase 
after the mushrooms intake, while a suggestive decrease was observed in Bacteroides, 
Prevotella, Mucispirillum, Dorea, Roseburia, Anaerotruncus, Oscillospira, Escherichiam, and 
Akkermansia (Shimizu, Mori, Ouchi, Kushida, & Tsuduki, 2018). More recently, Pleurotus 
eryngii mushrooms significantly increased the richness and diversity of gut microbiota and 
partially reversed the dysbiosis induced by dextran‐sodium‐sulfate (DSS)-treatment in mice (Q. 
Hu et al., 2019). P. eryngii administration significantly increased the relative abundance of S24-7 
and Odoribacteraceae at the family level, and Adlercreutzia, Akkermanisa, Lactobacillus, 
Anaerostipes, and Allobaculum at the genus level compared to the DSS group. Adlercreutzia 
reduction was observed in patients with IBD (Shaw et al., 2016). P. eryngii supplementation also 
reduced the abundance of Actinobacteria, Mollicutes, Desulfovibrionaceae, Enterococcaceae, 
Turicibacter, Dorea, rc4-4, Bacteroides, and Prvotella compared to the DSS group. It has been 
reported that the family Desulfovibrionacea, a sulfate-reducing bacteria, is a potential endotoxin 
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producer and might be associated with the low grade and chronic inflammation (Xiao et al., 
2014). 
1.3.3.13 Jerusalem artichokes 
Jerusalem artichokes, also called sunchoke, sunroot, or earth apple, are rich in dietary 
fiber, mainly Inulin-type fructans. The inulin content in Jerusalem artichokes ranges from 7 to 
30% for fresh weight or from 60 to 85.5% for dry weight (Aduldecha et al., 2016; Samal, 
Chaturvedi, & Pattanaik, 2017). A few studies have investigated the potential effect of Jerusalem 
artichoke on gut microbiota composition (Table 1. 11). Results from an in vivo study showed 
that Jerusalem artichoke supplementation increased the level of Lactobacillus spp. and 
Bifidobacterium spp. in the cecal, colonic, and rectal digesta in healthy rats. The Jerusalem 
artichoke supplementation decreased the Coliforms population in rats (Samal et al., 2017). More 
studies, especially in vivo studies, need to be done to assess the potential impact of Jerusalem 
artichoke on the gut microbiota composition and diversity. 
1.4 Conclusion 
Fruit and vegetable consumption profoundly modifies and shapes the gut microbiota 
ecosystem due to the intense content of dietary fibers and bioactive compounds, including 
polyphenols. Several health outcomes have been linked to reshaping the gut microbiota and their 
associated functions by fruit and vegetable supplementation, including promoting the host's 
general health, reducing the risk of several diseases and metabolic disorders. Phytochemicals and 
fibers are the compounds found in fruits and vegetables that impact the intestinal microbiota 
composition and diversity. A majority of nutritional and microbiological researches have focused 
on investigating the effect of extracted compounds on gut microbiota profiles instead of the 
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whole foods.  Berries have been more commonly used to investigate the impact of whole foods 
on gut microbiota. More studies of whole fruits and vegetables, and especially in combination, 
are needed due to potential synergies between compounds and interactions with the whole fruits 




Table 1. 1: Modulation of the gut microbiota by berries. 
HTS: High throughput sequencing; qPCR: Quantitative polymerase chain reaction; DGGE: 
Denaturing gradient gel electrophoresis; FISH: Fluorescent in situ hybridization; SHIME: 
Simulator of the human intestinal microbial ecosystem; PCR: polymerase chain reaction. 




Changes in gut 
microbiota 
Ref. 
Strawberry Animal study 
(diabetic mice) 
2.35% of dried 
strawberry 
powder 







 Bacteroides and 
Akkermansia 
   Dehalobacterium, 






Strawberry Animal study 
(colitic mice) 








 Bifidobacterium and 
Lactobacillus 
 Akkermansia, Dorea, 










































 Bifidobacterium and 
Lactobacillus 





Cranberry  Human study 
(healthy  
individuals) 
30 g of dried 
cranberry powder 





















10% of dried 
blueberry 
powder) 
21 weeks qPCR    Bacteroides-Prevotella-
Porphyromonas, 
Bifidobacterium, 


















Table 1. 1 (Cont.) 




Changes in gut 
microbiota 
Ref. 
Blueberry Animal study 
(healthy mice) 
5% of dried 
blueberry 
powder) 


















8 weeks HTS 
(Illumina 
Hiseq) 




Blueberry Animal study 
(healthy rats) 
8% of dried 
blueberry 
powder) 








 Bifidobacteriaceae and 
Coriobacteriaceae 
Genus level: 













25 g of wild 
blueberry powder 
in 250 mL of 
water) 
6 weeks qPCR  Bifidobacterium, 
Lactobacillus acidophilus 














25 g of wild 
blueberry powder 
in 250 mL of 
water) 
6 weeks qPCR   Bifidobacterium longum 
subsp. Infantis 
   Bifidobacterium 
adolescentis, B. longum 
subsp. longum, B. 



























10% of dried 
black raspberries 
powder 

















10% of dried 
black raspberries 
powder 
















5.3% of dried red 
raspberry 
8 weeks qPCR Order level: 
 Bacteroidales 
Family level: 
  Lachnospiraceae 
 Enterobacteriaceae and  
S24-7 
Genus level: 














Table 1. 1 (Cont.) 


















2 and 10 mg ml−1 
of dried berry 
powder 
24 hours Culture 
methods 














fraction of small 
intestine digested 
berries 
72 hours PCR-DGGE  Bifidobacteria, 
Bacteroides/Prevotella 






























1% of dried 
juçara pulp 
powder 
24 hours FISH  Bifidobacterium, 
Clostridium clusters XIVa, 
Bacteroides, Eubacterium 









(rats fed a high-
fat diet) 
0.5 and 0.25% of 
dried berry 
powder 







(mice fed a 
high-fat diet) 
1% of dried 
Lonicera 
cerula L. berry 
powder 


























1% of dried Goji 
berry powder 


























Table 1. 1 (Cont.) 




Changes in gut 
microbiota 
Ref. 
Lingonberry  Animal study 
(mice fed a 
high-fat diet) 
44% of dried  
Lingonberry 
powder 






































2 g of lyophilized 
berry mixture 





 Firmicutes and 
Proteobacteria 
Familly level: 











100 ml, twice a 
day 












Table 1. 2: Modulation of the gut microbiota by cherries. 
HTS: High throughput sequencing; qPCR: Quantitative polymerase chain reaction. 




Changes in gut 
microbiota 
Ref. 
Tart Cherry In vitro (batch-
culture 
fermentation) 
5 ml of 
concentrated tart 
cheery or 5g of 
tart cherry 
powder 
48 Hours Culture 
methods 
 Bacteroides, Veillonella, 
Bilophila,  Escherichia,  




















Table 1. 2 (Cont.) 




Changes in gut 
microbiota 
Ref. 
Tart Cherry Human study 
(healthy  
individuals) 
8 oz. of tart 
cherry juice daily 
5 days HTS 
(Illumina 
Miseq) 































10%  of dark 
sweet cherry 
powder 
12 weeks qPCR  Akkermansia spp. and 
fiber-degraders (the S24-7 
family)  















the juices (1/20 
v/v, 1/15 v/v, 
1/10 v/v, 1/7 v/v, 
and 1/4 v/v) 
every 5 days 
25 days HTS 
(Illumina 
Miseq) 









Table 1. 3: Modulation of the gut microbiota by mangos. 
HTS: High throughput sequencing; qPCR: Quantitative polymerase chain reaction. 




Changes in gut 
microbiota 
Ref. 
Mango Animal study 
(mice fed a 
high-fat diet) 
1% or 10% of 
dried  mango 
















400g of dried  
mango daily 
6 weeks qPCR  Lactococcus lactis 








Table 1. 4: Modulation of the gut microbiota by apples. 
HTS: High throughput sequencing; DGGE: Denaturing gradient gel electrophoresis. 




Changes in gut 
microbiota 
Ref. 
Apple Animal study 
(healthy rat) 





Table 1. 4 (Cont.) 


























 Actinobacteria (with all 
apple varieties)  
 Proteobacteria (with 
Renetta Canada and 
Golden Delicious) 
 Bacteroidetes (with 
Renetta Canada and 
Golden Delicious) 
   Firmicutes (with all 
apple varieties) 
Genus level: 
 Bifidobacterium spp. 
(with Renetta Canada and 
Golden Delicious) 
 Faecalibacterium 






Apple Animal study 
(rat fed a high-
fat or low-fat 
diet) 
5% of freeze 
dried apple 
6 weeks HTS 
(Illumina 
Miseq) 




Other levels (hight-fat diet 
group): 
 Clostridiales   
 Bacteroidaceae 









Apple Animal study 
(mice fed a 
high-fat or low-
fat diet) 
40% of freeze 
dried whole 
RedDel apple  










(mice fed a 
high-fat or low-
fat diet) 
20% of freeze 
dried RedDel 
apple peel 







Apple Human study 
(healthy  
individuals) 
















Table 1. 5: Modulation of the gut microbiota by grapes. 
HTS: High throughput sequencing; DGGE: Denaturing gradient gel electrophoresis; PCR: 
polymerase chain reaction. 




Changes in  gut 
microbiota 
Ref. 
Grape Animal study 
(mice following 
a high fat diet) 
3% or 5% 
powdered grapes 
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Changes in  gut 
microbiota 
Ref. 
Grape Animal study 




16 weeks HTS 
(Illumina 
Miseq) 














272 mL of red 
wine or de-
alcoholized red 
wine  daily 
20 days PCR-DGGE Phylum level: 
 Fusobacteria 
Genus level: 
 Bifidobacterium and 
Enterococcus 
Species level: 
 Eggerthella lenta, 
Blautia coccoides–














272 mL of red 
wine or de-
alcoholized red 
wine  daily 
30 days PCR-DGGE Phylum level: 
























Table 1. 6: Modulation of the gut microbiota by kiwifruits. 
qPCR: Quantitative polymerase chain reaction; DGGE: Denaturing gradient gel electrophoresis; 
PCR: polymerase chain reaction. 















1% of green or 
gold kiwifruit 
48 hours  qPCR  Bifidobacterium spp. 










10% of green 
kiwifruit 








25% of dried 
green kiwi 














Table 1. 7: Modulation of the gut microbiota by oranges. 
DGGE: Denaturing gradient gel electrophoresis; SHIME: Simulator of the human intestinal 
microbial ecosystem. 




Changes in gut 
microbiota 
Ref. 





105 ml of fresh 
orange juice 
14 days PCR-DGGE  Bifidobacterium spp., 
Lactobacillus spp., 












105 ml of 
pasteurized 
orange juice 







500 mL of orange 
juice 









Genus level:  











 500 mL of 
orange juice 








  Ruminococcaceae 





Orange juice Human study 
(healthy 
individuals) 
300 mL of orange 
juice 
8 weeks PCR-DGGE  Bifidobacterium spp. 





Table 1. 8: Modulation of the gut microbiota by pomegranates. 
HTS: High throughput sequencing; qPCR: Quantitative polymerase chain reaction; FISH: 
Fluorescent in situ hybridization. 












1.5 mL of POMx 0, 5, 10, 24 
and 48 
hours 
FISH  Bifidobacterium spp. 















Table 1. 8 












1000 mg of 
POMx 











1000 mg of 
POMx 





















Table 1. 9: Modulation of the gut microbiota by avocados. 
HTS: High throughput sequencing. 














1 Hass avocado 
daily 
































1 Hass avocado 
daily 
12 weeks HTS 
(Illumina 
Miseq) 







Table 1. 10: Modulation of the gut microbiota by bitter melons. 
HTS: High throughput sequencing. 
Bitter 
melons 












300 mg of bitter 
melon powder 
/kg 



















Table 1. 10 
Bitter 
melons 











400 mg of bitter 
melon powder 
/kg 




 Verrucomicrobia  
Genus level: 











(mice fed a 
high-fat diet) 
1.5% of freeze-
dried bitter melon 
juice 














Table 1. 11: Modulation of the gut microbiota by vegetables. 
HTS: High throughput sequencing; qPCR: Quantitative polymerase chain reaction. 




Changes in gut 
microbiota 
Ref. 





10% of dried 
broccoli powder) 




 Clostridium perfringens, 
Enterococcus, Lactobacill






Broccoli Animal study 
(healthy rats) 
10% of dried 
cocked broccoli 
powder) 







Oscillospira, and  
Ruminococcaceae  
 






Broccoli Human study 
(healthy  
individuals) 
200 g of cocked 
broccoli daily  


















1% of dried 
mushroom 






sub-classes Delta, Gamma, 
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75 g or 150 g of 
dried mushrooms 



















Succinivibrio, Sarcina, and 













0.1, 0.3, or 
0.9% of dried 
Armillariella 
tabescens 












(mice fed a 
high-fat diet) 
0.5% or 3% of 
dried mushrooms 





 Firmicutes and 
Actinobacteria 


































Table 1. 11 (Cont.) 


























 S24-7 and 
Odoribacteraceae 








 Turicibacter, Dorea, 










2, 4, or 6% of 
Jerusalem 
artichoke powder 
12 weeks Culture 
method 











2015–2020 Dietary Guidelines. (2015). Retrieved from https://health.gov/our-work/food-
nutrition/2015-2020-dietary-guidelines 
Aduldecha, C., Kaewpradit, W., Vorasoot, N., Puangbut, D., Jogloy, S., & Patanothai, A. (2016). 
Effects of water regimes on inulin content and inulin yield of Jerusalem artichoke 
genotypes with different levels of drought tolerance. Turkish Journal of Agriculture and 
Forestry, 40(3), 335-343.  
Aguirre, M., & Venema, K. (2015). Does the gut microbiota contribute to obesity? Going beyond 
the gut feeling. Microorganisms, 3(2), 213-235.  
Ajila, C. M., Naidu, K. A., Bhat, S. G., & Rao, U. J. S. P. (2007). Bioactive compounds and 
antioxidant potential of mango peel extract. Food Chemistry, 105(3), 982-988.  
Al Othaim, A., Marasini, D., & Carbonero, F. (2020). Impact of increasing concentration of tart 
and sweet cherries juices concentrates on healthy mice gut microbiota. Food Frontiers, 
1(3), 224-233. doi:10.1002/fft2.46 
Alhinai, E. A., Walton, G. E., & Commane, D. M. (2019). The Role of the Gut Microbiota in 
Colorectal Cancer Causation. International Journal of Molecular Sciences, 20(21), 5295.  
Amirullah, N. A., Abidin, N. Z., & Abdullah, N. (2018). The potential applications of 
mushrooms against some facets of atherosclerosis: A review. Food Research 
International, 105, 517-536.  
Angelino, D., Dosz, E. B., Sun, J., Hoeflinger, J. L., Van Tassell, M. L., Chen, P., . . . Jeffery, E. 
H. (2015). Myrosinase-dependent and–independent formation and control of 
isothiocyanate products of glucosinolate hydrolysis. Frontiers in plant science, 6, 831.  
Anonye, B. O. (2017). Commentary: dietary polyphenols promote growth of the gut bacterium 
Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome. 
Frontiers in immunology, 8, 850.  
Aoki, R., Kamikado, K., Suda, W., Takii, H., Mikami, Y., Suganuma, N., . . . Koga, Y. (2017). A 
proliferative probiotic Bifidobacterium strain in the gut ameliorates progression of 
metabolic disorders via microbiota modulation and acetate elevation. Scientific reports, 7, 
43522.  
Attri, S., & Goel, G. (2018). Influence of polyphenol rich seabuckthorn berries juice on release 
of polyphenols and colonic microbiota on exposure to simulated human digestion model. 
Food Research International, 111, 314-323.  
Attri, S., Sharma, K., Raigond, P., & Goel, G. (2018). Colonic fermentation of polyphenolics 
from Sea buckthorn (Hippophae rhamnoides) berries: Assessment of effects on microbial 
diversity by Principal Component Analysis. Food Research International, 105, 324-332.  
56 
 
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005). Host-
bacterial mutualism in the human intestine. Science, 307(5717), 1915-1920.  
Bai, J., Zhu, Y., & Dong, Y. (2016). Response of gut microbiota and inflammatory status to 
bitter melon (Momordica charantia L.) in high fat diet induced obese rats. Journal of 
Ethnopharmacology, 194, 717-726.  
Bai, J., Zhu, Y., & Dong, Y. (2018). Modulation of gut microbiota and gut-generated metabolites 
by bitter melon results in improvement in the metabolic status in high fat diet-induced 
obese rats. Journal of Functional Foods, 41, 127-134.  
Balamurugan, R., Rajendiran, E., George, S., Samuel, G. V., & Ramakrishna, B. S. (2008). Real‐
time polymerase chain reaction quantification of specific butyrate‐producing bacteria, 
Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. 
Journal of gastroenterology and hepatology, 23(8pt1), 1298-1303.  
Baldwin, J., Collins, B., Wolf, P. G., Martinez, K., Shen, W., Chuang, C.-C., . . . Chang, E. 
(2016). Table grape consumption reduces adiposity and markers of hepatic lipogenesis 
and alters gut microbiota in butter fat-fed mice. The Journal of nutritional biochemistry, 
27, 123-135.  
Balish, E., & Warner, T. (2002). Enterococcus faecalis induces inflammatory bowel disease in 
interleukin-10 knockout mice. The American journal of pathology, 160(6), 2253-2257.  
Bang, S.-J., Kim, G., Lim, M. Y., Song, E.-J., Jung, D.-H., Kum, J.-S., . . . Seo, D.-H. (2018). 
The influence of in vitro pectin fermentation on the human fecal microbiome. Amb 
Express, 8(1), 1-9.  
Bao, B., Chen, Y.-G., Zhang, L., Xu, Y. L. N., Wang, X., Liu, J., & Qu, W. (2013). Momordica 
charantia (Bitter Melon) reduces obesity-associated macrophage and mast cell infiltration 
as well as inflammatory cytokine expression in adipose tissues. PloS one, 8(12).  
Barlow, G. M., Yu, A., & Mathur, R. (2015). Role of the gut microbiome in obesity and diabetes 
mellitus. Nutrition in clinical practice, 30(6), 787-797.  
Barnes, R. C., Kim, H., Fang, C., Bennett, W., Nemec, M., Sirven, M. A., . . . Mertens‐Talcott, 
S. U. (2019). Body Mass Index as a Determinant of Systemic Exposure to Gallotannin 
Metabolites during 6‐Week Consumption of Mango (Mangifera indica L.) and 
Modulation of Intestinal Microbiota in Lean and Obese Individuals. Molecular nutrition 
& food research, 63(2), 1800512.  
Berkow, S. E., & Barnard, N. (2006). Vegetarian diets and weight status. Nutrition reviews, 
64(4), 175-188.  
Bhaduri, A., Dubey, A. K., & Basu, A. (2019). Method for increasing abundance of lachnospira. 
In: Google Patents. 
57 
 
Bialonska, D., Ramnani, P., Kasimsetty, S. G., Muntha, K. R., Gibson, G. R., & Ferreira, D. 
(2010). The influence of pomegranate by-product and punicalagins on selected groups of 
human intestinal microbiota. International journal of food microbiology, 140(2-3), 175-
182.  
Biragyn, A., & Ferrucci, L. (2018). Gut dysbiosis: a potential link between increased cancer risk 
in ageing and inflammaging. The Lancet Oncology, 19(6), e295-e304.  
Blatchford, P., Stoklosinski, H., Walton, G., Swann, J., Gibson, G., Gearry, R., & Ansell, J. 
(2015). Kiwifruit fermentation drives positive gut microbial and metabolic changes 
irrespective of initial microbiota composition. Bioactive Carbohydrates and Dietary 
Fibre, 6(1), 37-45.  
Bradbury, K. E., Crowe, F. L., Appleby, P. N., Schmidt, J. A., Travis, R. C., & Key, T. J. (2014). 
Serum concentrations of cholesterol, apolipoprotein AI and apolipoprotein B in a total of 
1694 meat-eaters, fish-eaters, vegetarians and vegans. European Journal of Clinical 
Nutrition, 68(2), 178-183.  
Brasili, E., Hassimotto, N. M. A., Del Chierico, F., Marini, F., Quagliariello, A., Sciubba, F., . . . 
Lajolo, F. (2019). Daily consumption of orange juice from Citrus sinensis L. Osbeck cv. 
Cara Cara and cv. Bahia differently affects gut microbiota profiling as unveiled by an 
integrated meta-omics approach. Journal of agricultural and food chemistry, 67(5), 1381-
1391.  
Budak, N. H. (2017). Bioactive components of Prunus avium L. black gold (red cherry) and 
Prunus avium L. stark gold (white cherry) juices, wines and vinegars. Journal of food 
science and technology, 54(1), 62-70.  
Cai, X., Han, Y., Gu, M., Song, M., Wu, X., Li, Z., . . . Xiao, H. (2019). Dietary cranberry 
suppressed colonic inflammation and alleviated gut microbiota dysbiosis in dextran 
sodium sulfate-treated mice. Food & Function, 10(10), 6331-6341.  
Cancer. (2018). Retrieved from https://www.who.int/health-topics/cancer#tab=tab_1 
Cani, P. D., & de Vos, W. M. (2017). Next-generation beneficial microbes: the case of 
Akkermansia muciniphila. Frontiers in microbiology, 8, 1765.  
Cardiovascular diseases (CVDs). (2017). Retrieved from https://www.who.int/en/news-
room/fact-sheets/detail/cardiovascular-diseases-(cvds) 
Cardona, F., Andrés-Lacueva, C., Tulipani, S., Tinahones, F. J., & Queipo-Ortuño, M. I. (2013). 
Benefits of polyphenols on gut microbiota and implications in human health. The Journal 
of nutritional biochemistry, 24(8), 1415-1422.  
Cassidy, A., & Minihane, A.-M. (2017). The role of metabolism (and the microbiome) in 
defining the clinical efficacy of dietary flavonoids. The American journal of clinical 
nutrition, 105(1), 10-22.  
58 
 
Centers for Disease Control and, P. (2020). National diabetes statistics report, 2020. Atlanta, GA: 
Centers for Disease Control and Prevention, US Department of Health and Human 
Services.  
Chassard, C., Delmas, E., Robert, C., Lawson, P. A., & Bernalier-Donadille, A. (2012). 
Ruminococcus champanellensis sp. nov., a cellulose-degrading bacterium from human 
gut microbiota. International Journal of Systematic and Evolutionary Microbiology, 
62(1), 138-143.  
Chen, W. B., Cheng, M. J., Tian, Y. B., Wang, Q. H., Wang, B., Li, M. J., & Fang, R. J. (2017). 
Effects of Armillariella tabescens mycelia on the growth performance and intestinal 
immune response and microflora of early‐weaned pigs. Animal Science Journal, 88(9), 
1388-1397.  
Chiu, T. H. T., Pan, W.-H., Lin, M.-N., & Lin, C.-L. (2018). Vegetarian diet, change in dietary 
patterns, and diabetes risk: a prospective study. Nutrition & diabetes, 8(1), 1-9.  
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., 
& Malanda, B. (2018). IDF Diabetes Atlas: Global estimates of diabetes prevalence for 
2017 and projections for 2045. Diabetes research and clinical practice, 138, 271-281.  
Chung, W. S. F., Meijerink, M., Zeuner, B., Holck, J., Louis, P., Meyer, A. S., . . . Duncan, S. H. 
(2017). Prebiotic potential of pectin and pectic oligosaccharides to promote anti-
inflammatory commensal bacteria in the human colon. FEMS microbiology ecology, 
93(11), fix127.  
Cirstea, M., Radisavljevic, N., & Finlay, B. B. (2018). Good bug, bad bug: breaking through 
microbial stereotypes. Cell host & microbe, 23(1), 10-13.  
Collins, B., Hoffman, J., Martinez, K., Grace, M., Lila, M. A., Cockrell, C., . . . Zhong, W. 
(2016). A polyphenol-rich fraction obtained from table grapes decreases adiposity, 
insulin resistance and markers of inflammation and impacts gut microbiota in high-fat-
fed mice. The Journal of nutritional biochemistry, 31, 150-165.  
Costa, C., Tsatsakis, A., Mamoulakis, C., Teodoro, M., Briguglio, G., Caruso, E., . . . Kouretas, 
D. (2017). Current evidence on the effect of dietary polyphenols intake on chronic 
diseases. Food and Chemical Toxicology, 110, 286-299.  
Crascì, L., Lauro, M. R., Puglisi, G., & Panico, A. (2018). Natural antioxidant polyphenols on 
inflammation management: Anti-glycation activity vs metalloproteinases inhibition. 
Critical Reviews in Food Science and Nutrition, 58(6), 893-904.  
Cui, J., Lian, Y., Zhao, C., Du, H., Han, Y., Gao, W., . . . Zheng, J. (2019). Dietary Fibers from 
Fruits and Vegetables and Their Health Benefits via Modulation of Gut Microbiota. 
Comprehensive Reviews in Food Science and Food Safety, 18(5), 1514-1532.  
Dao, M. C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E. O., . . . 
Hoyles, L. (2016). Akkermansia muciniphila and improved metabolic health during a 
59 
 
dietary intervention in obesity: relationship with gut microbiome richness and ecology. 
Gut, 65(3), 426-436.  
De Palma, G., Nadal, I., Medina, M., Donat, E., Ribes-Koninckx, C., Calabuig, M., & Sanz, Y. 
(2010). Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with 
coeliac disease in children. BMC microbiology, 10(1), 1-7.  
Del Chierico, F., Nobili, V., Vernocchi, P., Russo, A., De Stefanis, C., Gnani, D., . . . Capuani, 
G. (2017). Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese 
patients unveiled by an integrated meta‐omics‐based approach. Hepatology, 65(2), 451-
464.  
Denis, M.-C., Roy, D., Yeganeh, P. R., Desjardins, Y., Varin, T., Haddad, N., . . . Furtos, A. 
(2016). Apple peel polyphenols: a key player in the prevention and treatment of 
experimental inflammatory bowel disease. Clinical Science, 130(23), 2217-2237.  
Diabetes. (2020). Retrieved from https://www.who.int/news-room/fact-sheets/detail/diabetes 
Dinh, D. M., Volpe, G. E., Duffalo, C., Bhalchandra, S., Tai, A. K., Kane, A. V., . . . Ward, H. 
D. (2015). Intestinal microbiota, microbial translocation, and systemic inflammation in 
chronic HIV infection. The Journal of Infectious Diseases, 211(1), 19-27.  
Dinu, M., Abbate, R., Gensini, G. F., Casini, A., & Sofi, F. (2017). Vegetarian, vegan diets and 
multiple health outcomes: a systematic review with meta-analysis of observational 
studies. Critical Reviews in Food Science and Nutrition, 57(17), 3640-3649.  
Dreher, M. L., & Davenport, A. J. (2013). Hass avocado composition and potential health 
effects. Critical Reviews in Food Science and Nutrition, 53(7), 738-750.  
Dueñas, M., Muñoz-González, I., Cueva, C., Jiménez-Girón, A., Sánchez-Patán, F., Santos-
Buelga, C., . . . Bartolomé, B. (2015). A survey of modulation of gut microbiota by 
dietary polyphenols. BioMed research international, 2015.  
Duque, A. L. R. F., Monteiro, M., Adorno, M. A. T., Sakamoto, I. K., & Sivieri, K. (2016). An 
exploratory study on the influence of orange juice on gut microbiota using a dynamic 
colonic model. Food Research International, 84, 160-169.  
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., . . . 
Relman, D. A. (2005). Diversity of the human intestinal microbial flora. Science, 
308(5728), 1635-1638.  
Elkahoui, S., Levin, C. E., Bartley, G. E., Yokoyama, W., & Friedman, M. (2019). Levels of 
Fecal Procyanidins and Changes in Microbiota and Metabolism in Mice Fed a High-Fat 




Evans, S. F., Meister, M., Mahmood, M., Eldoumi, H., Peterson, S., Perkins-Veazie, P., . . . 
Lucas, E. A. (2014). Mango supplementation improves blood glucose in obese 
individuals. Nutrition and metabolic insights, 7, NMI-S17028.  
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., . . . Delzenne, N. 
M. (2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium 
controls diet-induced obesity. Proceedings of the National Academy of Sciences, 110(22), 
9066-9071.  
Falk, A., Olsson, C., Ahrné, S., Molin, G., Adawi, D., & Jeppsson, B. (2007). Ileal pelvic pouch 
microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, 
were unstable over time and showed the presence of Clostridium perfringens. 
Scandinavian journal of gastroenterology, 42(8), 973-985.  
Feng, Y., Stams, A. J. M., De Vos, W. M., & Sánchez-Andrea, I. (2017). Enrichment of 
sulfidogenic bacteria from the human intestinal tract. FEMS Microbiology Letters, 
364(4), fnx028.  
Feng, Z., Long, W., Hao, B., Ding, D., Ma, X., Zhao, L., & Pang, X. (2017). A human stool-
derived Bilophila wadsworthia strain caused systemic inflammation in specific-pathogen-
free mice. Gut pathogens, 9(1), 1-10.  
Fernandes, J., Su, W., Rahat-Rozenbloom, S., Wolever, T. M. S., & Comelli, E. M. (2014). 
Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. 
Nutrition & diabetes, 4(6), e121-e121.  
Ferrario, C., Taverniti, V., Milani, C., Fiore, W., Laureati, M., De Noni, I., . . . Guglielmetti, S. 
(2014). Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention 
with Lactobacillus paracasei DG varies among healthy adults. The Journal of nutrition, 
144(11), 1787-1796.  
Food demand Survey. (2018). Retrieved from 
http://www.agecon.okstate.edu/agecon_research.asp 
Fouhse, J. M., Gänzle, M. G., Beattie, A. D., Vasanthan, T., & Zijlstra, R. T. (2017). Whole-
grain starch and fiber composition modifies ileal flow of nutrients and nutrient 
availability in the hindgut, shifting fecal microbial profiles in pigs. The Journal of 
nutrition, 147(11), 2031-2040.  
Furet, J.-P., Kong, L.-C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.-L., . . . Henegar, C. 
(2010). Differential adaptation of human gut microbiota to bariatric surgery–induced 
weight loss: links with metabolic and low-grade inflammation markers. Diabetes, 59(12), 
3049-3057.  
Gagnière, J., Raisch, J., Veziant, J., Barnich, N., Bonnet, R., Buc, E., . . . Bonnet, M. (2016). Gut 




Garcia-Mazcorro, J. F., Lage, N. N., Mertens-Talcott, S., Talcott, S., Chew, B., Dowd, S. E., . . . 
Noratto, G. D. (2018). Effect of dark sweet cherry powder consumption on the gut 
microbiota, short-chain fatty acids, and biomarkers of gut health in obese db/db mice. 
PeerJ, 6, e4195.  
Garcia-Mazcorro, J. F., Pedreschi, R., Chew, B., Dowd, S. E., Kawas, J. R., & Noratto, G. 
(2018). Dietary supplementation with raspberry extracts modifies the fecal microbiota in 
obese diabetic db/db mice. J. Microbiol. Biotechnol, 28(8), 1247-1259.  
Garcia-Mazcorro, J. F., Pedreschi, R., Yuan, J., Kawas, J. R., Chew, B., Dowd, S. E., & Noratto, 
G. (2019). Apple consumption is associated with a distinctive microbiota, proteomics and 
metabolomics profile in the gut of Dawley Sprague rats fed a high-fat diet. PloS one, 
14(3).  
Gentile, C. L., & Weir, T. L. (2018). The gut microbiota at the intersection of diet and human 
health. Science, 362(6416), 776-780.  
Gomes, A., Oudot, C., Macià, A., Foito, A., Carregosa, D., Stewart, D., . . . Brenner, C. (2019). 
Berry-enriched diet in salt-sensitive hypertensive rats: metabolic fate of (poly) phenols 
and the role of gut microbiota. Nutrients, 11(11), 2634.  
Gondi, M., Basha, S. A., Bhaskar, J. J., Salimath, P. V., & Prasada Rao, U. J. S. (2015). Anti‐
diabetic effect of dietary mango (Mangifera indica L.) peel in streptozotocin‐induced 
diabetic rats. Journal of the Science of Food and Agriculture, 95(5), 991-999.  
Greetham, H. L., Gibson, G. R., Giffard, C., Hippe, H., Merkhoffer, B., Steiner, U., . . . Collins, 
M. D. (2004). Allobaculum stercoricanis gen. nov., sp. nov., isolated from canine feces. 
Anaerobe, 10(5), 301-307.  
Gu, J., Thomas‐Ahner, J. M., Riedl, K. M., Bailey, M. T., Vodovotz, Y., Schwartz, S. J., & 
Clinton, S. K. (2019). Dietary black raspberries impact the colonic microbiome and 
phytochemical metabolites in mice. Molecular nutrition & food research, 63(8), 
1800636.  
Guergoletto, K. B., Costabile, A., Flores, G., Garcia, S., & Gibson, G. R. (2016). In vitro 
fermentation of juçara pulp (Euterpe edulis) by human colonic microbiota. Food 
Chemistry, 196, 251-258.  
Guglielmetti, S., Fracassetti, D., Taverniti, V., Del Bo’, C., Vendrame, S., Klimis-Zacas, D., . . . 
Porrini, M. (2013). Differential modulation of human intestinal bifidobacterium 
populations after consumption of a wild blueberry (Vaccinium angustifolium) drink. 
Journal of agricultural and food chemistry, 61(34), 8134-8140.  
Hakansson, A., & Molin, G. (2011). Gut microbiota and inflammation. Nutrients, 3(6), 637-682.  
Hales, C. M., Carroll, M. D., Fryar, C. D., & Ogden, C. L. (2020). Prevalence of obesity and 
severe obesity among adults: United States, 2017–2018.  
62 
 
Han, K. S., Balan, P., Molist Gasa, F., & Boland, M. (2011). Green kiwifruit modulates the 
colonic microbiota in growing pigs. Letters in applied microbiology, 52(4), 379-385.  
Han, Y., Song, M., Gu, M., Ren, D., Zhu, X., Cao, X., . . . Yuan, B. (2019). Dietary intake of 
whole strawberry inhibited colonic inflammation in dextran-sulfate-sodium-treated mice 
via restoring immune homeostasis and alleviating gut microbiota dysbiosis. Journal of 
agricultural and food chemistry, 67(33), 9168-9177.  
Heart Disease and Stroke Statistics-2019 At-a-Glance. (2019). Retrieved from 
https://healthmetrics.heart.org/wp-content/uploads/2019/02/At-A-Glance-Heart-Disease-
and-Stroke-Statistics-%E2%80%93-2019.pdf 
Heintz‐Buschart, A., Pandey, U., Wicke, T., Sixel‐Döring, F., Janzen, A., Sittig‐Wiegand, E., . . . 
Wilmes, P. (2018). The nasal and gut microbiome in Parkinson's disease and idiopathic 
rapid eye movement sleep behavior disorder. Movement disorders, 33(1), 88-98.  
Henning, S. M., Summanen, P. H., Lee, R.-P., Yang, J., Finegold, S. M., Heber, D., & Li, Z. 
(2017). Pomegranate ellagitannins stimulate the growth of Akkermansia muciniphila in 
vivo. Anaerobe, 43, 56-60.  
Henning, S. M., Yang, J., Woo, S. L., Lee, R.-P., Huang, J., Rasmusen, A., . . . Tseng, C.-H. 
(2019). Hass avocado inclusion in a weight-loss diet supported weight loss and altered 
gut microbiota: a 12-week randomized, parallel-controlled trial. Current developments in 
nutrition, 3(8), nzz068.  
Hever, J., & Cronise, R. J. (2017). Plant-based nutrition for healthcare professionals: 
implementing diet as a primary modality in the prevention and treatment of chronic 
disease. Journal of geriatric cardiology: JGC, 14(5), 355.  
Hiippala, K., Jouhten, H., Ronkainen, A., Hartikainen, A., Kainulainen, V., Jalanka, J., & 
Satokari, R. (2018). The potential of gut commensals in reinforcing intestinal barrier 
function and alleviating inflammation. Nutrients, 10(8), 988.  
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. 
D., . . . Zabetian, C. P. (2017). Parkinson's disease and Parkinson's disease medications 
have distinct signatures of the gut microbiome. Movement disorders, 32(5), 739-749.  
Hillman, E. T., Lu, H., Yao, T., & Nakatsu, C. H. (2017). Microbial ecology along the 
gastrointestinal tract. Microbes and environments, ME17017.  
Hjorth, M. F., Roager, H. M., Larsen, T. M., Poulsen, S. K., Licht, T. R., Bahl, M. I., . . . Astrup, 
A. (2018). Pre-treatment microbial Prevotella-to-Bacteroides ratio, determines body fat 
loss success during a 6-month randomized controlled diet intervention. International 
journal of obesity, 42(3), 580-583.  




Hu, H.-J., Park, S.-G., Jang, H. B., Choi, M.-G., Park, K.-H., Kang, J. H., . . . Cho, S.-H. (2015). 
Obesity alters the microbial community profile in Korean adolescents. PloS one, 10(7).  
Hu, Q., Yuan, B., Wu, X., Du, H., Gu, M., Han, Y., . . . Xiao, H. (2019). Dietary intake of 
Pleurotus eryngii ameliorated dextran‐sodium‐sulfate‐induced colitis in mice. Molecular 
nutrition & food research, 63(17), 1801265.  
Huang, R.-Y., Huang, C.-C., Hu, F. B., & Chavarro, J. E. (2016). Vegetarian diets and weight 
reduction: a meta-analysis of randomized controlled trials. Journal of general internal 
medicine, 31(1), 109-116.  
Huttenhower, C., Gevers, D., Knight, R., Abubucker, S., Badger, J. H., Chinwalla, A. T., . . . 
Fulton, R. S. (2012). Structure, function and diversity of the healthy human microbiome. 
Nature, 486(7402), 207.  
Hwang, E.-S. (2018). Comparison of antioxidant capacity and α-glucosidase inhibitory activity 
between bitter melon (Momordica charanti) fruit and leaf extract. Asian Pacific Journal 
of Tropical Biomedicine, 8(4), 189.  
Iuchi, T., Hosaka, T., Shiroishi, M., Ono, H., Inukai, K., Sumita, T., . . . Awata, T. (2015). 
Influence of treatment with extracts of Hypsyzigus marmoreus mushroom on body 
composition during obesity development in kk-ay mice. Journal of nutritional science 
and vitaminology, 61(1), 96-100.  
Jakobsdottir, G., Blanco, N., Xu, J., Ahrné, S., Molin, G., Sterner, O., & Nyman, M. (2013). 
Formation of short-chain fatty acids, excretion of anthocyanins, and microbial diversity 
in rats fed blackcurrants, blackberries, and raspberries. Journal of nutrition and 
metabolism, 2013.  
Jamar, G., Santamarina, A. B., Mennitti, L. V., de Cássia Cesar, H., Oyama, L. M., de Rosso, V. 
V., & Pisani, L. P. (2018). Bifidobacterium spp. reshaping in the gut microbiota by low 
dose of juçara supplementation and hypothalamic insulin resistance in Wistar rats. 
Journal of Functional Foods, 46, 212-219.  
Janda, J. M., & Abbott, S. L. (2007). 16S rRNA gene sequencing for bacterial identification in 
the diagnostic laboratory: pluses, perils, and pitfalls. Journal of Clinical Microbiology, 
45(9), 2761-2764.  
Jandhyala, S. M., Talukdar, R., Subramanyam, C., Vuyyuru, H., Sasikala, M., & Reddy, D. N. 
(2015). Role of the normal gut microbiota. World journal of gastroenterology: WJG, 
21(29), 8787.  
Jayachandran, M., Chung, S. S. M., & Xu, B. (2019). A critical review of the relationship 
between dietary components, the gut microbe Akkermansia muciniphila, and human 
health. Critical Reviews in Food Science and Nutrition, 1-12.  
64 
 
Juan, B. A. I., Ying, Z. H. U., & Ying, D. (2017). Bitter melon powder protects against obesity-
associated fatty liver disease by improving colonic microenvironment in rats with high-
fat diet-induced obesity. Biomedical and environmental sciences, 30(8), 611-615.  
Jumpertz, R., Le, D. S., Turnbaugh, P. J., Trinidad, C., Bogardus, C., Gordon, J. I., & Krakoff, J. 
(2011). Energy-balance studies reveal associations between gut microbes, caloric load, 
and nutrient absorption in humans. The American journal of clinical nutrition, 94(1), 58-
65.  
Kaczmarek, J. L., Liu, X., Charron, C. S., Novotny, J. A., Jeffery, E. H., Seifried, H. E., . . . 
Holscher, H. D. (2019). Broccoli consumption affects the human gastrointestinal 
microbiota. The Journal of nutritional biochemistry, 63, 27-34.  
Kang, Y., Yang, G., Zhang, S., Ross, C. F., & Zhu, M. J. (2018). Goji Berry Modulates Gut 
Microbiota and Alleviates Colitis in IL‐10‐Deficient Mice. Molecular nutrition & food 
research, 62(22), 1800535.  
Karl, J. P., Hatch, A. M., Arcidiacono, S. M., Pearce, S. C., Pantoja-Feliciano, I. G., Doherty, L. 
A., & Soares, J. W. (2018). Effects of psychological, environmental and physical 
stressors on the gut microbiota. Frontiers in microbiology, 9, 2013.  
Kasai, C., Sugimoto, K., Moritani, I., Tanaka, J., Oya, Y., Inoue, H., . . . Takei, Y. (2015). 
Comparison of the gut microbiota composition between obese and non-obese individuals 
in a Japanese population, as analyzed by terminal restriction fragment length 
polymorphism and next-generation sequencing. BMC gastroenterology, 15(1), 100.  
Kawabata, K., Yoshioka, Y., & Terao, J. (2019). Role of intestinal microbiota in the 
bioavailability and physiological functions of dietary polyphenols. Molecules, 24(2), 370.  
Kim, H., Banerjee, N., Sirven, M. A., Minamoto, Y., Markel, M. E., Suchodolski, J. S., . . . 
Mertens-Talcott, S. U. (2017). Pomegranate polyphenolics reduce inflammation and 
ulceration in intestinal colitis—involvement of the miR-145/p70S6K1/HIF1α axis in vivo 
and in vitro. The Journal of nutritional biochemistry, 43, 107-115.  
Kim, H., Caulfield, L. E., Garcia‐Larsen, V., Steffen, L. M., Coresh, J., & Rebholz, C. M. 
(2019). Plant‐Based Diets Are Associated With a Lower Risk of Incident Cardiovascular 
Disease, Cardiovascular Disease Mortality, and All‐Cause Mortality in a General 
Population of Middle‐Aged Adults. Journal of the American Heart Association, 8(16), 
e012865.  
Kim, H. I., Kim, J.-K., Kim, J.-Y., Jang, S.-E., Han, M. J., & Kim, D.-H. (2019). Lactobacillus 
plantarum LC27 and Bifidobacterium longum LC67 simultaneously alleviate high-fat 
diet-induced colitis, endotoxemia, liver steatosis, and obesity in mice. Nutrition 
Research, 67, 78-89.  
Kinger, M., Kumar, S., & Kumar, V. (2018). Some important dietary polyphenolic compounds: 
an anti-inflammatory and immunoregulatory perspective. Mini reviews in medicinal 
chemistry, 18(15), 1270-1282.  
65 
 
Kobayashi, Y., Sugahara, H., Shimada, K., Mitsuyama, E., Kuhara, T., Yasuoka, A., . . . Xiao, J.-
z. (2017). Therapeutic potential of Bifidobacterium breve strain A1 for preventing 
cognitive impairment in Alzheimer’s disease. Scientific reports, 7(1), 1-10.  
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016). From dietary fiber to 
host physiology: short-chain fatty acids as key bacterial metabolites. Cell, 165(6), 1332-
1345.  
Koliada, A., Syzenko, G., Moseiko, V., Budovska, L., Puchkov, K., Perederiy, V., . . . Tkach, S. 
(2017). Association between body mass index and Firmicutes/Bacteroidetes ratio in an 
adult Ukrainian population. BMC microbiology, 17(1), 120.  
Koutsos, A., Lima, M., Conterno, L., Gasperotti, M., Bianchi, M., Fava, F., . . . Tuohy, K. M. 
(2017). Effects of commercial apple varieties on human gut microbiota composition and 
metabolic output using an in vitro colonic model. Nutrients, 9(6), 533.  
Koutsos, A., Tuohy, K. M., & Lovegrove, J. A. (2015). Apples and cardiovascular health—is the 
gut microbiota a core consideration? Nutrients, 7(6), 3959-3998.  
Kovatcheva-Datchary, P., Nilsson, A., Akrami, R., Lee, Y. S., De Vadder, F., Arora, T., . . . 
Bäckhed, F. (2015). Dietary fiber-induced improvement in glucose metabolism is 
associated with increased abundance of Prevotella. Cell metabolism, 22(6), 971-982.  
Kowalska-Duplaga, K., Gosiewski, T., Kapusta, P., Sroka-Oleksiak, A., Wędrychowicz, A., 
Pieczarkowski, S., . . . Fyderek, K. (2019). Differences in the intestinal microbiome of 
healthy children and patients with newly diagnosed Crohn’s disease. Scientific reports, 
9(1), 1-11.  
Kumar Singh, A., Cabral, C., Kumar, R., Ganguly, R., Kumar Rana, H., Gupta, A., . . . Pandey, 
A. K. (2019). Beneficial effects of dietary polyphenols on gut microbiota and strategies to 
improve delivery efficiency. Nutrients, 11(9), 2216.  
Kumari, R., Ahuja, V., & Paul, J. (2013). Fluctuations in butyrate-producing bacteria in 
ulcerative colitis patients of North India. World journal of gastroenterology: WJG, 
19(22), 3404.  
Lacombe, A., Li, R. W., Klimis-Zacas, D., Kristo, A. S., Tadepalli, S., Krauss, E., . . . Wu, V. C. 
H. (2013). Lowbush wild blueberries have the potential to modify gut microbiota and 
xenobiotic metabolism in the rat colon. PloS one, 8(6).  
Laparra, J. M., & Sanz, Y. (2010). Interactions of gut microbiota with functional food 
components and nutraceuticals. Pharmacological research, 61(3), 219-225.  
Lavefve, L., Howard, L. R., & Carbonero, F. (2020). Berry polyphenols metabolism and impact 
on human gut microbiota and health. Food & Function, 11(1), 45-65.  
66 
 
Lazar, V., Ditu, L.-M., Pircalabioru, G. G., Gheorghe, I., Curutiu, C., Holban, A. M., . . . 
Chifiriuc, M. C. (2018). Aspects of gut microbiota and immune system interactions in 
infectious diseases, immunopathology, and cancer. Frontiers in immunology, 9, 1830.  
LeBlanc, J. G., Chain, F., Martín, R., Bermúdez-Humarán, L. G., Courau, S., & Langella, P. 
(2017). Beneficial effects on host energy metabolism of short-chain fatty acids and 
vitamins produced by commensal and probiotic bacteria. Microbial cell factories, 16(1), 
79.  
Leontowicz, H., Leontowicz, M., Latocha, P., Jesion, I., Park, Y.-S., Katrich, E., . . . Gorinstein, 
S. (2016). Bioactivity and nutritional properties of hardy kiwi fruit Actinidia arguta in 
comparison with Actinidia deliciosa ‘Hayward’and Actinidia eriantha ‘Bidan’. Food 
Chemistry, 196, 281-291.  
Li, M., Fan, Y., Zhang, X., Hou, W., & Tang, Z. (2014). Fruit and vegetable intake and risk of 
type 2 diabetes mellitus: meta-analysis of prospective cohort studies. BMJ open, 4(11), 
e005497.  
Li, Z., Henning, S. M., Lee, R.-P., Lu, Q.-Y., Summanen, P. H., Thames, G., . . . Finegold, S. M. 
(2015). Pomegranate extract induces ellagitannin metabolite formation and changes stool 
microbiota in healthy volunteers. Food & Function, 6(8), 2487-2495.  
Li, Z., Summanen, P. H., Komoriya, T., Henning, S. M., Lee, R.-P., Carlson, E., . . . Finegold, S. 
M. (2015). Pomegranate ellagitannins stimulate growth of gut bacteria in vitro: 
Implications for prebiotic and metabolic effects. Anaerobe, 34, 164-168.  
Licht, T. R., Hansen, M., Bergström, A., Poulsen, M., Krath, B. N., Markowski, J., . . . Wilcks, 
A. (2010). Effects of apples and specific apple components on the cecal environment of 
conventional rats: role of apple pectin. BMC microbiology, 10(1), 13.  
Lima, A. C. D., Cecatti, C., Fidélix, M. P., Adorno, M. A. T., Sakamoto, I. K., Cesar, T. B., & 
Sivieri, K. (2019). Effect of daily consumption of orange juice on the levels of blood 
glucose, lipids, and gut microbiota metabolites: Controlled clinical trials. Journal of 
medicinal food, 22(2), 202-210.  
Liu, J.-P., Zou, W.-L., Chen, S.-J., Wei, H.-Y., Yin, Y.-N., Zou, Y.-Y., & Lu, F.-G. (2016). 
Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease 
development. World Journal of Gastroenterology, 22(32), 7353.  
Liu, W., Zhao, S., Wang, J., Shi, J., Sun, Y., Wang, W., . . . Liu, R. (2017). Grape seed 
proanthocyanidin extract ameliorates inflammation and adiposity by modulating gut 
microbiota in high‐fat diet mice. Molecular nutrition & food research, 61(9), 1601082.  
Liu, X., Wang, Y., Hoeflinger, J. L., Neme, B. P., Jeffery, E. H., & Miller, M. J. (2017). Dietary 
broccoli alters rat cecal microbiota to improve glucoraphanin hydrolysis to bioactive 
isothiocyanates. Nutrients, 9(3), 262.  
67 
 
Logan, A. C., Jacka, F. N., & Prescott, S. L. (2016). Immune-microbiota interactions: dysbiosis 
as a global health issue. Current allergy and asthma reports, 16(2), 13.  
Lu, F., Li, Y., Zhou, B., Guo, Q., Chen, F., Hu, X., & Zhang, Y. (2019). Early-Life 
Supplementation of Grape Pomace Extracts Lastingly Promotes Polyphenol Metabolism 
and Optimizes Gut Microbiota. Available at SSRN 3405555.  
Lu, Q.-Y., Zhang, Y., Wang, Y., Wang, D., Lee, R.-p., Gao, K., . . . Heber, D. (2009). California 
Hass avocado: profiling of carotenoids, tocopherol, fatty acid, and fat content during 
maturation and from different growing areas. Journal of agricultural and food chemistry, 
57(21), 10408-10413.  
Lv, L. X., Fang, D. Q., Shi, D., Chen, D. Y., Yan, R., Zhu, Y. X., . . . Wu, W. R. (2016). 
Alterations and correlations of the gut microbiome, metabolism and immunity in patients 
with primary biliary cirrhosis. Environmental microbiology, 18(7), 2272-2286.  
Majowicz, S. E., Musto, J., Scallan, E., Angulo, F. J., Kirk, M., O'Brien, S. J., . . . International 
Collaboration on Enteric Disease “Burden of Illness”, S. (2010). The global burden of 
nontyphoidal Salmonella gastroenteritis. Clinical infectious diseases, 50(6), 882-889.  
Martín, R., Chain, F., Miquel, S., Lu, J., Gratadoux, J.-J., Sokol, H., . . . Langella, P. (2014). The 
commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced 
chronic moderate and severe colitis models. Inflammatory bowel diseases, 20(3), 417-
430.  
Martín, R., Miquel, S., Benevides, L., Bridonneau, C., Robert, V., Hudault, S., . . . Chatel, J. M. 
(2017). Functional characterization of novel Faecalibacterium prausnitzii strains isolated 
from healthy volunteers: a step forward in the use of F. prausnitzii as a next-generation 
probiotic. Frontiers in microbiology, 8, 1226.  
Martínez, I., Wallace, G., Zhang, C., Legge, R., Benson, A. K., Carr, T. P., . . . Walter, J. (2009). 
Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are 
strongly linked to alterations of the gut microbiota. Applied and environmental 
microbiology, 75(12), 4175-4184.  
Maruo, T., Sakamoto, M., Ito, C., Toda, T., & Benno, Y. (2008). Adlercreutzia equolifaciens 
gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and 
emended description of the genus Eggerthella. International Journal of Systematic and 
Evolutionary Microbiology, 58(5), 1221-1227.  
Masibo, M., & He, Q. (2009). Mango bioactive compounds and related nutraceutical 
properties—a review. Food Reviews International, 25(4), 346-370.  
Masumoto, S., Terao, A., Yamamoto, Y., Mukai, T., Miura, T., & Shoji, T. (2016). Non-
absorbable apple procyanidins prevent obesity associated with gut microbial and 
metabolomic changes. Scientific reports, 6, 31208.  
68 
 
Mathur, R., & Barlow, G. M. (2015). Obesity and the microbiome. Expert Review of 
Gastroenterology & Hepatology, 9(8), 1087-1099.  
Matsumoto, S., Beeson, W. L., Shavlik, D. J., Siapco, G., Jaceldo-Siegl, K., Fraser, G., & 
Knutsen, S. F. (2019). Association between vegetarian diets and cardiovascular risk 
factors in non-Hispanic white participants of the Adventist Health Study-2. Journal of 
nutritional science, 8.  
Matziouridou, C., Marungruang, N., Nguyen, T. D., Nyman, M., & Fåk, F. (2016). Lingonberries 
reduce atherosclerosis in Apoe‐/‐mice in association with altered gut microbiota 
composition and improved lipid profile. Molecular nutrition & food research, 60(5), 
1150-1160.  
Mayta-Apaza, A. C., Pottgen, E., De Bodt, J., Papp, N., Marasini, D., Howard, L., . . . 
Carbonero, F. (2018). Impact of tart cherries polyphenols on the human gut microbiota 
and phenolic metabolites in vitro and in vivo. The Journal of nutritional biochemistry, 59, 
160-172.  
McMacken, M., & Shah, S. (2017). A plant-based diet for the prevention and treatment of type 2 
diabetes. Journal of geriatric cardiology: JGC, 14(5), 342.  
Meehan, C. J., & Beiko, R. G. (2014). A phylogenomic view of ecological specialization in the 
Lachnospiraceae, a family of digestive tract-associated bacteria. Genome biology and 
evolution, 6(3), 703-713.  
Melina, V., Craig, W., & Levin, S. (2016). Position of the academy of nutrition and dietetics: 
vegetarian diets. Journal of the Academy of Nutrition and Dietetics, 116(12), 1970-1980.  
Mikulic‐Petkovsek, M., Stampar, F., Veberic, R., & Sircelj, H. (2016). Wild Prunus fruit species 
as a rich source of bioactive compounds. Journal of Food Science, 81(8), C1928-C1937.  
Miquel, S., Leclerc, M., Martin, R., Chain, F., Lenoir, M., Raguideau, S., . . . Bowen, B. (2015). 
Identification of metabolic signatures linked to anti-inflammatory effects of 
Faecalibacterium prausnitzii. MBio, 6(2).  
Mizrahi-Man, O., Davenport, E. R., & Gilad, Y. (2013). Taxonomic classification of bacterial 
16S rRNA genes using short sequencing reads: evaluation of effective study designs. 
PloS one, 8(1).  
Moreno-Indias, I., Sánchez-Alcoholado, L., Pérez-Martínez, P., Andrés-Lacueva, C., Cardona, 
F., Tinahones, F., & Queipo-Ortuño, M. I. (2016). Red wine polyphenols modulate fecal 
microbiota and reduce markers of the metabolic syndrome in obese patients. Food & 
Function, 7(4), 1775-1787.  
Morgan, X. C., & Huttenhower, C. (2012). Human microbiome analysis. PLoS Comput Biol, 
8(12), e1002808.  
69 
 
Morissette, A., Kropp, C., Songpadith, J.-P., Junges Moreira, R., Costa, J., Mariné Casadó, R., . . 
. Boutekrabt, L. (2020). Blueberry proanthocyanidins and anthocyanins improve 
metabolic health through a gut microbiota-dependent mechanism in diet-induced obese 
mice. American Journal of Physiology-Endocrinology and Metabolism.  
Nash, V., Ranadheera, C. S., Georgousopoulou, E. N., Mellor, D. D., Panagiotakos, D. B., 
McKune, A. J., . . . Naumovski, N. (2018). The effects of grape and red wine polyphenols 
on gut microbiota–A systematic review. Food research international, 113, 277-287.  
Neish, A. S. (2009). Microbes in gastrointestinal health and disease. Gastroenterology, 136(1), 
65-80.  
Nerurkar, P. V., Orias, D., Soares, N., Kumar, M., & Nerurkar, V. R. (2019). Momordica 
charantia (bitter melon) modulates adipose tissue inflammasome gene expression and 
adipose-gut inflammatory cross talk in high-fat diet (HFD)-fed mice. The Journal of 
nutritional biochemistry, 68, 16-32.  
Neyrinck, A. M., Possemiers, S., Verstraete, W., De Backer, F., Cani, P. D., & Delzenne, N. M. 
(2012). Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by 
chitin–glucan fiber improves host metabolic alterations induced by high-fat diet in mice. 
The Journal of nutritional biochemistry, 23(1), 51-59.  
Nile, S. H., & Park, S. W. (2014). Edible berries: Bioactive components and their effect on 
human health. Nutrition, 30(2), 134-144.  
Noratto, G. D., Bertoldi, M. C., Krenek, K., Talcott, S. T., Stringheta, P. C., & Mertens-Talcott, 
S. U. (2010). Anticarcinogenic effects of polyphenolics from mango (Mangifera indica) 
varieties. Journal of agricultural and food chemistry, 58(7), 4104-4112.  
O’Connor, K., Morrissette, M., Strandwitz, P., Ghiglieri, M., Caboni, M., Liu, H., . . . Lewis, K. 
(2019). Cranberry extracts promote growth of Bacteroidaceae and decrease abundance of 
Enterobacteriaceae in a human gut simulator model. PloS one, 14(11), e0224836.  
Obesity and overweight. (2020). Retrieved from https://www.who.int/en/news-room/fact-
sheets/detail/obesity-and-overweight 
Ojo, B., El-Rassi, G. D., Payton, M. E., Perkins-Veazie, P., Clarke, S., Smith, B. J., & Lucas, E. 
A. (2016). Mango supplementation modulates gut microbial dysbiosis and short-chain 
fatty acid production independent of body weight reduction in C57BL/6 mice fed a high-
fat diet. The Journal of nutrition, 146(8), 1483-1491.  
Okumura, R., & Takeda, K. (2017). Roles of intestinal epithelial cells in the maintenance of gut 
homeostasis. Experimental & molecular medicine, 49(5), e338-e338.  
Okumura, R., & Takeda, K. (2018). Maintenance of intestinal homeostasis by mucosal barriers. 
Inflammation and regeneration, 38(1), 5.  
70 
 
Orlich, M. J., Singh, P. N., Sabaté, J., Fan, J., Sveen, L., Bennett, H., . . . Butler, T. L. (2015). 
Vegetarian dietary patterns and the risk of colorectal cancers. JAMA internal medicine, 
175(5), 767-776.  
Ostfeld, R. J. (2017). Definition of a plant-based diet and overview of this special issue. Journal 
of geriatric cardiology: JGC, 14(5), 315.  
Pan, P., Lam, V., Salzman, N., Huang, Y.-W., Yu, J., Zhang, J., & Wang, L.-S. (2017). Black 
raspberries and their anthocyanin and fiber fractions alter the composition and diversity 
of gut microbiota in F-344 rats. Nutrition and cancer, 69(6), 943-951.  
Papier, K., Appleby, P. N., Fensom, G. K., Knuppel, A., Perez-Cornago, A., Schmidt, J. A., . . . 
Key, T. J. (2019). Vegetarian diets and risk of hospitalisation or death with diabetes in 
British adults: results from the EPIC-Oxford study. Nutrition & diabetes, 9(1), 1-8.  
Papuc, C., Goran, G. V., Predescu, C. N., Nicorescu, V., & Stefan, G. (2017). Plant polyphenols 
as antioxidant and antibacterial agents for shelf‐life extension of meat and meat products: 
classification, structures, sources, and action mechanisms. Comprehensive Reviews in 
Food Science and Food Safety, 16(6), 1243-1268.  
Park, S.-K., Kim, M.-S., Roh, S. W., & Bae, J.-W. (2012). Blautia stercoris sp. nov., isolated 
from human faeces. International Journal of Systematic and Evolutionary Microbiology, 
62(4), 776-779.  
Paturi, G., Butts, C. A., Bentley‐Hewitt, K. L., & Ansell, J. (2014). Influence of green and gold 
kiwifruit on indices of large bowel function in healthy rats. Journal of Food Science, 
79(8), H1611-H1620.  
Paturi, G., Mandimika, T., Butts, C. A., Zhu, S., Roy, N. C., McNabb, W. C., & Ansell, J. 
(2012). Influence of dietary blueberry and broccoli on cecal microbiota activity and colon 
morphology in mdr1a−/− mice, a model of inflammatory bowel diseases. Nutrition, 
28(3), 324-330.  
Pereira-Caro, G., Oliver, C. M., Weerakkody, R., Singh, T., Conlon, M., Borges, G., . . . Crozier, 
A. (2015). Chronic administration of a microencapsulated probiotic enhances the 
bioavailability of orange juice flavanones in humans. Free Radical Biology and 
Medicine, 84, 206-214.  
Pereira‐Caro, G., Borges, G., Ky, I., Ribas, A., Calani, L., Del Rio, D., . . . Crozier, A. (2015). In 
vitro colonic catabolism of orange juice (poly) phenols. Molecular nutrition & food 
research, 59(3), 465-475.  
Peron, G., Hidalgo-Liberona, N., González-Domínguez, R., Garcia-Aloy, M., Guglielmetti, S., 
Bernardi, S., . . . Riso, P. (2019). Exploring the molecular pathways behind the effects of 
nutrients and dietary polyphenols on gut microbiota and intestinal permeability: a 
perspective on the potential of metabolomics and future clinical applications. Journal of 
agricultural and food chemistry.  
71 
 
Petersen, C., Wankhade, U. D., Bharat, D., Wong, K., Mueller, J. E., Chintapalli, S. V., . . . 
Symons, J. D. (2019). Dietary supplementation with strawberry induces marked changes 
in the composition and functional potential of the gut microbiome in diabetic mice. The 
Journal of nutritional biochemistry, 66, 63-69.  
Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., . . . Lichtenstein, 
L. (2017). A purified membrane protein from Akkermansia muciniphila or the 
pasteurized bacterium improves metabolism in obese and diabetic mice. Nature medicine, 
23(1), 107.  
Poretsky, R., Rodriguez-R, L. M., Luo, C., Tsementzi, D., & Konstantinidis, K. T. (2014). 
Strengths and limitations of 16S rRNA gene amplicon sequencing in revealing temporal 
microbial community dynamics. PloS one, 9(4).  
Prieto, I., Hidalgo, M., Segarra, A. B., Martínez-Rodríguez, A. M., Cobo, A., Ramirez, M., . . . 
Martinez-Canamero, M. (2018). Influence of a diet enriched with virgin olive oil or butter 
on mouse gut microbiota and its correlation to physiological and biochemical parameters 
related to metabolic syndrome. PloS one, 13(1).  
Puupponen‐Pimiä, R., Nohynek, L., Hartmann‐Schmidlin, S., Kähkönen, M., Heinonen, M., 
Määttä‐Riihinen, K., & Oksman‐Caldentey, K. M. (2005). Berry phenolics selectively 
inhibit the growth of intestinal pathogens. Journal of applied microbiology, 98(4), 991-
1000.  
Puupponen‐Pimiä, R., Seppänen‐Laakso, T., Kankainen, M., Maukonen, J., Törrönen, R., 
Kolehmainen, M., . . . Aura, A. M. (2013). Effects of ellagitannin‐rich berries on blood 
lipids, gut microbiota, and urolithin production in human subjects with symptoms of 
metabolic syndrome. Molecular nutrition & food research, 57(12), 2258-2263.  
Queipo-Ortuño, M. I., Boto-Ordóñez, M., Murri, M., Gomez-Zumaquero, J. M., Clemente-
Postigo, M., Estruch, R., . . . Tinahones, F. J. (2012). Influence of red wine polyphenols 
and ethanol on the gut microbiota ecology and biochemical biomarkers. The American 
journal of clinical nutrition, 95(6), 1323-1334.  
Quévrain, E., Maubert, M. A., Michon, C., Chain, F., Marquant, R., Tailhades, J., . . . Pigneur, B. 
(2016). Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, 
a commensal bacterium deficient in Crohn’s disease. Gut, 65(3), 415-425.  
Quigley, E. M. M. (2013). Gut bacteria in health and disease. Gastroenterology & hepatology, 
9(9), 560.  
Rahman, S. U., Li, Y., Huang, Y., Zhu, L., Feng, S., Wu, J., & Wang, X. (2018). Treatment of 
inflammatory bowel disease via green tea polyphenols: Possible application and 
protective approaches. Inflammopharmacology, 26(2), 319-330.  
Rajilić-Stojanović, M., & de Vos, W. M. (2014). The first 1000 cultured species of the human 
gastrointestinal microbiota. FEMS microbiology reviews, 38(5), 996-1047.  
72 
 
Rajilić–Stojanović, M., Biagi, E., Heilig, H. G. H. J., Kajander, K., Kekkonen, R. A., Tims, S., & 
de Vos, W. M. (2011). Global and deep molecular analysis of microbiota signatures in 
fecal samples from patients with irritable bowel syndrome. Gastroenterology, 141(5), 
1792-1801.  
Ravn-Haren, G., Dragsted, L. O., Buch-Andersen, T., Jensen, E. N., Jensen, R. I., Nemeth-
Balogh, M., . . . Licht, T. R. (2013). Intake of whole apples or clear apple juice has 
contrasting effects on plasma lipids in healthy volunteers. European journal of nutrition, 
52(8), 1875-1889.  
Redondo, D., Arias, E., Oria, R., & Venturini, M. E. (2017). Thinned stone fruits are a source of 
polyphenols and antioxidant compounds. Journal of the Science of Food and Agriculture, 
97(3), 902-910.  
Reeves, A. E., Koenigsknecht, M. J., Bergin, I. L., & Young, V. B. (2012). Suppression of 
Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a 
murine isolate from the family Lachnospiraceae. Infection and immunity, 80(11), 3786-
3794.  
Ri, B., Magbagbeola, O. A., Akinwande, A. I., & Okunowo, O. W. (2010). Nutritional and 
chemical evaluation of Momordica charantia. Journal of Medicinal Plants Research, 
4(21), 2189-2193.  
Ritchie, L. E., Sturino, J. M., Carroll, R. J., Rooney, L. W., Azcarate-Peril, M. A., & Turner, N. 
D. (2015). Polyphenol-rich sorghum brans alter colon microbiota and impact species 
diversity and species richness after multiple bouts of dextran sodium sulfate-induced 
colitis. FEMS microbiology ecology, 91(3).  
Rivera-Chávez, F., Zhang, L. F., Faber, F., Lopez, C. A., Byndloss, M. X., Olsan, E. E., . . . 
Winter, S. E. (2016). Depletion of butyrate-producing Clostridia from the gut microbiota 
drives an aerobic luminal expansion of Salmonella. Cell host & microbe, 19(4), 443-454.  
Rizzo, N. S., Sabaté, J., Jaceldo-Siegl, K., & Fraser, G. E. (2011). Vegetarian dietary patterns are 
associated with a lower risk of metabolic syndrome: the adventist health study 2. 
Diabetes care, 34(5), 1225-1227.  
Rodríguez-Morató, J., Matthan, N. R., Liu, J., de la Torre, R., & Chen, C. Y. O. (2018). 
Cranberries attenuate animal-based diet-induced changes in microbiota composition and 
functionality: a randomized crossover controlled feeding trial. The Journal of nutritional 
biochemistry, 62, 76-86.  
Rom, O., Korach-Rechtman, H., Hayek, T., Danin-Poleg, Y., Bar, H., Kashi, Y., & Aviram, M. 
(2017). Acrolein increases macrophage atherogenicity in association with gut microbiota 
remodeling in atherosclerotic mice: protective role for the polyphenol-rich pomegranate 
juice. Archives of toxicology, 91(4), 1709-1725.  
73 
 
Rosell, M., Appleby, P., Spencer, E., & Key, T. (2006). Weight gain over 5 years in 21 966 
meat-eating, fish-eating, vegetarian, and vegan men and women in EPIC-Oxford. 
International journal of obesity, 30(9), 1389-1396.  
Rossi, O., Khan, M. T., Schwarzer, M., Hudcovic, T., Srutkova, D., Duncan, S. H., . . . Samsom, 
J. N. (2015). Faecalibacterium prausnitzii strain HTF-F and its extracellular polymeric 
matrix attenuate clinical parameters in DSS-induced colitis. PloS one, 10(4), e0123013.  
Rossi, O., Van Berkel, L. A., Chain, F., Khan, M. T., Taverne, N., Sokol, H., . . . Langella, P. 
(2016). Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in 
human and murine dendritic cells and modulates T cell responses. Scientific reports, 6, 
18507.  
Round, J. L., & Mazmanian, S. K. (2009). The gut microbiota shapes intestinal immune 
responses during health and disease. Nature reviews immunology, 9(5), 313-323.  
Round, J. L., & Mazmanian, S. K. (2010). Inducible Foxp3+ regulatory T-cell development by a 
commensal bacterium of the intestinal microbiota. Proceedings of the National Academy 
of Sciences, 107(27), 12204-12209.  
Rowland, I., Gibson, G., Heinken, A., Scott, K., Swann, J., Thiele, I., & Tuohy, K. (2018). Gut 
microbiota functions: metabolism of nutrients and other food components. European 
journal of nutrition, 57(1), 1-24.  
Sakamoto, M., Lan, P. T. N., & Benno, Y. (2007). Barnesiella viscericola gen. nov., sp. nov., a 
novel member of the family Porphyromonadaceae isolated from chicken caecum. 
International Journal of Systematic and Evolutionary Microbiology, 57(2), 342-346.  
Sakamoto, M., Takagaki, A., Matsumoto, K., Kato, Y., Goto, K., & Benno, Y. (2009). 
Butyricimonas synergistica gen. nov., sp. nov. and Butyricimonas virosa sp. nov., butyric 
acid-producing bacteria in the family ‘Porphyromonadaceae’isolated from rat faeces. 
International Journal of Systematic and Evolutionary Microbiology, 59(7), 1748-1753.  
Samal, L., Chaturvedi, V. B., & Pattanaik, A. K. (2017). Effects of dietary supplementation with 
Jerusalem artichoke (Helianthus tuberosus L.) tubers on growth performance, nutrient 
digestibility, activity and composition of large intestinal microbiota in rats. J Anim Feed 
Sci, 26(1), 50-58.  
Sánchez, C. (2017). Bioactives from mushroom and their application. In Food bioactives (pp. 23-
57): Springer. 
Santisteban, M. M., Qi, Y., Zubcevic, J., Kim, S., Yang, T., Shenoy, V., . . . Rubiano, A. (2017). 
Hypertension-linked pathophysiological alterations in the gut. Circulation research, 
120(2), 312-323.  
Sarrabayrouse, G., Bossard, C., Chauvin, J.-M., Jarry, A., Meurette, G., Quévrain, E., . . . 
Labarrière, N. (2014). CD4CD8αα lymphocytes, a novel human regulatory T cell subset 
74 
 
induced by colonic bacteria and deficient in patients with inflammatory bowel disease. 
PLoS Biol, 12(4), e1001833.  
Satija, A., Bhupathiraju, S. N., Rimm, E. B., Spiegelman, D., Chiuve, S. E., Borgi, L., . . . Hu, F. 
B. (2016). Plant-based dietary patterns and incidence of type 2 diabetes in US men and 
women: results from three prospective cohort studies. PLoS medicine, 13(6).  
Savage, D. C. (1977). Microbial ecology of the gastrointestinal tract. Annual review of 
microbiology, 31(1), 107-133.  
Schippa, S., & Conte, M. P. (2014). Dysbiotic events in gut microbiota: impact on human health. 
Nutrients, 6(12), 5786-5805.  
Sender, R., Fuchs, S., & Milo, R. (2016). Revised estimates for the number of human and 
bacteria cells in the body. PLoS biology, 14(8), e1002533.  
Sharoba, A. M., Farrag, M. A., & Abd El-Salam, A. M. (2013). Utilization of some fruits and 
vegetables waste as a source of dietary fiber and its effect on the cake making and its 
quality attributes. Journal of Agroalimentary Processes and Technologies, 19(4), 429-
444.  
Shaw, K. A., Bertha, M., Hofmekler, T., Chopra, P., Vatanen, T., Srivatsa, A., . . . Zwick, M. E. 
(2016). Dysbiosis, inflammation, and response to treatment: a longitudinal study of 
pediatric subjects with newly diagnosed inflammatory bowel disease. Genome medicine, 
8(1), 75.  
Shimizu, T., Mori, K., Ouchi, K., Kushida, M., & Tsuduki, T. (2018). Effects of dietary intake of 
Japanese mushrooms on visceral fat accumulation and gut microbiota in mice. Nutrients, 
10(5), 610.  
Shinohara, K., Ohashi, Y., Kawasumi, K., Terada, A., & Fujisawa, T. (2010). Effect of apple 
intake on fecal microbiota and metabolites in humans. Anaerobe, 16(5), 510-515.  
Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA: A Cancer Journal 
for Clinicians, 70(1), 7-30.  
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., . 
. . Corthier, G. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal 
bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of 
the National Academy of Sciences, 105(43), 16731-16736.  
Solano-Aguilar, G. I., Jang, S., Lakshman, S., Gupta, R., Beshah, E., Sikaroodi, M., . . . Urban, J. 
F. (2018). The effect of dietary mushroom Agaricus bisporus on intestinal microbiota 
composition and host immunological function. Nutrients, 10(11), 1721.  
Song, M.-y., Wang, J.-h., Eom, T., & Kim, H. (2015). Schisandra chinensis fruit modulates the 
gut microbiota composition in association with metabolic markers in obese women: a 
randomized, double-blind placebo-controlled study. Nutrition Research, 35(8), 655-663.  
75 
 
Sonnenburg, E. D., Smits, S. A., Tikhonov, M., Higginbottom, S. K., Wingreen, N. S., & 
Sonnenburg, J. L. (2016). Diet-induced extinctions in the gut microbiota compound over 
generations. Nature, 529(7585), 212-215.  
Stella, S. P., Ferrarezi, A. C., dos Santos, K. O., & Monteiro, M. (2011). Antioxidant activity of 
commercial ready‐to‐drink orange juice and nectar. Journal of food science, 76(3), C392-
C397.  
Stinco, C. M., Fernández-Vázquez, R., Escudero-Gilete, M. L., Heredia, F. J., Meléndez-
Martínez, A. J., & Vicario, I. M. (2012). Effect of orange juice’s processing on the color, 
particle size, and bioaccessibility of carotenoids. Journal of agricultural and food 
chemistry, 60(6), 1447-1455.  
Taing, M.-W., Pierson, J.-T., Hoang, V. L. T., Shaw, P. N., Dietzgen, R. G., Gidley, M. J., . . . 
Monteith, G. R. (2012). Mango fruit peel and flesh extracts affect adipogenesis in 3T3-L1 
cells. Food & Function, 3(8), 828-836.  
Tamanai-Shacoori, Z., Smida, I., Bousarghin, L., Loreal, O., Meuric, V., Fong, S. B., . . . Jolivet-
Gougeon, A. (2017). Roseburia spp.: a marker of health? Future Microbiology, 12(2), 
157-170.  
Tannock, G. W. (2010). The bowel microbiota and inflammatory bowel diseases. International 
journal of inflammation, 2010.  
Tantamango-Bartley, Y., Jaceldo-Siegl, K., Fan, J., & Fraser, G. (2013). Vegetarian diets and the 
incidence of cancer in a low-risk population. Cancer Epidemiology and Prevention 
Biomarkers, 22(2), 286-294.  
Tantamango-Bartley, Y., Knutsen, S. F., Knutsen, R., Jacobsen, B. K., Fan, J., Beeson, W. L., . . 
. Penniecook, J. (2016). Are strict vegetarians protected against prostate cancer? The 
American journal of clinical nutrition, 103(1), 153-160.  
Therkelsen, S. P., Hetland, G., Lyberg, T., Lygren, I., & Johnson, E. (2016). Cytokine Levels 
After Consumption of a Medicinal Agaricus blazei Murill‐Based Mushroom Extract, 
AndoSan™, in Patients with Crohn's Disease and Ulcerative Colitis in a Randomized 
Single‐Blinded Placebo‐Controlled Study. Scandinavian journal of immunology, 84(6), 
323-331.  
Therkelsen, S. P., Hetland, G., Lyberg, T., Lygren, I., & Johnson, E. (2016). Effect of the 
medicinal Agaricus blazei murill-based mushroom extract, andosantm, on symptoms, 
fatigue and quality of life in patients with crohn’s disease in a randomized single-blinded 
placebo controlled study. PloS one, 11(7).  
Thevaranjan, N., Puchta, A., Schulz, C., Naidoo, A., Szamosi, J. C., Verschoor, C. P., . . . Foley, 
K. P. (2017). Age-associated microbial dysbiosis promotes intestinal permeability, 




Thompson, S., Edwards, C., Reeser, G., Khan, N., & Holscher, H. (2019). Effects of avocado 
consumption on gastrointestinal microbial metabolite concentrations and taxa 
abundances: a randomized, controlled trial (OR23-07-19). Current developments in 
nutrition, 3(Supplement_1), nzz040-OR023.  
Thursby, E., & Juge, N. (2017). Introduction to the human gut microbiota. Biochemical Journal, 
474(11), 1823-1836.  
Tian, S., Liu, X., Lei, P., Zhang, X., & Shan, Y. (2018). Microbiota: a mediator to transform 
glucosinolate precursors in cruciferous vegetables to the active isothiocyanates. Journal 
of the Science of Food and Agriculture, 98(4), 1255-1260.  
Tims, S., Derom, C., Jonkers, D. M., Vlietinck, R., Saris, W. H., Kleerebezem, M., . . . 
Zoetendal, E. G. (2013). Microbiota conservation and BMI signatures in adult 
monozygotic twins. The ISME journal, 7(4), 707-717.  
Togo, A. H., Khelaifia, S., Bittar, F., Maraninchi, M., Raoult, D., & Million, M. (2016). 
‘Eisenbergiella massiliensis’, a new species isolated from human stool collected after 
bariatric surgery.  
Tomova, A., Bukovsky, I., Rembert, E., Yonas, W., Alwarith, J., Barnard, N. D., & Kahleova, H. 
(2019). The effects of vegetarian and vegan diets on gut microbiota. Frontiers in 
nutrition, 6, 47.  
Tonstad, S., Stewart, K., Oda, K., Batech, M., Herring, R. P., & Fraser, G. E. (2013). Vegetarian 
diets and incidence of diabetes in the Adventist Health Study-2. Nutrition, Metabolism 
and Cardiovascular Diseases, 23(4), 292-299.  
Tu, P., Bian, X., Chi, L., Gao, B., Ru, H., Knobloch, T. J., . . . Lu, K. (2018). Characterization of 
the functional changes in mouse gut microbiome associated with increased Akkermansia 
muciniphila population modulated by dietary black raspberries. ACS omega, 3(9), 10927-
10937.  
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. 
(2006). An obesity-associated gut microbiome with increased capacity for energy harvest. 
Nature, 444(7122), 1027.  
Tuso, P. J., Ismail, M. H., Ha, B. P., & Bartolotto, C. (2013). Nutritional update for physicians: 
plant-based diets. The Permanente Journal, 17(2), 61.  
Ubeda, C., Djukovic, A., & Isaac, S. (2017). Roles of the intestinal microbiota in pathogen 
protection. Clinical & translational immunology, 6(2), e128.  
Vacca, M., Celano, G., Calabrese, F. M., Portincasa, P., Gobbetti, M., & De Angelis, M. (2020). 
The Controversial Role of Human Gut Lachnospiraceae. Microorganisms, 8(4), 573.  
Van Hul, M., Geurts, L., Plovier, H., Druart, C., Everard, A., Ståhlman, M., . . . Delzenne, N. M. 
(2018). Reduced obesity, diabetes, and steatosis upon cinnamon and grape pomace are 
77 
 
associated with changes in gut microbiota and markers of gut barrier. American Journal 
of Physiology-Endocrinology and Metabolism, 314(4), E334-E352.  
Varshney, J., Ooi, J. H., Jayarao, B. M., Albert, I., Fisher, J., Smith, R. L., . . . Cantorna, M. T. 
(2013). White button mushrooms increase microbial diversity and accelerate the 
resolution of Citrobacter rodentium infection in mice. The Journal of nutrition, 143(4), 
526-532.  
Vendrame, S., Guglielmetti, S., Riso, P., Arioli, S., Klimis-Zacas, D., & Porrini, M. (2011). Six-
week consumption of a wild blueberry powder drink increases bifidobacteria in the 
human gut. Journal of agricultural and food chemistry, 59(24), 12815-12820.  
Vetvicka, V., & Vetvickova, J. (2014). Immune-enhancing effects of Maitake (Grifola frondosa) 
and Shiitake (Lentinula edodes) extracts. Annals of translational medicine, 2(2).  
Vital, M., Howe, A. C., & Tiedje, J. M. (2014). Revealing the bacterial butyrate synthesis 
pathways by analyzing (meta) genomic data. MBio, 5(2), e00889-00814.  
Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., 
. . . Blennow, K. (2017). Gut microbiome alterations in Alzheimer’s disease. Scientific 
reports, 7(1), 1-11.  
Walters, W. A., Xu, Z., & Knight, R. (2014). Meta‐analyses of human gut microbes associated 
with obesity and IBD. FEBS letters, 588(22), 4223-4233.  
Wang, F., Zheng, J., Yang, B., Jiang, J., Fu, Y., & Li, D. (2015). Effects of vegetarian diets on 
blood lipids: a systematic review and meta‐analysis of randomized controlled trials. 
Journal of the American Heart Association, 4(10), e002408.  
Wankhade, U. D., Zhong, Y., Lazarenko, O. P., Chintapalli, S. V., Piccolo, B. D., Chen, J.-R., & 
Shankar, K. (2019). Sex-specific changes in gut microbiome composition following 
blueberry consumption in C57BL/6J mice. Nutrients, 11(2), 313.  
Williams, B. A., Grant, L. J., Gidley, M. J., & Mikkelsen, D. (2017). Gut fermentation of dietary 
fibres: physico-chemistry of plant cell walls and implications for health. International 
Journal of Molecular Sciences, 18(10), 2203.  
Wright, N., Wilson, L., Smith, M., Duncan, B., & McHugh, P. (2017). The BROAD study: A 
randomised controlled trial using a whole food plant-based diet in the community for 
obesity, ischaemic heart disease or diabetes. Nutrition & diabetes, 7(3), e256.  
Wu, H.-J., & Wu, E. (2012). The role of gut microbiota in immune homeostasis and 
autoimmunity. Gut microbes, 3(1), 4-14.  
Wu, S., Hu, R., Nakano, H., Chen, K., Liu, M., He, X., . . . Hou, D.-X. (2018). Modulation of gut 
microbiota by Lonicera caerulea L. Berry polyphenols in a mouse model of fatty liver 
induced by high fat diet. Molecules, 23(12), 3213.  
78 
 
Wylie, K. M., Truty, R. M., Sharpton, T. J., Mihindukulasuriya, K. A., Zhou, Y., Gao, H., . . . 
Pollard, K. S. (2012). Novel bacterial taxa in the human microbiome. PloS one, 7(6), 
e35294.  
Xiao, S., Fei, N., Pang, X., Shen, J., Wang, L., Zhang, B., . . . Li, M. (2014). A gut microbiota-
targeted dietary intervention for amelioration of chronic inflammation underlying 
metabolic syndrome. FEMS microbiology ecology, 87(2), 357-367.  
Xu, J., Cao, K., Li, Y., Zou, X., Chen, C., Szeto, I. M.-Y., . . . Wang, J. (2014). Bitter gourd 
inhibits the development of obesity-associated fatty liver in C57BL/6 mice fed a high-fat 
diet. The Journal of nutrition, 144(4), 475-483.  
Yan, Z., Yang, F., Hong, Z., Wang, S., Jinjuan, Z., Han, B., . . . Yang, Q. (2019). Blueberry 
Attenuates Liver Fibrosis, Protects Intestinal Epithelial Barrier, and Maintains Gut 
Microbiota Homeostasis. Canadian Journal of Gastroenterology and Hepatology, 2019.  
Yang, I., Eibach, D., Kops, F., Brenneke, B., Woltemate, S., Schulze, J., . . . Fox, J. G. (2013). 
Intestinal microbiota composition of interleukin-10 deficient C57BL/6J mice and 
susceptibility to Helicobacter hepaticus-induced colitis. PloS one, 8(8), e70783.  
Yang, J. Y., Lee, Y. S., Kim, Y., Lee, S. H., Ryu, S., Fukuda, S., . . . Kim, M. S. (2017). Gut 
commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in 
mice. Mucosal immunology, 10(1), 104-116.  
Yang, Q., Liang, Q., Balakrishnan, B., Belobrajdic, D. P., Feng, Q.-J., & Zhang, W. (2020). Role 
of dietary nutrients in the modulation of gut microbiota: A narrative review. Nutrients, 
12(2), 381.  
Yang, S. J., Choi, J. M., Park, S. E., Rhee, E. J., Lee, W. Y., Oh, K. W., . . . Park, C.-Y. (2015). 
Preventive effects of bitter melon (Momordica charantia) against insulin resistance and 
diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed 
OLETF rats. The Journal of nutritional biochemistry, 26(3), 234-240.  
Yokoyama, Y., Barnard, N. D., Levin, S. M., & Watanabe, M. (2014). Vegetarian diets and 
glycemic control in diabetes: a systematic review and meta-analysis. Cardiovascular 
diagnosis and therapy, 4(5), 373.  
Yokoyama, Y., Nishimura, K., Barnard, N. D., Takegami, M., Watanabe, M., Sekikawa, A., . . . 
Miyamoto, Y. (2014). Vegetarian diets and blood pressure: a meta-analysis. JAMA 
internal medicine, 174(4), 577-587.  
Zeng, M. Y., Inohara, N., & Nuñez, G. (2017). Mechanisms of inflammation-driven bacterial 
dysbiosis in the gut. Mucosal immunology, 10(1), 18-26.  
Zhang, M., Zhou, Q., Dorfman, R. G., Huang, X., Fan, T., Zhang, H., . . . Yu, C. (2016). 
Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in 
rats. BMC gastroenterology, 16(1), 1-9.  
79 
 
Zhang, X., Zhao, Y., Zhang, M., Pang, X., Xu, J., Kang, C., . . . Zhang, Y. (2012). Structural 
changes of gut microbiota during berberine-mediated prevention of obesity and insulin 
resistance in high-fat diet-fed rats. PloS one, 7(8), e42529.  
Zhang, Y.-J., Li, S., Gan, R.-Y., Zhou, T., Xu, D.-P., & Li, H.-B. (2015). Impacts of gut bacteria 
on human health and diseases. International Journal of Molecular Sciences, 16(4), 7493-
7519.  
Zhao, Y., Nakatsu, C., & Jiang, Q. (2019). A Grape Powder Attenuates Colonic Inflammation, 
Inhibits Colitis-associated Colorectal Cancer Development and Causes Favorable 
Changes of Gut Microbiota in Mice (OR04-07-19). Current developments in nutrition, 
3(Supplement_1), nzz030-OR004.  
Zhao, Y., Wu, J., Li, J. V., Zhou, N.-Y., Tang, H., & Wang, Y. (2013). Gut microbiota 
composition modifies fecal metabolic profiles in mice. Journal of proteome research, 
12(6), 2987-2999.  
Zhong, Y., Nyman, M., & Fåk, F. (2015). Modulation of gut microbiota in rats fed high‐fat diets 
by processing whole‐grain barley to barley malt. Molecular nutrition & food research, 
59(10), 2066-2076.  
Zhu, Y., Bai, J., Zhang, Y., Xiao, X., & Dong, Y. (2016). Effects of bitter melon (Momordica 
charantia L.) on the gut microbiota in high fat diet and low dose streptozocin-induced 





CHAPTER 2:  
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Abstract 
Cherries are an excellent source of dietary polyphenols and are marketed as sports and 
health dietary supplements. However, there is still limited direct evidence for their purported 
nutritional and health benefits. Gut microbiota modulation ought to be tested since most 
polyphenols reach the colon where they undergo microbial metabolization to become bioactive 
and bioavailable metabolites. In the present study, varying dilutions of three concentrate cherry 
juices, Montmorency tart cherry juice, Balaton tart cherry juice, and sweet cherry juice, were 
examined to determine their potential effect on the murine gut microbiota composition. Forty-
five mice were randomly assigned to three different groups. Each group received an increased 
concentration of an assigned juice (1/20 v/v, 1/15 v/v, 1/10 v/v, 1/7 v/v, and 1/4 v/v) every five 
days for 25 days. Fecal samples were collected after each administration for microbiota 
characterization by high throughput 16S rRNA gene sequencing using Illumina Miseq. The 
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results revealed consistent gut microbiota modulation based on the concentration regardless of 
the juice type, but not in a true dose-dependent manner. The two median and the two higher 
concentrations were significantly different from each other and from the baseline and lowest 
concentration. Increasing cherry consumption consistently resulted in a significant increase of 
the relative abundance of Barnesiella and Akkermansia, whereas Bacteroides abundance was 
negatively correlated with the concentration of the juice. Overall, we demonstrate that cherries 
induce an overall beneficial modulation of the murine gut microbiota, and that amounts of fruits 
consumed need to be considered to devise appropriate health and nutrition studies. 
Keywords: Tart cherries, Sweet cherries, Gut microbiota, Polyphenols, Dietary supplement. 
2.1 Introduction 
Cherry fruits belong to the genus Prunus from the family Rosaceae. The most common 
types of cherries consumed by humans are Prunus cerasus, designated as sour or tart 
cherries, and Prunus avium, designated as sweet cherries (Kelley, Adkins, & Laugero, 2018; 
Mayta-Apaza, Marasini, & Carbonero, 2017). Cherry production has been steadily increasing 
worldwide in the last few decades (Cásedas, Les, Gómez-Serranillos, Smith, & López, 2016), 
with the average world cherry production 27% higher from 2010 to 2014 than it was from 1995 
to1999 according to data from Food and Agriculture Organization (FAO). Furthermore, data 
from The United States Department of Agriculture (USDA) showed that the average cherry 
production in the United States, the second leading global producers and suppliers of cherries, 
during 2014 to 2016 was nearly double the average production during the 1990s (Perez, Ferreira, 
& Minor, 2017), and in 2019, the US total cherries production was more than one billion pounds 
("Crop Production," 2019). This dramatic growth of cherries production is probably due to the 
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increasing awareness among food industries and consumers about the purported health-
promoting properties of cherries (Blando & Oomah, 2019; Kelley et al., 2018; Mayta-Apaza et 
al., 2017). 
Cherries are nutrient-dense foods and an excellent source of bioactive components 
including phytochemicals, mainly polyphenols, with relatively low caloric and sugar content 
(Kelley et al., 2018; Khoo, Clausen, Pedersen, & Larsen, 2011; McCune, Kubota, Stendell-
Hollis, & Thomson, 2010; Wojdyło, Nowicka, Laskowski, & Oszmiański, 2014). These 
properties give cherries unique organoleptic characteristics and desirable nutritional value 
leading to consumer attractiveness and cash crop status (Bak et al., 2010; P. G. Bell, McHugh, 
Stevenson, & Howatson, 2014; Mayta-Apaza et al., 2017). A growing body of research indicates 
that polyphenols have antioxidant and anti-inflammatory properties and may exhibit a wide 
range of potential health benefits through the regulation of metabolism, chronic disease, weight, 
and cell proliferation (Cory, Passarelli, Szeto, Tamez, & Mattei, 2018; Levers et al., 2016; 
Tomás-Barberán, Selma, & Espín, 2016). Generally, both sweet and tart cherries have higher 
concentrations of total phenolic compounds (Commisso et al., 2017; Ferretti, Bacchetti, 
Belleggia, & Neri, 2010; McCune et al., 2010). In fact, the total phenolic content in tart cherries 
is roughly twice higher than sweet cherry, while sweet cherries contain more anthocyanins (Kim, 
Heo, Kim, Yang, & Lee, 2005; McCune et al., 2010). Cherries are rich in phenolic compounds, 
mainly, anthocyanins, flavonoids (anthocyanins, flavan-3-ols and flavonols) which are the major 
class of polyphenolics in tart cherry, and phenolic acids (hydroxycinnamic acids or 
Hydroxycinnamates) which are the major class of polyphenolics in sweet cherry (Abrankó & 
Szilvássy, 2015; Chaovanalikit & Wrolstad, 2004; Damar & Ekşi, 2012; Gonçalves, Bento, 
Jesus, Alves, & Silva, 2018; Mayta-Apaza et al., 2017; Wojdyło et al., 2014).  Several studies 
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have reported potential health benefits of cherry consumption which includes promoting 
cardiovascular health and reducing the risk of diabetes, obesity, and metabolic syndrome (Blando 
& Oomah, 2019; Chai, Davis, Wright, Kuczmarski, & Zhang, 2018; Csiki et al., 2015; Juhasz et 
al., 2013; Lachin, 2014; Nemes et al., 2019). Furthermore, the use of tart cherry juice has been 
rapidly increasing in sports medicine due to its beneficial impact on improving muscle function 
and reducing muscle soreness, muscle damage, oxidative stress, and inflammation in athletes 
(Gao & Chilibeck, 2020; Vitale, Hueglin, & Broad, 2017) 
Polyphenols, in general, are relatively large molecules with high molecular weights 
(Costa et al., 2017; Peron et al., 2019; Santhakumar, Battino, & Alvarez-Suarez, 2018). As a 
consequence, the absorption of these compounds is relatively low in the upper intestinal tract 
(Espín, González-Sarrías, & Tomás-Barberán, 2017). The vast majority of polyphenols persist 
into the large intestine where they undergo biotransformation by bacterial members of gut 
microbiota, mainly in the colon (Edwards et al., 2017; Ozdal et al., 2016; Peron et al., 2019). The 
complex interplay between gut microbiota and food indigestible nutrients and phytochemicals, 
particularly polyphenols, largely contributes to the host’s overall health (Kalt et al., 2020). There 
is a reciprocal relationship between gut microbiota and polyphenols (Gowd, Karim, Shishir, Xie, 
& Chen, 2019). The gut microbial residence actively drives the metabolism of polyphenols and 
modulates the biological activity of polyphenols by converting them into phenolic metabolites 
(Cardona, Andrés-Lacueva, Tulipani, Tinahones, & Queipo-Ortuño, 2013; Kumar Singh et al., 
2019). On the other hand, polyphenols and their metabolites can impact the intestinal ecosystem 
and modulate gut microbiota composition (Braune, Engst, & Blaut, 2016; Gowd et al., 2019; 
Marín, Miguélez, Villar, & Lombó, 2015; Mayta-Apaza et al., 2018; Nash et al., 2018). 
However, the knowledge on how dietary polyphenols influence the gut microbiota and its 
84 
 
metabolic potential is still scarce with an emphasis on specific berries and grapes (Espín et al., 
2017; Lavefve, Howard, & Carbonero, 2020). In addition to the prevailing focus on specific food 
products or extracts, there is still limited knowledge about the impact of the concentration or 
amounts of polyphenols on the gut microbiota. Often, amounts of food used are selected 
arbitrarily and would be unrealistically high or low concerning a typical human dietary intake. 
Tart cherry juice, for instance, has been used in most research studies, mainly in sports medicine, 
in a wide range of dosage and concentrations, mostly from 1oz of concentrated juice to 12oz of 
non-concentrated juice, with dilution ratio ranges from 1/3 v/v to 1/8 v/v of concentrated juice in 
water, twice a day. (Phillip G. Bell, Stevenson, Davison, & Howatson, 2016; Phillip G. Bell, 
Walshe, Davison, Stevenson, & Howatson, 2014; Phillip G. Bell, Walshe, Davison, Stevenson, 
& Howatson, 2015; Bowtell, Sumners, Dyer, Fox, & Mileva, 2011; Howatson et al., 2012; Kent 
et al., 2017; Lynn et al., 2014; Mayta-Apaza et al., 2018). That range of tart cherry juice dose 
seems efficient in accelerating strength recovery after exercise and decreasing blood markers of 
inflammation and oxidative stress in athletes, but some concentrations may only be realistic for 
consumption as a dietary supplement. In particular, the optimal bioactive dose to modulate the 
gut microbiome with a desired response is most often unclear because of the lack of studies 
including a dose-dependent experimental design. To the best of our knowledge, only two human 
studies have investigated the potential impact of tart cherry juice on modifying the composition 
of gut microbiota (Lear et al., 2019; Mayta-Apaza et al., 2018). Choosing the ideal dosage is 
quite challenging as the phenolic content depends on many factors including product preparation, 
processing, and shelf-life (Vitale et al., 2017). Therefore, the goal of this study was to investigate 




2.2 Materials and Methods 
2.2.1 Animals 
The animal study was conducted at the Animal House Facility of the University of 
Arkansas after receiving approval from the Institutional Animal Care and Use Committee 
(IACUC). Forty-five (45) male mice (Mus musculus strain C57BL/6J) aged ten weeks were 
purchased from The Jackson Laboratory (Bar Harbor, ME, USA). Mice were housed in stainless 
steel cages under standard pathogen-free conditions at a temperature of 22 °C with 50% humidity 
and exposed to a 12 h light/12 h dark cycle. Before the dietary intervention, mice were provided 
with standard Teklad chow pellets (Envigo, Madison, WI) and water ad libitum for one week. 
2.2.2 Treatments 
Commercially available pure cherry juices concentrates were used in this study; (i) 
Montmorency tart cherry juice (MTC) (King Orchards, Central Lake, MI), (ii) Balaton tart 
cherry juice (BTC) (Royal Farms, Inc., Ellsworth, MI), and (iii) sweet cherry juice (SC) 
(Plentiful Planet Brands, Boulder, CO). 
2.2.3 Experiment intervention 
Mice were randomly assigned into three different groups (n = 15 per treatment group), 
and each major group was split into five sub-groups of three. The groups had been assigned 
based on the type of juice they received. In this study, group (1) received (MTC), group (2) 
received (BTC), and group (3) received (SC). The experiment was performed for a duration of 
23 days. Animals had ad libitum access to chow pellets throughout the experiment. Furthermore, 
groups received an increased concentration of their assigned juices added to their drinking water 
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(1/20 v/v, 1/15 v/v, 1/10 v/v, and 1/7 v/v) every five days; except the final intervention where the 
animals received the highest juice concentration (1/4 v/v) for only three days (Figure 2. 1). At 
the end of each period, mice were transferred from stainless steel cages into metabolic cages 
(Tecniplast Cdd, 170013) for 6 hours in order to collect fecal samples at day 0, 5, 10, 15, 20, and 
23, where day 0 samples represented the baseline. Samples were stored at −20 °C until used for 
microbiome analysis. 
2.2.4 DNA extraction 
A cell lysis step was performed initially to ensure full disruption of microbial cells. 
Briefly, 220 mg of fecal content were weighed and transformed to 2 ml tube containing 0.1 g of 
0.1 mm diameter and 0.1 g of 0.5 mm diameter zirconia-silica beads (BioSpec Products, 
Bartlesville, OK, United States), and 1 mL of InhibitEX Buffer (from the QIAamp® Fast DNA 
Stool Mini Kit) was added to the tubes. The tubes were then subjected to a bead-beater for 60 
seconds at maximum speed using a FastPrep®-24 bead-beater (MP Biomedicals, Santa Ana, CA, 
United States) and then heated to 70°C for 5 min in a Thermomixer (Eppendorf, Montesson, 
France). Microbial DNA was then extracted using a commercial QIAamp DNA stool mini kit 
(QIAGEN, Valencia, CA) following the manufacturer’s protocol. 
The NanoDropTM 1000 Spectrophotometer (Thermo Fisher Scientific Inc., Waltham, 
MA, United States) was used to determine the DNA concentration. Extracted DNA was then 
visualized following electrophoresis in a 2% agarose gel and 1X TAE (Tris-acetate 





2.2.5 Universal polymerase chain reaction 
16S ribosomal RNA gene was amplified by PCR (95 °C for 3 min, followed by 35 cycles 
at 98 °C for 30 s, 55 °C for 30 s, and 72 °C for 1 min and a final extension at 72 °C for 5 min) 
using primers (8F 5' - AGAGTTTGATCCTGGCTCAG - 3' and 1541R 5' - 
AAGGAGGTGATCCAGCCGCA  - 3'). PCR reactions were performed in 25 μL mixture 
containing 3 μL of DNA template; 1 μL of each universal primer (8F and 1541R); 12.5 μL of 
GoTaq® Green Master Mix (Promega™ Corporation, Wisconsin, USA); and 7.5 μL of 
Nuclease-Free Water.  Agarose gel electrophoresis was then performed to check the success of 
the amplification by using 1 μL of SYBR Safe DNA Gel Stain (Thermo Fisher Scientific, USA) 
fluorescent dye. 
2.2.6 Libraries Preparation and Sequencing 
Index PCR was performed by targeting the V4 region of the bacterial 16S rRNA gene 
using the dual-index strategy for primer design as previously described (Kozich, Westcott, 
Baxter, Highlander, & Schloss, 2013). Briefly, dual-index PCR was performed in 25 μL reaction 
components with 3 μL of DNA template, 2.5 μL of AccuPrime™ PCR buffer II, 0.5 μL of each 
index primers, 0.1 μL of AccuPrime™ Taq DNA Polymerase (Invitrogen, USA), and 18.4 μL of 
Nuclease-Free Water following the manufacture’s protocol. The PCR consisted of initial 
denaturation at 95 °C for 3 min, followed by 30 cycles of denaturation at 95 °C for 30 sec, 
primer annealing at 55 °C for 30 sec, and an extension at 72 °C for 1 min, with a final extension 
step at 72 °C for 5 min. After successful amplification, the correct size amplicons were subjected 
to purification and normalization by using SequalPrep kits (Invitrogen, USA) following the 
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manufacturer’s protocol. Amplicon concentrations were measured by Agilent bioanalyzer after 
pooling the library. 
For a very accurate concentration, the amplicons library was quantified by qPCR using 
the same primers and PerfeCta NGS library quantification kits (Quanta Biosciences, USA) 
following manufacturer instructions. The library was then denatured and diluted to appropriate 
concentrations and sequenced on an Illumina MiSeq.  
The sequencing reads were downloaded from the Illumina Basespace server in Fastq files 
format. The sequences were demultiplexed in read 1 and read 2 with approximately 250bp in 
length. Operational taxonomic units (OTUs) with 97% of identity were determined and classified 
against the SILVA database as a reference. The Mothur v.1.41.1 pipeline was used for further 
analysis (Schloss et al., 2009). Non-metric multidimensional scaling (NMDS) plots based on the 
Bray-Curtis index were obtained in PAST 3.18 software (Hammer, Harper, & Ryan, 2001). 
2.2.7 Statistical analysis 
Statistical analysis including t-test, ANOVA followed by Tukey post hoc, Mann-Whitney 
U test, and Kruskal-Wallis were performed to detect significant differences between groups (by 
convention, differences were considered significant when 𝑃 < 0.05). Non-Metric 
Multidimensional scaling (NMDS) based on count distance metrics (Bray-Curtis similarity 





2.3 Results and Discussion 
2.3.1 Nutritional analyses 
It was observed that the addition of juice to drinking water resulted in increased 
consumption, but mainly for the median concentration (1/15 and 1/10 v/v; Figure 2. 2 A). This 
would be ascribed to the sweetness of the juices making the water more palatable, as well as a 
source of calories. Notably, at higher concentration, palatability decreased markedly; and it was 
noticed that mice started spitting out the water. Such concentrations are tolerable by human 
consumers when drinking cherry juice as a supplement. We elected to provide juices in drinking 
water to limit the stress on the animals, but these observations showed that there are limits of 
such an approach depending on the food tested, and tart cherries, in particular, being astringent 
with a strong flavor (Clausen, Pedersen, Bertram, & Kidmose, 2011). 
The type of cherry juice consumed significantly affected mice weight trajectories, 
regardless of the concentration in drinking water (Figure 2. 2 B). Specifically, the Balaton and 
sweet cherries juices resulted in significant weight gain, whereas the Montmorency juice resulted 
in stable weight. Montmorency cherries are known to have lower sugar content, which would 
directly explain this observation, also supporting their potential as a low-calorie dietary 
supplement (Blando & Oomah, 2019; Wang et al., 1997). 
2.3.2 Gut microbiota modulation 
Without considering the concentration, Bray-Curtis dissimilarity-based non-metric 
multidimensional scaling (NMDS) revealed no significant clustering of the gut microbiota 
profile  based on juice type (Figure 2. 3 A). This is somewhat unexpected given the difference in 
sugars, carbohydrates, and possibly phytochemicals in the different juices. However, it is clear 
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from our observation that the gut microbiota modulation was almost entirely the same with each 
cherry type. While caution should be used with animal data, this observation suggests that other 
cherries than the Montmorency variety may provide similar benefits, at least from the gut 
microbiota perspective. 
Regardless of juice type, there was significant clustering based on concentration. 
Specifically, the two median concentrations (1/15 and 1/10 v/v) and the two higher (1/7 and 1/4 
v/v) were significantly different from each other and from the baseline and lowest concentration 
(Figure 2. 3 B, C, D). It is interesting to note that this response does not fulfill the definition of a 
true dose-dependent response which had been suggested by previous reports (Li et al., 2015) 
based on comparing low and high doses only. It can thus be postulated that dietary modulation of 
the gut microbiota probably follows a multimodal response to any nutrient/food dose, and that 
the amounts used for nutrition and microbiome research need to be tested and validated. 
Diversity indices were influenced differently by the concentration of the different juices. 
MTC induced a consistent decline in diversity regardless of concentration (Figure 2. 4 A and 
B). BTC resulted in fluctuating diversity, but a significant decline for the two highest 
concentrations (Figure 2. 4 C and D). In stark contrast, SC brought diversity down at the 
median concentrations, especially the 1/10 v/v (Figure 2. 4 E and F). Interestingly, these results 
were inconsistence with another cherry-based study result which showed that obese diabetic 
mice that were fed the dark sweet cherry supplementation had the highest diversity compared to 
obese and lean controls (Garcia-Mazcorro et al., 2018). 
In this experiment, the mice gut microbiota were initially dominated by relatively similar 
relative abundance of Bacteroidetes and Firmicutes, followed by Verrucomicrobia, 
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Proteobacteria, Actinobacteria, and Tenericutes, in line with commonly described murine gut 
microbiota profiles (Hugenholtz & de Vos, 2018; Nagpal et al., 2018; Nguyen, Vieira-Silva, 
Liston, & Raes, 2015). While the different juices exerted various dynamics of the phyla, 
Firmicutes relative abundances were consistently and significantly decreased and replaced by 
Verrucomicrobia with increasing concentration of the juices, while Bacteroidetes stayed 
relatively stable (Figure 2. 5 A and B). The negative correlation between the abundance of 
Firmicutes and Verrucomicrobia was also reported in healthy mice supplemented black raspberry 
as well as in high-fat fed mice consuming Lonicera caerulea L. berry for seven weeks and 45 
days, respectively (Tu et al., 2018; Wu et al., 2018). Blueberry consumption for four weeks also 
significantly decreased Firmicutes population in mice (Wankhade et al., 2019). 
While Bacteroidetes were stable, there were still significant changes among the genera, 
with a decrease in Bacteroides and an increase in Barnesiella (Figure 2. 6 A and B). The 
decrease in Bacteroides is consistent with what we observed in human subjects who had initially 
high Bacteroides levels after tart cherry consumption (Mayta-Apaza et al., 2018). The increase in 
Barnesiella was particularly marked at the highest concentrations (from non-detectable to 5-
10%). This increase by cherry consumption may be one explanation for tart cherry benefits for 
exercise recovery, as Barnesiella has been reported to increase with exercise and being possibly 
beneficial (Fielding et al., 2019; Liu et al., 2017).  
Lactobacillus has been reported, with wide variation, to respond significantly to berries 
and other polyphenol-rich fruit consumption (Han & Xiao, 2020; Lavefve et al., 2020). In this 
study, the increase of Lactobacillus was observed only for specific and different concentrations 
for each different juice (Figure 2. 6 C). While these erratic dynamics are difficult to interpret, 
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they may also be a good illustration of the reason for the large variation in Lactobacillus bloom 
in response to polyphenol-rich fruits. 
The clear and consistent impact of the cherry consumption was a steep increase of 
Akkermansia (Figure 2. 6 D). The increase was specifically marked at higher concentrations, 
with the BTC even inducing the changes at the median concentrations. In agreement with our 
findings, the Akkermansia spp. relative abundance was increased in obese diabetic mice fed dark 
sweet cherry powder compared to obese and lean control groups (Garcia-Mazcorro et al., 2018). 
Akkermansia muciniphila is atype species of the genus typically detected in intestinal samples 
(Derrien, Belzer, & de Vos, 2017; Everard et al., 2013; van Passel et al., 2011). This 
genus/species has been increasingly reported as highly responsive to polyphenol-rich food 
consumption in murine models (Anhê et al., 2015; Tu et al., 2018; Wu et al., 2018; Zhang et al., 
2017). However, such a response has not been commonly described, at least not as remarkable, 
in human subjects, which needs to be accounted when discussing such a bloom. Akkermansia has 
also recently been associated with exercise and exercise recovery (Munukka et al., 2018), and 
this effect of cherry juices is again noteworthy in that light. 
2.4 Conclusion 
We report that cherry juices concentrations in normal drinking water impacted weight 
gain and palatability in mice, which is important to consider for future animal studies. The 
impact of cherry juices on gut microbiota was notably influenced by the variation in the 
concentrations of the juices, but not significantly according to the type of cherry. Increasing 
concentration of juices was positively correlated with some bacterial genera, including 
Akkermansia and Barnesiella, whereas the opposite response was observed for Bacteroides 
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population. These consistent trends can be considered positive, and specifically Akkermansia and 
Barnesiella have recently been suggested to play roles in improved exercise recovery, which 
would make sense knowing that cherries as dietary supplements have been shown to provide 
such benefits. 
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Figure 2. 2: (A) Palatability of cherries juices concentrates as represented by daily water 
consumption. Values are expressed as mean ± standard error (SE) (n = 15). Different letters 
indicate significant difference (𝑃 < 0.05) between concentrations for (MTC) group. (B) The 
impact of cherries juices consumption on weight trajectories for 23 days. Values are expressed as 
mean ± standard error (SE) (n = 15). Different letters indicate significant difference (𝑃 < 0.05) 












Figure 2. 3: Cherries type (A) have less impact on gut microbiota than concentration and 
amounts consumed (B, C, and D). Gut microbiota data are shown on non-metric multidirectional 








Figure 2. 4: The impact of concentration of cherries juices on gut microbiota diversity. (A) 
represents the impact of varying concentration of (MTC) on the number of taxa. (B) represents 
the impact of varying concentration of (MTC) on Shannon_H and Evenness_e^H/S indexes. (C) 
represents the impact of varying concentration of (BTC) on the number of taxa. (D) represents 
the impact of varying concentration of (BTC) on Shannon_H and Evenness_e^H/S indexes. (E) 
represents the impact of varying concentrations of (SC) on the number of taxa. (F) represents the 
impact of varying concentration of (SC) on Shannon_H and Evenness_e^H/S indexes. Values are 
expressed as mean ± standard error (SE) (n = 15). Different letters indicate significant difference 





Figure 2. 5: Impact of varying concentrations of cherries juices on the phylum level.  Increasing 
concentration of cherries juices result in a decrease of Firmicutes (A) and an increase of 
Verrucomicrobia (B), with a slight variation by cherries type. Values are expressed as mean ± 












Figure 2. 6: Impact of varying concentrations of cherries juices on the genus level.  Cherries 
consumption consistently resulted in decreased (A) Bacteroides and increased (B) Barnesiella 
and (D) Akkermansia in healthy mice. Values are expressed as mean ± standard error (SE) (n = 
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Abstract 
Cranberries have long been purported to provide protection against urinary tract 
infections (UTIs). There is a line of evidence suggesting that causal pathogens might be seeded 
from the bacteria reservoirs in the intestinal and vaginal tracts. We tested the hypothesis whether 
cranberry intake would reshape bacteria taxa in the gut, as well as the vaginal ecosystem. A total 
of 25 postmenopausal women were enrolled into a randomized, double-blind, placebo-controlled 
study. Stool samples and vaginal swabs were collected at baseline and after 15 days of 
consumption of placebo or cranberry beverages, microbiota analyses were performed by Illumina 
Miseq sequencing following a double index 16S rRNA gene amplicon. All baseline stool 
samples generally fell in the Bacteroides enterotype. Significant increases of Prevotella (𝑃 = 
0.04), Clostridium XIVa members (𝑃 = 0.04), Eggerthella (𝑃 = 0.03), and Bifidobacterium (𝑃 = 
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0.02) were shown following the cranberry juice intervention; this indicates modulation of the gut 
microbiota by cranberry components. Baseline vaginal microbiotas fell in three distinct patterns, 
Lactobacillus dominant, diversified microbiome, and Streptococcus dysbiosis. Compared with 
the placebo, the cranberry intervention significantly reduced the abundance of pathogenic 
Streptococcus (𝑃 = 0.04) in the dysbiosis group and increased commensal bacteria 
Anaerococcus, Finegoldia, Actinomyces, and Corynebacterium in the diversified microbiome 
and dysbiosis groups. Overall, these data suggest that cranberry consumption may improve 
vaginal microbiota composition in individuals with dysbiosis. Gut-borne taxa stimulation by the 
combination of cranberry oligosaccharides and polyphenols present in the cranberry product 
potentially mediates these beneficial properties. 
Keywords: Cranberries; Urinary Tract Infection, Gut microbiota, Vaginal microbiota; Dysbiosis 
3.1 Introduction 
Urinary tract infections (UTIs) are one of the most common bacterial infections among 
women in general, and postmenopausal women are at in increased risk of recurrent infections 
(Fu, Liska, Talan, & Chung, 2017; Jung & Brubaker, 2019). It is estimated that more than 50% 
of women will have at least one occurrence of a UTI during their life spans and approximately 
20–30% are affected with recurrent infections (Beerepoot & Geerlings, 2016; Fu et al., 2017). 
While UTIs are generally benign, their prevalence poses medical and economic issues resulting 
in millions of visits yearly and an estimated cost of $2.8 billion in medical care expenses in the 
United States (Simmering, Tang, Cavanaugh, Polgreen, & Polgreen, 2017). In addition, the need 
for antibiotic treatment is problematic both for the patient’s natural microbiota stability and for 
the community and environment, since antibiotic-resistance can result from such treatments 
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(Ianiro, Tilg, & Gasbarrini, 2016; Koutzoumis et al., 2020; Morgun et al., 2015; Stapleton, 
2016). 
While pathogenic bacteria, most often Escherichia coli and Streptococcus, are the main 
UTI causative bacteria, it has been proposed that a reduction in the abundance of commensal 
vaginal microbes may also contribute to an increased UTI risk in postmenopausal women (Reid, 
2018; Stapleton, 2016). It is now well understood that the normal vaginal microbiome is 
dominated by Lactobacilli, and the vaginal tract is naturally populated with a relatively dense 
and diverse collection of bacteria (Mendling, 2016; Ravel et al., 2011; White, Creedon, Nelson, 
& Wilson, 2011; Witkin & Linhares, 2017). An imbalance of the vaginal microbiome is not only 
a common cause for bacterial vaginosis (BV) (Stapleton, 2016; White et al., 2011) but may 
directly affect the potential pathogens to colonize the urethra and/or bladder (Czaja et al., 2009; 
Stapleton, 2016). Thus, it would appear that asymptomatic changes in the vaginal microbiome 
may trigger UTI development, either by seeding pathogens or by creating a niche for pathogens 
to thrive (Czaja et al., 2009; Stapleton, 2016). 
The factors shaping the vaginal microbiota composition and stability are still not well 
known (Braundmeier et al., 2015). In this context, we hypothesize that the vaginal microbiome is 
strongly influenced by the gut microbiome. There are different lines of evidence to support this 
hypothesis. First, because of the anatomical proximity, gut microbes in the rectum and distal 
colon can easily come in contact with the vaginal tract, and indeed several vaginal Lactobacillus 
species are also found in the digestive tract (Marchesi, Silva, Wiese, & Nader-Macías, 2020; 
Pan, Hidalgo-Cantabrana, Goh, Sanozky-Dawes, & Barrangou, 2020). Second, it has become 
increasingly evident that metabolites produced by the gut microbiome are highly bioavailable 
and distributed to any organ/region of the human body and these metabolites may influence the 
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vaginal ecosystem as well (Possemiers, Bolca, Verstraete, & Heyerick, 2011). Since the gut 
microbiome is strongly individualized, shaped by external factors, and naturally evolving to 
some extent, this would in part explain why the underlying causes of UTI and BV are often 
challenging to identify. 
It is plausible that the different responses to cranberry intervention might be the 
consequence of inter-individual differences in gut microbiome composition. During the last 
decade, reports of potential positive modulation of the human gut microbiota by berries have 
emerged (Cai et al., 2019; Lavefve, Howard, & Carbonero, 2020; O’Connor et al., 2019; 
Rodríguez-Morató, Matthan, Liu, de la Torre, & Chen, 2018). Polymeric cranberry phenolic 
compounds generally have poor bioavailability. However, when they reach the distal intestine, 
those molecules are broken down and metabolized by microbiota under anaerobic conditions, a 
process known as fermentation. Compared to their parent compounds, these bacteria-derived 
metabolites are highly bioavailable and bioactive. Previous studies showed that γ-valerolactone 
and its sulphate conjugates (Mena et al., 2017) phenylacetic acid, 3,4-dihydroxyphenylacetic 
acid (González de Llano et al., 2015), hippuric and α-hydroxyhippuric acids (González de Llano, 
Liu, Khoo, Moreno-Arribas, & Bartolomé, 2019) have anti-bacteria effects under experimental 
conditions. These findings highlight the critical need to understand how cranberries could affect 
the possible crosstalk between intestinal and other microbiome ecosystems, thereby modulating 
the impact of dietary cranberries on UTI prevention. This project aimed to assessing the 
relationships between the gut microbiome and vaginal microbiome, and how cranberry 
consumption affecting the gut microbiome may also impact the vaginal microbiome. It is 
expected that in the long term, nutritional studies using other dietary elements (such as 
prebiotics) may be designed to optimize and maximize the beneficial effects of cranberries. 
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3.2 Materials and Methods 
3.2.1 Subjects 
Twenty-three (23) women volunteered and participated in this study. The eligibility (no 
menstrual period for at least 12 months) of the participants was determined using a 
questionnaire. The participants were postmenopausal women between the ages of 50-75 years 
old who met the inclusion criteria including no recent antibiotics or immunosuppressive 
therapies; surgery of the stomach, small or large intestines; appendectomy, gastric bypass or 
gastric banding in the previous 6 months, and diagnosis with any autoimmune diseases. 
3.2.2 Study Design and sample collection 
This study was a randomized, placebo-controlled, crossover, dietary intervention. Ocean 
Spray Cranberries, Inc. provided the experimental and placebo beverages, which have been 
validated and used in previous studies (Hsia, Zhang, Beyl, Greenway, & Khoo, 2020; Haiyan 
Liu, Howell, Zhang, & Khoo, 2019; Maki et al., 2016; Zhao, Liu, Su, Khoo, & Gu, 2020). Both 
beverages were similar in appearance, taste, and aroma and assigned to volunteers according to 
computer-generated random orders. Both investigators and participants were blind to the 
assignment and the products. The products were identified by a random 3-digit code pre-printed 
on the cap. The participants consumed either cranberry juice or the placebo beverage daily (8 fl 
oz per day) for 15 days (Table 3. 1). Analytical methods for testing the products were previously 
described (Maki et al., 2016). Biological samples were collected at baseline and after each 
intervention (Figure 3. 1). Subjects were provided with polyester tipped swabs with a 
neutralizing buffer solution using the Environmental Sampling Kit (Puritan Diagnostics, USA) 
for collecting vaginal samples and the Precision™ Stool Collector (Cardinal Health, USA) for 
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collecting stool samples. They were also provided with instructions for self-sampling at each 
sampling event. Vaginal swabs and stool samples were stored at −20 °C until used for 
microbiome analysis. 
3.2.3 DNA extraction 
Microbial DNA was extracted from all samples with the QIAamp DNA stool kit 
(QIAGEN, Valencia, CA) following the manufacturer’s protocol with the addition of cell lysis 
step to rapidly and completely disrupt cells in the samples to release DNA. The cell lysis was 
performed by adding 0.1 g of 0.1 mm diameter and 0.1 g of 0.5 mm diameter zirconia-silica 
beads (BioSpec Products, Bartlesville, OK, United States) to 2 ml tubes. Stool and vaginal 
samples were transferred to the 2 ml tubes containing zirconia-silica beads. One ml of InhibitEX 
Buffer (from the QIAamp® Fast DNA Stool Mini Kit) was then added to the tubes. The tubes 
were subjected to a bead-beater for 60 seconds at maximum speed using a FastPrep®-24 bead-
beater (MP Biomedicals, Santa Ana, CA, United States). 
The NanoDropTM 1000 Spectrophotometer (Thermo Fisher Scientific Inc., Waltham, 
MA, United States) was used to determine the DNA concentration. Extracted DNA was then 
visualized following electrophoresis on a 2% agarose gel in 1X TAE (Tris-acetate 
ethylenediaminetetraacetic acid) buffer (AMRESCO®, Cleveland, OH, United States). 
3.2.4 Universal polymerase chain reaction 
16S ribosomal RNA gene was amplified by PCR (95 °C for 3 min, followed by 35 cycles 
at 98 °C for 30 s, 55 °C for 30 s, and 72 °C for 1 min and a final extension at 72 °C for 5 min) 
using primers (8F 5’ – AGAGTTTGATCCTGGCTCAG – 3’ and 1541R 5’ – 
AAGGAGGTGATCCAGCCGCA  - 3’) (Carbonero, Oakley, & Purdy, 2014). PCR reactions 
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were performed in 25 μL mixture containing 3 μL of DNA template; 1 μL of each universal 
primer (8F and 1541R); 12.5 μL of GoTaq® Green Master Mix (Promega™ Corporation, 
Wisconsin, USA); and 7.5 μL of Nuclease-Free Water. Amplicons were run on agarose gel 
electrophoresis to confirm the success of the PCR by using 1 μL of SYBR safe DNA Gel Stain 
(Thermo Fisher Scientific, USA) fluorescent dye. 
3.2.5 Libraries Preparation and Sequencing 
For 16S rRNA gene sequencing analyses, a dual-indexed amplicon strategy was 
performed using universal primers tagged with Illumina adapters and barcodes as previously 
described (Aljahdali et al., 2017; Kozich, Westcott, Baxter, Highlander, & Schloss, 2013; Mayta-
Apaza et al., 2018). Briefly, PCR was set up in 25 μL reaction components with: 3 μL of the 
DNA template; 2.5 μL of the AccuPrime™ PCR buffer II; 0.5 μL of each index primers; 0.1 μL 
of AccuPrime™ Taq DNA Polymerase (Invitrogen, USA); and 18.4 μL of Nuclease-Free Water 
following the recommended protocol. The PCR consisted of initial denaturation at 95 °C for 3 
min, followed by 30 cycles of denaturation at 95 °C for 30 sec, primer annealing at 55 °C for 30 
sec, and an extension at 72 °C for 1 min, with a final extension step at 72 °C for 5 min. Correct 
size amplicons were subjected to purification and normalization with the Invitrogen SequalPrep 
kits following the manufacturer’s protocol. Amplicons were pooled into two different libraries 
and concentrations were measured by Agilent bioanalyzer and qPCR using the same primers and 
PerfeCta NGS library quantification kits (Quanta Biosciences, USA). Libraries were then 
denatured and diluted to appropriate concentrations and sequenced on an Illumina MiSeq.  
Resulting sequencing files were analyzed using the Mothur software. Operational 
taxonomic units (OUT) were determined and classified against reference databases (Ribosomal 
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Database Projet (RDP), SILVA, GenBank). Basic and multivariate statistical analyses were 
performed in PAST. 
3.2.6 Statistical analyses 
Statistical analyses including Wilcoxon signed-rank test and Mann-Whitney U test 
(depending on the availability of fully paired sample sets) were performed to detect significant 
differences between groups (by convention, differences were considered significant when 𝑃 < 
0.05). Non-metric multidimensional scaling (NMDS) and analysis of similarities (ANOSIM) 
based on count distance metrics (Bray-Curtis similarity index; ANOSIM: 𝑃 < 0.05) were 
obtained with Past4 software (Al Othaim, Marasini, & Carbonero, 2020; Hammer, Harper, & 
Ryan, 2001). 
3.3 Results and Discussion 
The human study was completed with 23 volunteers, and 21of witch provided the full set 
of samples. The volunteers’ demographics are described in Table 3. 2. 
For the baseline samples, 23 stool and 23 vaginal swabs were collected, 22 of each for the 
first period samples, and 21 of each for the second period. Therefore, a total of 66 stool samples 
and 66 vaginal swabs have been collected. However, for several subjects, self-sampling of stool 
resulted in problematic samples for at least one of the three samples. As these samples did not 
yield satisfactory levels of microbial DNA, only eight subjects with the full set of samples were 





3.3.1 Impact of the cranberry juice on the gut microbiota 
Cranberry juice significantly increased the numbers of Bifidobacterium (𝑃 = 0.02) and 
Eggerthella (𝑃 = 0.03), two Actinobacteria members that have been shown previously to be able 
to grow and metabolize dietary polyphenols (Fogliano et al., 2011; Koutsos & Lovegrove, 2015; 
Morais, de Rosso, Estadella, & Pisani, 2016; Queipo-Ortuño et al., 2012). Bifidobacterium are 
also known as probiotics and the increased abundance is considered a sign of improved intestinal 
health (Cuervo et al., 2014; Rajkumar et al., 2014; Singh et al., 2017). Cranberry juice  also 
resulted in a significant increase of Prevotella (𝑃 = 0.04), which is considered a beneficial genus 
associated with polysaccharides and fiber consumption (David et al., 2014; De Filippis et al., 
2016; Wu et al., 2011) (Figure 3. 2). 
The most remarkable trend among the Firmicutes was a significant increase of 
Clostridium XIVa (𝑃 = 0.04) and other known butyrate producers (Eubacterium, Flavonifractor, 
and Subdoligranulum) after the consumption of cranberry juice (El Aidy, Van den Abbeele, Van 
de Wiele, Louis, & Kleerebezem, 2013; Rivière, Selak, Lantin, Leroy, & De Vuyst, 2016; 
Walker, Duncan, Louis, & Flint, 2014) (Figure 3. 2). Butyrate is a short-chain fatty acid shown 
to offer benefits to not only the local intestinal environment, but also contributes to systemic 
metabolism (Hu Liu et al., 2018; O’Keefe, 2016). Akkermansia, a genus that has been associated 
with a number of health properties, was increased with cranberry consumption in animal models 
(Anhê et al., 2017; Rodríguez-Daza et al., 2020) and to some extent in humans (Bekiares, 
Krueger, Meudt, Shanmuganayagam, & Reed, 2018), it showed a slight but non-significant 
increase between cranberry and placebo beverages (Dao et al., 2016; Png et al., 2010) (Figure 3. 
2). It should be noted that all those trends were strongly individualized, and further validation is 
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warranted in more clinical studies with a larger sample size. Overall, cranberry consumption 
appears to stimulate beneficial genera. 
3.3.2 Impact of the cranberry juice on the vaginal microbiota 
The vaginal microbiotas were found to be extremely heterogeneous at baseline, and have 
therefore been stratified into three groups based on the most abundant genera and their known 
relation to vaginal health (Figure 3. 3): 
Group 1 comprises individuals whose baseline vaginal microbiotas were strongly 
dominated by Lactobacillus, which is considered the ideal healthy state (Ravel et al., 2011). 
Group 2 comprises individuals whose baseline vaginal microbiotas were characterized by diverse 
and relatively well distributed high number of different taxa, without obvious dominant 
detrimental genus. Group 3 comprises individuals whose baseline vaginal microbiotas were 
characterized by high abundance of Streptococcus, which is strongly indicative of microbial 
dysbiosis that could potentially lead to vaginosis or UTI (Leclercq et al., 2016; Tan, Ulett, Steele, 
Benjamin, & Ulett, 2012; Ulett et al., 2009). Individuals were roughly equally distributed among 
the 3 groups which allowed statistical analyses for each group. 
3.3.2.1 Lactobacillus dominant vaginal microbiota 
Consumption of both products appeared to have little impact on the vaginal microbiota of 
volunteers that have Lactobacillus as the major bacterial taxa (Figure 3. 4). 
3.3.2.2 Diverse baseline vaginal microbiota 
As expected with the criterion used to segregate the groups, the vaginal microbiota of 
these subjects was significantly more diverse (Figure 3. 5). The number of taxa was significantly 
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decreased after the consumption of cranberry juice, and even more with the placebo. However, 
the decrease of the Shannon index was only significant in the placebo group. It can be 
hypothesized that loss of diversity not associated with Lactobacillus dominance may be 
detrimental to some extent; but the loss of the diversity does not appear to be different between 
the interventions and thus, it is likely not associated with cranberry components. 
Several significant changes were observed in the bacteria abundance at genus level 
(Figure 3. 6). Compared with baseline, consumption of cranberry juice allowed for the 
maintenance of several moderately abundant Firmicutes (Lactobacillus, Anaerococcus, 
Finegoldia, and Peptoniphilus) and Actinobacteria (Actinomyces, Varibaculum, Actinomycetales, 
and Corynebacterium). In contrast, aforementioned bacteria were significantly reduced following 
placebo beverage consumption. Different responses between the cranberry and placebo beverage 
from baseline were statistically significant. The status of these genera is somewhat controversial, 
but they would be considered as mostly harmless to vaginal health (Boskey, 2001; Ma, Forney, 
& Ravel, 2012). The placebo beverage led to an unexplainable increase of Prevotella, which was 
different from the response following cranberry beverage intake. Prevotella in the gut microbiota 
are associated with plant-based diets with a possible role in digestion of complex carbohydrates 
and production of short-chain fatty acids (Geva-Zatorsky et al., 2017; Precup & Vodnar, 2019; 
Zhu, Sunagawa, Mende, & Bork, 2015). However, the function of Prevotella in the vaginal tract 
is less clear. Some lines of evidence suggested that high levels of SCFAs might promote 
dysbiosis and inflammation in the vaginal tract (Aldunate et al., 2015; Amabebe & Anumba, 
2020). To conclude, cranberry juice appears to maintain the diversity of vaginal microbiota 
which is a presumably healthier profile for these volunteers. 
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3.3.2.3 Streptococcus dysbiosis 
Several women (n =7) were found to have a strong dysbiosis of their vaginal microbiota, 
characterized by a high initial abundance 22% to 81% of Streptococcus, a well-known causative 
agent of vaginosis and UTI (Jass & Reid, 2009; Leclercq et al., 2016; Tan et al., 2012; Ulett et 
al., 2009). 
As suggested by the diversity trends, cranberry juice had a very strong and specific 
impact on the dysbiosed vaginal microbiota (Figure 3. 7). Most notably, although both 
beverages reduced the abundance of Streptococcus compared to baseline, the consumption of 
cranberry juice significantly reduced the relative abundance of Streptococcus to a greater extent, 
compared to the placebo beverage. Intriguingly, it appeared that Streptococcus has been replaced 
with a range of different Firmicutes (Anaerococcus and Finegoldia) and Actinobacteria 
(Actinobaculum, Actinomyces, Varibaculum, and Corynebacterium; Figure 3. 8). Streptococcus, 
both group A and B, colonization has been associated with an increased risk of vaginitis, 
bacterial vaginosis, through the female life span (Clark & Atendido, 2005; Verstraelen, Verhelst, 
Vaneechoutte, & Temmerman, 2011). The presence of this genus also significantly increased 
chances of vertical transmission to neonates during pregnancy (Puopolo, Lynfield, Cummings, & 
Committee On Infectious, 2019). The exact mechanism of the reduction of the abundance of 
Streptococcus by cranberries is unknown. However, Feliciano and colleagues showed that 
cranberry proanthocyanidins (PAC) reduced extra-intestinal pathogenic E. coli agglutination and 
inhibited the invasion of enterocytes (Feliciano, Meudt, Shanmuganayagam, Krueger, & Reed, 
2014). Cranberry-derived PACs might impair virulence and quorum sensing of Pseudomonas 
aeruginosa, according to another study (Maisuria, Lopez-de Los Santos, Tufenkji, & Déziel, 
2016). In the research performed by O’May and Tufenkji, cranberry PAC and other tannin-
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containing materials blocked swarming motility of P. aeruginosa, possibly via inhibition of the 
flagellin gene expression (O’May & Tufenkji, 2011). It can be hypothesized that cranberries and 
metabolites generated and absorbed in the gut affected Streptococcus through multiple 
mechanisms, inhibition of bacteria growth or viability, disruption of cytoskeleton structure, and 
etc. These hypotheses will warrant future experiments to explore. 
3.4 Conclusion 
These findings suggest a beneficial impact of cranberry juice on vaginal microbiota with 
dysbiosis, and possibly its contribution to vaginal health. It can be speculated that Streptococcus 
dysbiosis could be improved directly within the local niche environment by increasing 
competition of other commensal bacteria or indirectly by decreasing the bacteria migration from 
the gut reservoir, and thereby restoring a healthier vaginal microbiota. Due to that possible 
relationship, the beneficial impact of cranberry juice on the gut microbiota is also encouraging 
for vaginal health. As reported previously, the ageing gut microbiota tends to be less diverse and 
responsive to dietary changes. Herein, a relatively short-term consumption and daily 
consumption of cranberry juice shows promising prebiotic effect and may help maintain levels of 
a wide range of beneficial genera (Prevotella, Bifidobacterium, and butyrate-producing 
Firmicutes). 
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Table 3. 1: The analytical data for the cranberry and placebo beverages. ND indicates non-
detectable 






























Table 3. 2: Volunteers demographics. 
Age (years) 61±7 (min=51; max=74) 
BMI 28.5±7.8 (min=18; max=46) 
Height (inches) 64.2±2.3 (min=60.2; max=72.2) 
Weight (lbs) 170.5±49.7 (min=112; max=278) 
 
 




Figure 3. 2: Impact of cranberry juice and placebo on the relative abundance of genera from 
Actinobacteria, Bacteroidetes, Verrucomicrobia, and Firmicutes. Values are expressed as mean ± 
standard error (SE) (n = 8). Different letters indicate significant difference (𝑃 < 0.05), whereas 





Figure 3. 3: Non-metric Multidimensional Scaling (Bray-Curtis index) sowing the three 
different clusters of baseline vaginal microbiota. 
 
 
Figure 3. 4: Diversity indices and changes in relative abundances in volunteers with 
Lactobacillus-dominated vaginal microbiota. Values are expressed as mean ± standard error (SE) 






Figure 3. 5: Diversity indices changes in subjects with diverse vaginal microbiota at baseline. 
Values are expressed as mean ± standard error (SE) (n = 6). Different letters indicate significant 




Figure 3. 6: Impact of cranberry juice and the placebo on the relative abundance of the major 
genera in subjects with diverse vaginal microbiota at baseline. Values are expressed as mean ± 
standard error (SE) (n = 6). Different letters indicate significant difference (𝑃 < 0.05), whereas 




Figure 3. 7: Diversity indices changes in subjects with Streptococcus dysbiosis. Values are 
expressed as mean ± standard error (SE) (n = 7). Different letters indicate significant difference 
(𝑃 < 0.05), whereas N.S. indicates no significant difference. 
 
 
Figure 3. 8: Impact of cranberry juice and the placebo on the relative abundance of the major 
genera in subjects with Streptococcus dysbiosis at baseline. Values are expressed as mean ± 
standard error (SE) (n = 7). Different letters indicate significant difference (𝑃 < 0.05), whereas 
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CHAPTER 4:  
Botanical Diversity and Amount of Dietary Fruits and Vegetables Distinctly Affect the 
Human Gut Microbiome 
Abstract 
While increasing fruit and vegetable (FV) intake is a near-universal recommendation for 
improved health outcomes, information on dietary FV the impact amount and diversity on health 
biomarkers is scarce. FV are a major dietary source of accessible gut microbiota carbohydrates 
and phytochemicals, however, most studies have focused on single food items or their extracted 
components, with few holistic studies available. Here, two separate randomized dietary 
interventions were used to assess the impact of low vs. adequate FV intake and low vs. high 
botanical diversity on gut microbiota profiles in healthy adults. We hypothesized that increasing 
FV would result in beneficial modulations to gut microbiota with further increases to benefit 
those consuming FV from diverse botanical families. The SMART-Diet study was a pilot, 
randomized, cross-over dietary intervention where male volunteers were randomized to start 
diets of low FV or adequate FV over 9 days. Stool samples were obtained at day 0, 3, 6 and 9 for 
each treatment period. In the SMART-Valid study, 21 individuals were provided a low FV lead-
in diet for 4 days and then randomly assigned to a high FV diet with either low (11 families) or 
high botanical diversity (24 families) for an additional 4 days. Stool was collected at baseline and 
after each diet intervention. Gut microbiota was analyzed using 16S rRNA sequencing 
performed on an Illumina MiSeq. The Mothur pipeline was used for preliminary data analysis, 
followed by statistical analyses in PAST. In the SMART-Diet study, the low FV treatment 
resulted in minimal microbiota alterations, while a significant increase in Bacteroidetes and 
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decrease in Firmicutes (which peaked at day 6) was observed in the adequate FV treatment 
group. Intriguingly, the low group experienced a short-term increase in Bifidobacterium and 
Lactobacillus, and both treatments incurred significant increases in Bacteroides and 
Akkermansia and a decline of Faecalibacterium. In the SMART-Valid study, the transition from 
low to high FV resulted in similar trends as the SMART-Diet study. However, the high botanical 
treatment resulted in a more diverse gut microbiota, characterized by increased relative 
abundances of beneficial Firmicutes (Lachnospiraceae, Faecalibacterium, and Clostridium 
XIVa). Our results suggest that both the amounts of FV consumed and botanical diversity 
modulate the gut microbiota. Determining better FV combinations from a gut microbiota 
perspective, thus, appears as a possible task for future research. 
Keywords: Fruits, Vegetables, Gut microbiota, Fibers, Polyphenols. 
4.1 Introduction 
A balanced diet is a substantial factor in promoting human health and limiting chronic 
disease risks (Cena & Calder, 2020; Fischer, Pallazola, Xun, Cainzos-Achirica, & Michos, 2020; 
Slavin & Lloyd, 2012; World Health, 2019). Fruits and vegetables (FV) are fundamental 
components of a healthy diet and have been the keystone foods of dietary recommendations for 
decades (Dietary Guidelines Advisory, 2015; Lampe, 1999; Phe, 2016; Trichopoulou et al., 
2003; Vanderlee, McCrory, & Hammond, 2015; Wallace et al., 2019; World Health, 2019). The 
U.S. Departments of Health and Human Services (DHHS) and Agriculture (USDA) 
recommended that half of a meal consists of FV (Dietary Guidelines Advisory, 2015). Generally, 
FV contain a diverse collection of nutrients and biologically active components that provide 
potential health benefits, including dietary fibers, phytochemicals, and vitamins (Sharoba, 
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Farrag, & Abd El-Salam, 2013; Slavin & Lloyd, 2012; Yahia, García-Solís, & Celis, 2019). 
Epidemiologic studies have overwhelmingly confirmed the role of FV in the reduction of 
systemic inflammation and the prevention of various chronic diseases and metabolic disorders 
such as obesity, diabetes, high blood pressure, cardiovascular diseases, and cancers (Bertoia et 
al., 2015; Farvid et al., 2016; Farvid et al., 2019; Gehlich et al., 2020; Gluba-Brzózka, Franczyk, 
& Rysz, 2017; Jurikova et al., 2017; Lee & Park, 2017; Muraki et al., 2013; Mursu, Virtanen, 
Tuomainen, Nurmi, & Voutilainen, 2014; Tome-Carneiro & Visioli, 2016; Wang et al., 2014; 
Yokoyama et al., 2014). 
FV are an excellent source of dietary fibers, which are primarily credited with imparting 
the health benefits associated with adequate consumption (Korcz, Kerényi, & Varga, 2018). 
Many types of dietary fibers support gastrointestinal and digestive health by modulation of the 
gut microbiota. The gut microbiota has recently emerged as an important regulator of human 
health, and fermentable fibers serve as a critical energy source for colonic microorganisms, 
which subsequently result in the production of bioactive metabolites, such as short chain fatty 
acids (SCFAs) (Flint, Duncan, & Louis, 2017; Holscher, 2017; Makki, Deehan, Walter, & 
Bäckhed, 2018). A series of meta-analyses and systematic reviews recently summarized in the 
Lancet concluded that dietary fiber intake is inversely associated with the risk of developing non-
communicable diseases (Reynolds et al., 2019); and the strong dose-responsiveness of risk 
reduction suggests a causal link between fiber and disease protection. Furthermore, fiber rich FV 
are also high in other bioactive compounds, such as phytochemicals, which may be partially 




Phytochemicals are a chemically diverse array of secondary metabolites produced by 
plants. In nature, they play a role in the plant’s growth and defense against competitors, 
pathogens, predators, or environmental factors (Bartwal, Mall, Lohani, Guru, & Arora, 2013; 
Rasmann & Agrawal, 2009). Phytochemicals are organized according to their chemical structure; 
therefore, phytochemicals in the same group typically have similar mechanisms of action in the 
human body (Produce for Better Health, 2015). They exert various physiologic effects in 
humans, including acting as anti-inflammatory and anti-oxidant agents (Hussain et al., 2016; Li 
et al., 2014; Williamson, 2017; H. Zhang & Tsao, 2016). Major categories of health-promoting 
phytochemicals include phenolic compounds, terpenoids, alkaloids, and other nitrogen-
containing compounds and sulphur-containing compounds. While some of these compounds, 
such as polyphenols, are widely distributed among FV (Abbas et al., 2017; Abuajah, Ogbonna, & 
Osuji, 2015; Edwards et al., 2017; Williamson, 2017), others classes, such as alkaloids and 
glucosinolates, are much more restricted in occurrence. Like dietary fiber, phytochemicals can 
positively alter the gut microbiota composition both through provision of conjugated sugars that 
can be used as an energy source as well as through anti-microbial activity that can selectively 
inhibit some microorganisms and reduce competition within mixed microbial populations. These 
effects on the microbiota, along with direct anti-inflammatory and anti-oxidant activity within 
the intestines, can promote homeostasis within the gastrointestinal tract (Cardona, Andrés-
Lacueva, Tulipani, Tinahones, & Queipo-Ortuño, 2013; Kumar Singh et al., 2019; Lavefve, 
Howard, & Carbonero, 2020; Ozdal et al., 2016). Furthermore, the metabolism of these 
compounds within the gut may also increase their bioavailability and bioactivity, suggesting that 
inter-individual variability in microbial composition and capacity to metabolize phytochemicals 
can influence their response to exposure to these compounds. 
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Despite near-universal recommendations regarding the intake of FV to improve health 
outcomes, the average vegetable intake was found to be below the recommendations of 240 
g/day in approximately 88% of the countries (Kalmpourtzidou, Eilander, & Talsma, 2020). In the 
U.S., only one in 10 adults report adequate intake of FV (Lee-Kwan, Moore, Blanck, Harris, & 
Galuska, 2017). Not only are Americans falling short in their FV consumption, but the variety 
and botanical diversity of commonly consumed FV is also low. The most consumed whole fruits 
by Americans include bananas, apples, and berries, while the most consumed vegetables include 
white potatoes, lettuce, onions, and tomatoes (Produce for Better Health, 2015). Among, these 
most popular vegetables are provided similar phytochemicals. Therefore, not only is FV intake 
generally inadequate, but the lack of phytochemical diversity in consumed foods may be limiting 
potential health benefits, both in gut health and in overall disease prevention. Here, we aim to 
identify the impact of adequate versus inadequate FV intake on the gut microbiota as well as 
identify whether botanical diversity can promote microbial diversity in the gut. In this study, two 
separate randomized short-term dietary interventions were used to assess the impact of low vs. 
adequate FV intake, according to the USDA recommendations (Dietary Guidelines Advisory, 
2015), and low vs. high botanical diversity on gut microbiome profiles in healthy adults. We 
hypothesized that increasing FV in meals would result in beneficial modulations to the gut 
microbiota such as increased diversity and increased relative abundance of beneficial genera, 





4.2 Materials and Methods 
4.2.1 Subjects 
4.2.1.1 SMART-Diet study 
This study was a pilot, randomized, cross-over dietary intervention and was conducted to 
investigate the impact of low vs. adequate FV intake on the gut microbiota ecosystem. Eleven 
(11) males between 18-35 years of age at Colorado State University participated in this study; 
however, only a full set of samples from six (6) participants were used for gut microbiota 
analysis, and that is what is used for the sequence data.  Recruitment was conducted by word of 
mouth, email, and flyers. Inclusion and exclusion criteria are detailed in Table 4. 1. Study 
protocol was approved by the Colorado State University Institutional Review Board (CSU IRB), 
Protocol #13-4278H and all participants consented in writing before participating in the study.  
4.2.1.2 SMART-Valid study 
This study was a pilot, parallel-arm dietary intervention which was conducted to assess 
the impact of low vs. high botanical diversity on gut microbiome profiles. This study was 
completed by twenty-one (21) healthy volunteers, nine (9) males and twelve (12) females 
between 18-65 years old with BMI’s between 20-29.9. Eligibility was determined using a 
questionnaire. Inclusion and exclusion criteria are outlined in Table 4. 1. All participants 






4.2.2 Study Design and sample collection 
4.2.2.1 SMART-Diet study 
Participants were randomized into adequate (five cups of FV daily) and low (two cups of 
FV daily) starting treatments at the beginning of the study. Starting diet treatments spanned nine 
days followed by a twelve-day wash-out period and a second nine-day treatment intervention 
(Figure 4. 1). Biological samples (blood and stool) and anthropometric measures were recorded 
during clinical visits. All samples were stored at -80C prior to processing. Dietary intake 
information was collected using three-day food logs, which included two weekdays and one 
weekend day. Diet data was collected prior to the start of both diet treatments (baseline) and 
during each treatment period (compliance). FV were provided, but remaining foods were self-
selected by participants. Participants were given menu suggestions, developed by registered 
dieticians at Colorado State University’s Kendall Reagan Nutrition Center (KRNC), for the 
remainder of their intake. A sample menu for each treatment is provided in Appendix 1.  
Participants were asked to consume all of the provided foods and the remainder of their diet was 
ad libitum. All provided FV were prepared in kitchen facilities located in the KRNC. Participants 
were provided with new portions of FV every three days during their clinical visits. To measure 
compliance, diet interviews were conducted at each clinical visit and food containers and any 
uneaten food portions (including peels, pits, and skins) were returned.   
4.2.2.2 SMART-Valid study 
Participants were assigned to the two intervention groups based upon schedule 
availability. Those who were available during the earlier intervention schedule followed the low 
botanical diversity protocol and those who requested the later intervention schedule followed the 
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high botanical diversity protocol. Baseline diet was assessed using two 24-hour recalls using the 
ASA24 tool (https://epi.grants.cancer.gov/asa24/) the week before the start of the intervention 
period. Prior to starting the diet intervention, participants collected baseline stool samples, and 
returned them to the clinic the following day. Participants were instructed to store all stool 
samples in the refrigerator until they were delivered to the lab. Baseline anthropometric measures 
were collected as well as a fasting blood sample.  
After completing the clinic visit, all participants consumed a pre-specified lead-in low FV 
diet for a period of four days. Following this, participants provided a second stool sample on the 
morning of day five. They then began one of two treatment groups: high FV intake with low 
biodiversity, or high FV intake with high biodiversity. They followed their intervention diets for 
four days. On day nine of the intervention, participants provided a third stool sample (Figure 4. 
2). All samples were stored at -80C prior to processing. 
The treatment meals were specified by a pre-designed menu and provided varying 
amounts of FV depending on the respective treatment groups (Appendix 2, 3). The low FV diets 
were comprised of two to three cups of FV per day coming from six different botanical families. 
Both of the high FV diets contained five to nine cups of FV daily, with the high biodiversity diet 
containing foods from 24 different botanical families and the low diversity diet containing foods 
from 11 different botanical families. All foods were provided through CSU’s Housing and 
Dining Services. Compliance with prescribed menus was determined through pre- and post-meal 





4.2.3 DNA extraction 
Bacterial DNA extraction from stool samples was conducted using commercial QIAamp 
DNA stool mini kits (QIAGEN, Valencia, CA) following the manufacturer’s protocol with the 
addition of a cell lysis step to rapidly and completely disrupt cells in the samples to release DNA. 
The cell lysis was performed by adding 0.1 g of 0.1 mm diameter and 0.1 g of 0.5 mm diameter 
zirconia-silica beads (BioSpec Products, Bartlesville, OK, United States) to 2 ml tubes. 
Subsequently, Stool content was transferred to the 2 ml tubes containing zirconia-silica beads, 
and 1 ml of InhibitEX Buffer (from the QIAamp® Fast DNA Stool Mini Kit) was added to the 
tubes. The tubes were then subjected to a bead-beater for 60 seconds at maximum speed using a 
FastPrep®-24 bead-beater (MP Biomedicals, Santa Ana, CA, United States). 
The NanoDropTM 1000 Spectrophotometer (Thermo Fisher Scientific Inc., Waltham, 
MA, United States) was used to determine the DNA concentration. Extracted DNA was then 
visualized following electrophoresis in a 2% agarose gel and 1X TAE (Tris-acetate 
ethylenediaminetetraacetic acid) buffer (AMRESCO®, Cleveland, OH, United States). 
4.2.4 Universal polymerase chain reaction 
16S ribosomal RNA gene was amplified by the polymerase chain reaction (PCR) (95 °C 
for 3 min, followed by 35 cycles at 98 °C for 30 s, 55 °C for 30 s, and 72 °C for 1 min and a final 
extension at 72 °C for 5 min) using primers (8F 5' - AGAGTTTGATCCTGGCTCAG - 3' and 
1541R 5' - AAGGAGGTGATCCAGCCGCA  - 3'). PCR reactions were performed in 25 μL 
mixture containing 3 μL of DNA template; 1 μL of each universal primer (8F and 1541R); 12.5 
μL of GoTaq® Green Master Mix (Promega™ Corporation, Wisconsin, USA); and 7.5 μL of 
Nuclease-Free Water. Agarose gel electrophoresis was then accomplished to confirm the success 
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of the PCR by using 1 μL of SYBR Safe DNA Gel Stain (Thermo Fisher Scientific, USA) 
fluorescent dye. 
4.2.5 Amplicon Library Preparation and Sequencing 
For 16S rRNA gene sequencing (ITag) analyses, universal primers tagged with Illumina 
adapters and barcodes were used for PCR from the DNA extracts (Kozich, Westcott, Baxter, 
Highlander, & Schloss, 2013). Briefly, the PCR dual-indexed strategy was performed in 25 μL 
reaction components with 3 μL of the DNA template; 2.5 μL of the AccuPrime™ PCR buffer II; 
0.5 μL of each index primers; 0.1 μL of AccuPrime™ Taq DNA Polymerase (Invitrogen, USA); 
and 18.4 μL of Nuclease-Free Water following the manufacture's protocol. The PCR consisted of 
initial denaturation at 95 °C for 3 min, followed by 30 cycles of denaturation at 95 °C for 30 sec, 
primer annealing at 55 °C for 30 sec, and an extension at 72 °C for 1 min, with a final extension 
step at 72 °C for 5 min. Correct size amplicons were subjected to purification and normalization 
using Invitrogen SequalPrep kits following the manufacturer’s protocol. Amplicons 
concentrations were measured by Agilent bioanalyzer after pooling as two different libraries. 
For accurate concentration, amplicon libraries were quantified by qPCR using the same 
primers and PerfeCta NGS library quantification kits (Quanta Biosciences, USA) following 
manufacturer instructions. Libraries were then denatured and diluted to appropriate 
concentrations and sequenced on an Illumina MiSeq.  
Resulting sequencing files were analyzed using the Mothur v.1.41.1 pipeline (Schloss et 
al., 2009). Operational taxonomic units (OTU) were determined and classified against reference 
databases (Ribosomal Database Project (RDP), SILVA,)). Basic and multivariate statistical 
144 
 
analyses were performed in PAST (Al Othaim, Marasini, & Carbonero, 2020; Hammer, Harper, 
& Ryan, 2001). 
4.2.6 Short-chain fatty acids analyses 
Frozen stool samples from the SMART-Valid study were extracted for SCFAs by mixing 
0.75 g of frozen feces with acidified water (pH 2.5) and sonicating for 10 min. as described 
previously (Sheflin et al., 2015; Weir et al., 2013). Briefly, samples were analyzed on a 6890 
series Gas Chromatograph with a flame ionization detector (GC_FID; Agilent). Samples were 
injected at a 10:1 split ratio; the inlet was held at 22°C and the transfer line was held at 230°C. 
Separation of SCFAs was achieved on a 30m TG-WAX-A column (0.25-mm ID, 0.25-μm film 
thickness; Thermo Scientific) by using a temperature program of 100°C for 1 min, increased by 
8°C/min to 180°C, held at 180°C for 1 min, increased by 200°C at 20°C/min, and held at 200°C 
for 5 min. Helium carrier flow was held at 1.2 mL/min. Commercial standards of acetic acid, 
propionic acid and butyric acid, (Sigma, St. Louis, MO, USA) were used to confirm compound 
identities. 
4.2.7 Statistical analysis 
Statistical analyses including Wilcoxon signed-rank test and Mann-Whitney U test 
(depending on the availability of fully paired sample sets) were performed to detect significant 
differences between groups (by convention, differences were considered significant when 𝑃 < 
0.05). Non-Metric Multidimensional scaling (NMDS) based on count distance metrics (Bray-
Curtis similarity index; ANOSIM: 𝑃 < 0.05) were considered to be significant similarities 




4.3 Results and Discussion 
4.3.1 SMART-Diet study: Longitudinal assessment of the impact of low and adequate FV 
intake 
Using NMDS visualization of Bray-Curtis distances, short-term changes to FV intake did 
not significantly impact the general gut microbiota profiles (Figure 4. 3). These results are in 
line with other studies which revealed no significant impact from a vegetarian diet on the 
microbial community composition in healthy and obese individuals (Kim, Hwang, Park, & Bae, 
2013; Losasso et al., 2018). Likewise, a study showed that short-term dietary changes could alter 
the gut in as little as 24 hours, but that the diet high in animal products had a much greater 
immediate impact on the microbiota than the plant-based diet (David et al., 2014). It is clear 
from the NMDS that the individuality of each subject had a stronger impact than the diet 
assignment; specifically, half of the subjects were responders to the diet change, while the other 
half were not responders (Figure 4. 4). This observation is also logical considering the numerous 
reports of metabotypes with differing response to dietary phytochemicals (Cortés-Martín et al., 
2020; Mayta-Apaza et al., 2018) as well as differential responses to fiber and other plant-derived 
oligosaccharides (Davis, Martínez, Walter, Goin, & Hutkins, 2011; G. D. Wu et al., 2011). 
Both diet interventions significantly increased the gut microbiota diversity (Shannon 
index), but the increase was gradual with the low FV diet (Figure 4. 5). Improving the gut 
microbiota diversity is generally considered a healthy outcome, whereas dysbiosis, loss of gut 
microbiota, was associated with many diseases and metabolic disorders (Kriss, Hazleton, 
Nusbacher, Martin, & Lozupone, 2018). A study reported that the fiber intake increased the gut 
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microbiota diversity and richness in overweight pregnant women (Röytiö, Mokkala, Vahlberg, & 
Laitinen, 2017). 
When comparing phyla-level changes across the different FV intake periods, both 
treatments showed similar trends. The low FV diet had more heterogeneity, probably because of 
responder/non-responder effects. Generally, both diets showed reductions in the 
Firmicutes/Bacteroidetes ratio, although the maximum change from baseline occurred on 
different days (peak at day 6 for adequate; peaks at day 3 and 9 for low). During the low FV diet, 
the Firmicutes relative abundance was significantly decreased from baseline to day 9, although 
the Bacteroidetes were not significantly changed. In comparison, from baseline to day 9 on the 
adequate FV diet, there was a decrease in Firmicutes which became apparent by day 6, and an 
increase in Bacteroidetes, which appeared by day 3 of the diet intervention (Figure 4. 6). 
Alteration of the Firmicutes/Bacteroidetes ratio, associated with adequate FV intake, may 
indicate a beneficial change to the gut microbiota. Many animal and human studies have 
demonstrated that the Firmicutes/Bacteroidetes ratio is increased in the microbiota of obese 
individuals compared to lean individuals, making it a potential indicator/biomarker for obesity 
(Barlow, Yu, & Mathur, 2015; Kim et al., 2013; Koliada et al., 2017; Xu, Li, Zhang, & Zhang, 
2012; Zou et al., 2020). However, other studies have not observed this correlation with obesity 
(Hu et al., 2015; Magne et al., 2020; Tims et al., 2013; Walters, Xu, & Knight, 2014). A recent 
review suggests that differences in sample processing, participant demographics, and lack of 
control in other variables that influence the microbiota may account for some of these 
discrepancies in the literature, but that it is currently difficult to interpret the 
Firmicutes/Bacteroidetes ratio in light of human health and obesity status (Magne et al., 2020). 
147 
 
Genus-level microbial dynamics were mostly mirrored in both diet interventions. Among 
Bacteroidetes, the Bacteroides, Prevotella, Alistipes, and Parabacteroides genera were increased 
by both diet interventions compared to baseline, whereas Faecalibacterium, Blautia, Dorea, and 
Lachnospiraceae_unclarified, which belong to Firmicutes phyla, were decreased (Figure 4. 7, 4. 
8). Both adequate and low FV diets induced the relative abundance of butyrate producing 
bacteria Oscillibacter, Clostridium_IV, and Clostridium_XIVa (Gophna, Konikoff, & Nielsen, 
2017; Moens & De Vuyst, 2017). A significant increase in Akkermansia relative abundance with 
a slight decrease in Bifidobacterium relative abundance was observed after the adequate FV diet 
(Figure 4. 9, 4. 10). The gut commensal Akkermansia muciniphila is a potential probiotic 
bacterium that is associated with systemic effects on host metabolism and immune response 
(Ansaldo et al., 2019; T. Zhang, Li, Cheng, Buch, & Zhang, 2019). It promises to be a 
therapeutic target in microbiota‐related diseases, such as colitis, metabolic syndrome, immune 
diseases and cancer (T. Zhang et al., 2019). 
4.3.2 SMART-Valid: Impact of botanical diversity of a high FV diet 
In line with SMART-Diet study, we observed that the strong gut microbiota individuality 
prevented the detection of significantly different clusters by NMDS and ANOSIM (Figure 4. 
11). 
Both diets increased taxonomic diversity, but only significantly in the case of the high 
botanical diversity (Figure 4. 12). It can be hypothesized that this is a reflection of the diversity 
of glycans and phytochemicals leading to the stimulation of rare taxa with very specific 
metabolic abilities. The gut microbiota diversity (Shannon index) increased slightly after both 
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botanical diversity diets but was more marked with high botanical diversity (Figure 4. 12). This 
observation was not significant possibly because of the short dietary intervention period. 
Regardless of botanical diversity, similar trends were observed at the phylum level. The 
Firmicutes/Bacteroidetes ratio was induced by increasing the relative abundance of Firmicutes 
and decreasing the relative abundance of Bacteroidetes. The Proteobacteria level was reduced in 
both intervention but was only significant in the low botanical diversity diet. It is commonly 
considered that higher abundance of Proteobacteria is a microbial signature of disease (Rizzatti, 
Lopetuso, Gibiino, Binda, & Gasbarrini, 2017). Similar response of Actinobacteria was observed 
in both groups. The low FV diet increased the abundance of Actinobacteria; however, the trends 
dropped with the high FV diet (Figure 4. 13). 
Surprisingly, the low botanical diversity diet led to a decrease of the relative abundance 
of Prevotella and Butyricimonas, whereas the relative abundance of Alistipes was increased 
(Figure 4. 14). It has been reported that Butyricimonas, a butyrate producing bacteria, plays a 
potential role in maintaining the gut function and enhancing the intestinal barrier integrity 
(Tomsett et al., 2020; E. Wu, Jingzhu, Lingpeng, & Yaqin, 2020). The reduction of the 
abundance of Butyricimonas was found to be linked with the incidence of irritable bowel 
syndrome (IBS) (E. Wu et al., 2020; Yang et al., 2017). It has been fund that the higher-fiber diet 
increased the relative abundance of Butyricimonas and Prevotella (de Moraes et al., 2017; 
Tomsett et al., 2020). 
The low botanical diversity diet, however, led to a significant increase in the relative 
abundance of the butyrate producers Faecalibacterium and Lachnospiraceae_unclarified as well 
as a suggestive increase in the Clostridium_XIVa level. The results also showed a significant 
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decrease in the relative abundance of some other genera belonging to Firmicutes phyla including 
Blautia, Ruminococcus, Dorea, and Clostridium_XI with a suggestive decrease in the 
Clostridium_IV abundance. Similar trends were observed for the high botanical diversity diet but 
they were not significant (Figure 4. 15). Regardless of the botanical diversity, high amounts of 
FV interestingly limited the increase of commensal bacteria Bifidobacterium and Akkermansia 
(Figure 4. 16). The possible explanation is that these genera were outcompeted with higher 
abundance of other bacteria in the presence of higher amounts of FV in the diets. The low 
botanical diversity diet significantly decreased the relative abundance of the family 
Enterobacteriaceae (Figure 4. 16). The decrease of Enterobacteriaceae abundance was not 
significant with the high botanical diversity diet, but the abundance was very low in the baseline. 
Enterobacteriaceae family includes opportunistic pathogens that are known to cause morbidity 
and mortality among humans (Sassone-Corsi et al., 2016). It was reported that the relative 
abundance of Enterobacteriaceae was significantly low in vegan individuals (Zimmer et al., 
2012). 
A general limitation of DNA-based microbiota analysis is that any trends observed do not 
necessarily reflect the fermentation metabolic rates (Fricker, Podlesny, & Fricke, 2019; Wurm et 
al., 2018). To better assess them, we measured the SCFAs in stool samples from subjects of this 
study (Figure 4. 17). Remarkably, while only slight microbiota changes were observed, SCFAs 
levels were strikingly different between the low and high botanical diversity group. SCFAs 
intriguingly trended slightly down in response to low botanical diversity. The high botanical 
diversity resulted in significantly higher SCFA levels. It can be hypothesized that effective 
fermentative metabolism improvements require a higher botanical diversity in concert with a 
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higher amount of dietary FV. The composition of diet has rarely been the focus in such studies, 
and our data demonstrate it should be. 
On the other hand, acetate, propionate and particularly butyrate were each significantly 
increased by the high botanical diversity diet. This outcome clearly indicates that botanical 
diversity is likely to be beneficial in stimulating the gut microbiota and the fermentative 
metabolism. All SCFAs have been associated with beneficial health properties (Chambers, 
Preston, Frost, & Morrison, 2018; De Filippis et al., 2016; Gill, Van Zelm, Muir, & Gibson, 
2018). Models derived from different animal models can explain this observation, with cross-
feeding and intra-genus diversity potentially at play (Ríos-Covián et al., 2016; Solden et al., 
2018). 
4.4 Conclusion 
General trends were similar in terms of diversity indices which indicate the potential 
impact of FV consumption in enhancing the gut microbiota ecosystem for the participants 
regardless of the amount. Intriguingly, at phylum level, changes were almost opposite between 
the two studies as the SMART-Diet study showed a reduction of the Firmicutes/Bacteroidetes 
ratio whereas the SMART-Valid study resulted in an increase in the Firmicutes/Bacteroidetes 
ratio. This might be due to differences in the type and the amount of meals provided to the 




Table 4. 1: Inclusion/Exclusion criteria for the SMART-Diet and SMART-Valid Studies. 
 SMART-Diet SMART-Valid 
Inclusion Criteria  Male 
 18-40 years old  
 BMI between 20-29.9 
 Non-smoker 
 18-65 years old  
 BMI between 20-29.9 
 Non-smoker 
Exclusion Criteria  Female 
 Outside of the age and BMI 
requirements 
 Smokers 
 Dietary restrictions and/or 
food allergies 
 Metabolic or intestinal 
disease diagnosis 
 Use of antibiotics, probiotics, 
dietary supplements and/or 
prescription drugs in 
previous 2 months 
 Inability to abstain from 
recreational drugs and limit 
alcohol to 1 beverage/day. 
 Outside of the age and BMI 
requirements 
 Smokers 
 Strong food aversions 
 Dietary restrictions and/or 
food allergies 
 Metabolic or intestinal 
disease diagnosis 
 Use of antibiotics, 
probiotics, dietary 
supplements and/or 
prescription drugs in 
previous 2 months 
 Inability to abstain from 
recreational drugs and limit 













Figure 4. 3: Impact on general microbiota profiles of the low and adequate FV treatment 
interventions at day 3, 6, and 9 compared to subjects’ baseline. Gut microbiota data are shown on 





Figure 4. 4: Impact on individuals’ gut microbiota profiles (NMDS) of the low and high FV 
botanical biodiversity diet interventions. Gut microbiota data are shown on non-metric 





Figure 4. 5: Impact on diversity indices (Number of taxa, Shannon index) of the low and 
adequate FV treatment interventions at day 3, 6, and 9 compared to subjects’ baseline. Values are 
expressed as mean ± standard error (SE). Different letters indicate significant difference 


















Figure 4. 6: Impact of low FV and adequate FV diets at the phylum level for each time point. 
Values are expressed as mean ± standard error (SE). Different letters indicate significant 








Figure 4. 7: Impact of low FV and adequate FV diets on the composition of genera that belong 
to the Bacteroidetes phyla. Values are expressed as mean ± standard error (SE). Different letters 







Figure 4. 8: Impact of low FV and adequate FV diets on the composition of genera that belong 
to the Firmicutes phyla. Values are expressed as mean ± standard error (SE). Different letters 





Figure 4. 9: Impact of low FV and adequate FV diets on the composition of genera that belong 
to the Firmicutes phyla. Values are expressed as mean ± standard error (SE). Different letters 












Figure 4. 10: Impact of low FV and adequate FV diets on the composition of Bifidobacterium, 
Akkermansia, and Enterobacteriaceae. Values are expressed as mean ± standard error (SE). 





Figure 4. 11: Impact on general microbiota profiles (NMDS) of the low and high FV botanical 
biodiversity diet interventions. Gut microbiota data are shown on non-metric multidirectional 




Figure 4. 12: Impact on diversity indices (Number of taxa, Shannon index) of the low and high 
FV botanical diversity diet interventions. Values are expressed as mean ± standard error (SE). 












Figure 4. 13: Impact of the low and high FV botanical diversity consumption at the phylum 
level. Values are expressed as mean ± standard error (SE). Different letters indicate significant 





Figure 4. 14: Impact of the low and high FV botanical diversity consumption of the genera 
belong to the Bacteroidetes phyla. Values are expressed as mean ± standard error (SE). Different 





Figure 4. 15: Impact of the low and high FV botanical diversity consumption of the genera 
belong to the Firmicutes phyla. Values are expressed as mean ± standard error (SE). Different 












Figure 4. 16: Impact of the low and high FV botanical diversity consumption of 
Bifidobacterium, Akkermansia, and Enterobacteriaceae Unclassified. Values are expressed as 
mean ± standard error (SE). Different letters indicate significant difference (p < 0.05), whereas 




Figure 4. 17: Impact of low and high FV botanical diversity consumption on SCFAs levels. 
Values are expressed as mean ± standard error (SE). Different letters indicate significant 
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The relation between gut microbiota and human health has been increasingly recognized 
in the last few decades. Gut microbiota plays critical roles in the overall health of the host by, for 
instance, contributing to metabolism, maintaining homoeostasis, providing energy, and educating 
the immune system. Fruits and vegetables are rich in dietary fibers and polyphenols which aid in 
the modifying and reshaping of the gut microbiota ecosystem. Most of the microbiological and 
nutritional studies have traditionally focused on investigating the impact of extracted compounds 
on gut microbiota profiles instead of whole foods. Therefore, this work brings attention to the 
possible impact of whole foods — including cherry juices, cranberries juice, and the amounts 
and botanical diversity of fruit and vegetable diets — on the gut microbiota composition. 
The impact of cherry juices in gut microbiota in mice was notably influenced by the 
variation in the juices concentrations. Increasing cherry juices concentration was positively 
correlated with some considerably beneficial bacteria, including Akkermansia and Barnesiella, 
whereas the opposite response was observed for the Bacteroides population. 
Cranberry juice consumption impacted the gut and vaginal microbiota in postmenopausal 
women. Cranberry juice intake resulted in an increase of the relative abundance of 
Bifidobacterium, a well-known probiotic bacterium. The clear beneficial impact of cranberry 
juice was the improvement of dysbiosed vaginal microbiota by reducing the relative abundance 
of Streptococcus. 
Fruit and vegetable consumption enhanced the gut microbiota ecosystem for the 
participants regardless of the amount. Intriguingly, the effects of fruit and vegetable consumption 
at the phylum level were almost opposite between the two studies, the SMART-Diet and 
SMART-Valid. The SMART-Diet study showed a reduction of the Firmicutes/Bacteroidetes 
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ratio whereas the SMART-Valid study resulted in an increase in the Firmicutes/Bacteroidetes 
ratio.  Remarkably, a higher botanical diversity of fruits and vegetables was clearly associated 
with higher short-chain fatty acids levels, suggesting that this botanical diversity may be needed 






Appendix 1: SMART-Diet Sample Menu. 
HIGH 
Day Food Item Serving Day Food Item Serving 
1 Pre-Washed Salad Mix 1 Cup 1 Grapes 1/2 Cup 
  Frozen Corn-Off Cob 1 Cup   Banana 1 Cup 
  Baby Carrots 1 Cup   Blueberries  1/2 Cup 




  Tomato Cucumber Salad 1/2 Cup   Strawberries 1/2 Cup 
  Chicken Vegetable Stir Fry 1 1/2 Cups   Pineapple 
Chunks 
1/2 Cup 
3 Broccoli Floret & Cucumber Mix 1 Cup 3 Orange 1 Cup 
  Asparagus Spears 1 Cup   Red Apple 1 Cup 
  Marinara Sauce (No Meat) 1 Cup    
LOW 
Day Food Item Serving Day Food Item Serving 
1 Pre-Washed Salad Mix 1 Cup 1 Green Apple 1 Cup 
2 Pre-Washed Salad Mix 1 Cup 2 Banana 1 Cup 
3 Pre-Washed Salad Mix 1 Cup 3 Orange 1 Cup 
 
Appendix 2: Low Diversity Cohort Menus. 
Low Diversity Cohort Menu: 
Lead-in: 6 Total Botanical families: Rutaceae (orange), Roasaceae (apple), Solanaceae 
(peppers, potato, tomato), Asteraceae (lettuce), Poaceae (corn), Alliaceae (onion). 
High FV:  11 Total Botanical families: Rutaceae (orange), Roasaceae (apple, peaches, pears, 
berries), Solanaceae (peppers, potato, tomato), Asteraceae (lettuce), Poaceae (corn), Alliaceae 
(onion), Muscaceae (banana), Brassicaceae (broccoli, cauliflower), Fabaceae/Leguminosae 
(beans, soybeans, chickpeas), Cucurbitaceae (cucumber, watermelon, squash), 
Apiaceae/Umbelliferae (carrots, celery). 
Condition Day Meal Menu 
Lead in 1 Breakfast 1/4 plate (1/2 cup) scrambled eggs, wheat bagel with 
tablespoon plain cream cheese or butter, 1/4 plate (1/2 
cup) breakfast potatoes, 8 oz glass of skim milk 
  Lunch Deli turkey/ham sandwich (3oz meat) on wheat bread 
(1 slice cheese, mustard or light mayo, lettuce, 
tomato), apple  with 2 tablespoons peanut butter 
 
Dinner  ½ plate (2 cups) penne pasta with 1/2 cup red meat 
sauce with 2 tablespoons of parmesan cheese, 1 
breadstick 
Snack/Dessert Cup of ice cream 
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Appendix 2 (Cont.) 
Condition Day Meal Menu 
 2 Breakfast 1/2 plate Scrambled eggs with cheese, 2 slices of 
wheat toast lightly buttered, 8oz glass of orange juice 
  Lunch 2 slices of pepperoni pizza, small side salad (romaine 
lettuce or iceberg lettuce) with tablespoon of dressing, 
cup of corn chowder soup (1 ½ ladle fulls) 
Dinner  1 piece garlic grilled salmon, ¼ plate (1/2 cup) potato 
au gratin dinner roll 
Snack/Dessert Cookie (any kind but oatmeal raisin) with 8oz glass of 
skim milk 
3 Breakfast cup of oatmeal (approximately 1 ½ ladle fulls) with ~1 
oz milk, 2 tablespoons brown sugar or honey, 2 turkey 
sausage 
Lunch 3 beef tacos w/ salsa, ½ cup tortilla chips, 2 
tablespoons nacho cheese 
Dinner  2 plum glazed chicken thighs, baked potato  w/ 
tablespoon chz and tablespoon sour cream, side salad 
(romaine or iceberg lettuce) with dressing, 8oz glass 
of skim milk 
Snack/Dessert apple with 2 tablespoons peanut butter 
4 Breakfast 2 pancakes/french toast tablespoon butter and syrup, 
8oz glass of milk, 2 turkey sausage 
Lunch Hamburger (no cheese), ¼ (1/2 cup) plate fries with 2 
tablespoons of ketchup, orange, ½ cup flavored yogurt 
  Dinner  3 slices of cheese pizza, 1/2C bell peppers or side 
salad (romaine or iceberg lettuce) with tablespoon 
ranch, apple 
Snack/Dessert None 
High FV 1 Breakfast ¼ plate (1/2 cup) scrambled eggs with cheese, 2 pieces 
of wheat toast lightly butter, banana 
Lunch Chicken burrito- (1 whole wheat tortilla, ask for extra 
grilled veggies, shredded cheese, lettuce, salsa), 1/4 
plate (1/2cup) of beans, ¼ plate (1/2 cup) rice 
Dinner  (2 pieces or “boats)” Zucchini stuffed with tomato, 
and faro, dinner roll, 1 cup of berries (no blueberries) 
or melon, 8oz glass of skim milk 











Appendix 2 (Cont.) 
Condition Day Meal Menu 
 2 Breakfast ¼ plate scrambled eggs with cheese, ¼ plate breakfast 
potatoes, 2 veggie sausage, 2 slices of toast lightly 
buttered or with peanut butter, 1 cup of melon, 
Lunch 2 black bean tamales with 2 tablespoons salsa, 1 cup 
(1 ½ ladle fulls) butternut squash bisque, side salad, 
(no spinach) with dressing, cookie (any kind but 
oatmeal raisin) 
  Dinner  carved roast sirloin (3oz) with tablespoon creamy 
horseradish, ½ plate (1 cup) steamed fresh vegetables, 
dinner roll, apple, 8oz glass skim milk 
Snack/Dessert ½ cup or 1 Cup n celery/ carrots/ broccoli/ bell 
peppers 
3 Breakfast ¼ plate scrambled eggs with salsa, 2 pieces of toast 
lightly buttered, orange  
Lunch ~ ¼ plate (1 cup) whole wheat pasta with (1/4  cup) 
red meat sauce, and tablespoon of parmesan cheese,  
½ plate (1 cup) steamed broccoli, breadstick, ½ cup 
yogurt with ¼ cup berries, (no blueberries) 
Dinner  tandoori chicken, ¼ plate (½ cup) basmati rice, ¼ 
plate (1/2 cup) roasted cauliflower, 8oz glass of milk, 
side salad, (no spinach) with dressing 
Snack/Dessert banana,  with tablespoon peanut butter 
4 Breakfast 1 cup plain Greek yogurt, ½ cup peaches or berries 
(no blueberries),   1/2 cup granola, 2 veggie sausages 
Lunch Falafel,  gyro sandwich with tzatiki, ¼ plate (½ cup) 
quinoa tabbouleh, 1 cup cucumbers,  with tablespoon 
hummus 
Dinner  Cobb Salad, 1 piece of cornbread with tablespoon 
butter, 8oz glass of chocolate milk, 1 cup watermelon 
Snack/Dessert ½ cup carrots /bell peppers /broccoli /celery 
 
Appendix 3: High Diversity Cohort Menus. 
High Diversity Cohort Menu: 
Lead-in: 6 Total Botanical families: Rutaceae (orange), Roasaceae (apple), Solanaceae 
(peppers, potato, tomato), Asteraceae (lettuce), Poaceae (corn), Alliaceae (onion). 
High FV: 24 Total Botanical Families: Rutaceae (orange), Roasaceae 
(apple/berries/peach/pear), Solanaceae (peppers, potato, tomato), Asteraceae (lettuce), Poaceae 
(corn), Alliaceae (onion), Muscaceae (banana), Brassicaceae (broccoli, cauliflower), 
Fabaceae/Leguminosae (beans, peas, soybeans), Cucurbitaceae (cucumber, melon, squash), 
Apiaceae/Umbelliferae (carrots, celery), Chenopodiaceae (spinach), Actinidaceae (kiwi), 
Ericaceae (blueberry, cranberry), Convolvulaceae (sweet potatoes), Vitaceae (grape), 
Anacardiaceae (mango), Arecaceae (date, coconut), Bromeliaceae (pineapple), Caricaceae 
(papaya), Asparaaaceae (asparagus), Dioscoreaceae (yam), Agaricaceae (mushrooms), 
Grossulariaceae (black currant). 
183 
 
Condition Day Meal Menu 
Lead in 1 Breakfast 1/4 plate (1/2 cup) scrambled eggs, wheat bagel with 
tablespoon low fat plain cream cheese or butter, 1/4 
plate (1/2 cup) jalapeno cheddar potato rounds, 8 oz 
glass of skim milk 
Lunch Deli turkey/ham sandwich (3oz meat) on wheat bread 
(1 slice cheese, mustard or light mayo, lettuce, 
tomato), apple, with 2 tablespoons peanut butter, ¼ 
plate (1/2 cup) steamed corn 
Dinner  ½ plate (2 cups) penne pasta with 1/2 cup meat sauce, 
and 2 tablespoons of parmesan cheese, 1 breadstick 
Snack/Dessert Cup of ice cream 
 2 Breakfast 1/2 plate (1 cup) Scrambled eggs with cheese, 2 slices 
of wheat toast lightly buttered, 8oz glass of orange 
juice  
Lunch 2 slices of pepperoni pizza, small side salad, (romaine 
or iceberg lettuce) with tablespoon of dressing (no 
raspberry vinaigrette), 2 focaccia sticks, ½ cup 
(roughly size of tennis ball) greek yogurt drizzled with 
honey 
Dinner  Tempura chicken with 2 tablespoons honey mustard, ¼ 
plate (1/2 cup) mashed potatoes , dinner roll 
Snack/Dessert Cookie (any kind but oatmeal raisin) with 8oz glass of 
skim milk 
3 Breakfast cup of oatmeal (approximately 1.5 ladle fulls) with ~1 
oz milk, 2 tablespoons brown sugar, 1 turkey sausage 
patty 
Lunch 3 tacos w/ red salsa or pico de galo,  ½ cup (roughly 
size of tennis ball) tortilla chips, 2 tablespoons nacho 
cheese 
Dinner  Spicy marinated cod, baked potato, with tablespoon 
cheese and tablespoon sour cream, side salad,  
(romaine or iceberg lettuce) with dressing (not 
raspberry vinaigrette), 8oz glass of skim milk 
  Snack/Dessert Apple with 2tbsp peanut butter 
4 Breakfast 2 cinnamon vanilla pancakes with butter and syrup, 
8oz glass of skim milk, 1/4 cup scrambled eggs or hard 
boiled egg 
Lunch Hamburger (no cheese), ¼ plate fries (1/2 cup)   with 2 
tablespoons of ketchup, orange 
Dinner  2 slices of cheese pizza, ½ cup bell peppers or side 
salad (romaine or iceberg lettuce), with tablespoon 
ranch, apple 





Appendix 3 (Cont.) 
Condition Day Meal Menu 
High FV 1 Breakfast ¼ plate (1/2 cup) plate scrambled eggs with cheese, 
~15 grapes,  2 veggie sausage, oatmeal yam muffin 
Lunch Vegetarian burrito bowl: cilantro lime rice, black 
beans, 2 tablespoons shredded cheese, extra peppers 
and onions, lettuce, salsa, w/ tropical smoothie (made 
with 1C frozen papaya & mango, 4oz OJ, 1/4C plain 
greek yogurt)  
 
  Dinner  Chicken Florentine, ½ plate (1 cup) roasted potatoes 
and vegetables (sweet potatoes), spinach side salad 
(include sliced mushrooms), with dressing 
Snack/Dessert 1/2C carrots/celery and ½ cup dried figs, 8oz glass of 
skim milk 
2 Breakfast 1 cup (1 ½ ladle full) oatmeal with 1oz milk, ¼ cup 
dried black currants, and 2 tablespoons brown sugar, ½ 
cup pineapple  
Lunch Chipotle lime tilapia with ¼ cup chipotle pineapple 
salsa, ¼ plate (½ cup) Jamaican peas and rice, ¼ plate 
(½  cup) asparagus 
Dinner  Meatloaf, ¼ plate (1/2 cup) mashed potatoes, ½ plate, 
(1 cup) sautéed spinach w/ garbanzo beans, 8oz lowfat 
chocolate milk 
Snack/Dessert ½ cup of mushrooms and banana with 1- 2 tablespoons 
peanut butter 
3 Breakfast ¼ plate scrambled eggs, bagel with tablespoon cream 
cheese, 1 cup melon 
  Lunch Salmon with ¼ cup tropical fruit salsa, ¼ plate (½ cup) 
aztec blend or rice pilaf, ½ plate (1 cup) steamed fresh 
vegetables 
Dinner  Plate of salad,  (include raisins, cheese, and nuts of 
some sort) cup of vegetable soup of the day,  (1 ½ 
ladles full), 1 piece of cornbread, 8 oz glass of skim 
milk 












Appendix 3 (Cont.) 
Condition Day Meal Menu 
 4 Breakfast Banana walnut pancakes topped w/ whipped cream, ½ 
cup peaches/pears/apple/strawberries, 8oz glass of 
milk 
Lunch 2 fish or chicken tacos with ~ 3 tablespoons mango 
salsa, ½ cup black beans 
Dinner  ¼ plate (1 cup) pasta with marinara sauce,  and 2 
tablespoons parmesan, ½ plate (1 cup)  roasted 
cauliflower,  side salad (romaine lettuce, sliced 
mushrooms, craisins,  any other veg) with tablespoon 
dressing 
Snack/Dessert 1 cup greek yogurt with 1 cup blueberries and sweet 
potato chips 
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